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Abstract 
Background: Bacterial meningitis is a life threatening condition associated with high 
morbidity and mortality. The prognosis of the disease depends on early diagnosis and 
management. In low resource countries the major drawback is prompt diagnosis due to 
poor laboratory quality.   
Aims: To study the performance of urine reagent strip in a low resource setting and 
compare it with standard local results and clinical outcome. To create a clinical 
algorithms for bed side diagnosis using reagent strip. 
Methods: A prospective study among children with suspicion of bacterial meningitis, 
conducted for 15 months. Bacterial meningitis for analysis purpose was based on 
confirmed and probable cases based on modified WHO criteria for diagnosis of 
meningitis based on local available laboratory test. 
Results: Among 180 cerebrospinal fluid (CSF) specimen evaluated, 125 were normal 
and 43(25.5%) were considered as having pleocytosis. The overall performance of urine 
leucocyte strip for the diagnosis of bacterial meningitis was better with a sensitivity of 
75%, specificity of 85.14% a NPV of 94.0% and PPV of 52.1% in comparison to CSF 
wbc count with 56.7%, specificity of 85.14%, NPV of 89.6% and PPV of 39.53% 
respectively, The Protein portion of urine strip also performed better than the pandy test 
with sensitivity of 78.1%, specificity of 70.2%, PPV of 36.2% and NPV of 93.6% in 
comparison to 43.3%, 93.8%, 61.9% and 87.7% respectively. 
Conclusions: Urine reagent strip is a useful test for evaluation of CSF and may aid in 
bedside diagnosis of meningitis. They can further aid decision making of whether or not 
to initiate antimicrobial therapy in low resource settings. 
 
 
 
 
3 
 
 
TABLE OF CONTENTS 
 
 
List of figures ......................................................................................................5 
List of tables ........................................................................................................6 
List of abbreviations ...........................................................................................8 
Aknowledgment...................................................................................................9 
 
1.General Introduction ........................................................................................11 
1.1 History of bacterial meningitis .........................................................................11 
1.2 Definition .........................................................................................................13 
1.3 Epidemiology ...................................................................................................13 
1.4 Etiology ...........................................................................................................14 
1.5 Risk factors .....................................................................................................22 
1.6 Pathophysiology of bacterial meningitis ..........................................................24 
   1.6.1 Transmission and carriage state ...............................................................24 
   1.6.2 Survival in blood stream ............................................................................26 
   1.6.3 Bacterial invasion ......................................................................................26 
   1.6.4 Inflammatory responses ............................................................................28 
   1.6.5 Cerebral edema .........................................................................................29 
1.7 Clinical picture .................................................................................................31 
1.8 Diagnosis and Management approach to bacterial meningitis ........................33 
1.9 Laboratory diagnosis of bacterial meningitis ...................................................37 
   1.9.1 CSF: formation and composition ...............................................................37 
   1.9.2 CSF alterations in bacterial meningitis   ....................................................40 
   1.9.3 Gram stain .................................................................................................44 
   1.9.4 Culture .......................................................................................................44 
   1.9.5 Latex agglutination ....................................................................................46 
   1.9.6 PCR ...........................................................................................................46 
1.10 Empirical treatment in bacterial meningitis  ...................................................48 
1.11 Complications   ..............................................................................................51 
1.12 Prognosis ......................................................................................................55 
2. Rationale of the thesis  ......................................................................................56 
2.1 Objective of the thesis .....................................................................................58 
2.2 Research questions .........................................................................................58 
3. Material and Methods ........................................................................................59 
3.1 Study design, location ,study population and recruitment   .............................59 
3.2 Use of reagent strip .........................................................................................58 
   3.2.1 Storage and handling of strips ...................................................................62 
   3.2.2 Factor affecting the reagents strip results .................................................63 
   3.2.3 Reagent test strip general information  ......................................................63 
   3.2.4 CSF evaluation using reagent strip ...........................................................67 
3.3 Patient evaluation and data recording .............................................................68 
3.4 Examination of cerebro spinal fluid ..................................................................70 
 
 
4 
 
   3.4.1 Physical examination of cerebro Spinal Fluid ............................................70 
   3.4.2 CSF cell count and pandy test...................................................................71 
   3.4.3 CSF gram Stain .........................................................................................74 
   3.4.4.CSF culture ...............................................................................................76 
3.5 Case definition of bacterial meningitis according WHO ...................................83 
   3.5.1 Case classification of bacterial meningitis according to WHO criteria .......83 
   3.5.2 Case classification of bacterial meningitis using modified Who  
            criteria .......................................................................................................84 
3.6 Ethical consideration .......................................................................................85 
3.7 Statistical analysis  ..........................................................................................86 
4. Results .............................................................................................................88 
4.1 Baseline characterization of the study population  ..........................................88 
4.2 General characteristics and demographics of children with bacterial  
meningitis ..............................................................................................................95  
4.3 Cerebrospinal fluid analysis ............................................................................96 
4.4 CSF analysis using urine reagent strip  ...........................................................99 
4.5 Cerebro spinal fluid gram stain results ............................................................112 
4.6 Cerebrospinal fluid culture results  ..................................................................113 
4.7 Other laboratory tests for evaluation of CSF ...................................................113 
4.8 Laboratory parameters and imaging among children with BM  .......................115 
4.9 Treatment of bacterial meningitis in Central Hospital of Beira  ........................116 
4.10 Logistic regression analysis ..........................................................................117 
4.11 Cerebral malaria and meningoencephalitis ...................................................123 
5. Discussion .......................................................................................................126 
6. Conclusion and limitation ..............................................................................136 
7. Appendices ......................................................................................................146 
 
 
5 
 
LIST OF FIGURES 
 
Figure 1.1 Worldwide distribution of N.meningitidis serogroups responsible 
for meningococcal meningitis ................................................................................16 
Figure 1.2 Trend of case fatality rate among the three 
main pathogens responsible for bacterial meningitis over the past 90 years ........20 
Figure 1.3 Summary of pathophysiology cascade in bacterial meningitis .............30 
Figure 1.4 Algorithm for managemnt of patient suspected with community 
acquired bacterial meningitis .................................................................................36 
Fig. 3.1 Picture of urine dip strip used in the study, Siemens ................................62 
Fig. 4.1 ROC curve for urine strip leucocyte for the diagnosis of BM ....................103 
Fig 4.2 Pairwise comparison of two ROC for measurement of leucocytes in  
diagnosis of bacterial meningitis ...........................................................................105 
Fig. 4.3 ROC   demonstrating overall performance of the urine strip to detect  
protein in pandy test ..............................................................................................107 
Fig. 4.4 Comparison of the two ROC for measurement of protein in diagnosis 
of BM.. ...................................................................................................................110 
Fig 4.5 Box plot demonstrating the difference between the 2 groups (Cerebral  
malaria and meningoencephalit) ...........................................................................124 
Fig. 4.6 Box plot demonstrating the difference between the 2 groups in CSF 
wbc (Bacterial meningitis and meningoencephalitis) .............................................125 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 
 
LIST OF TABLES 
 
Table 1.1 Etiology of bacterial meningitis according to different age groups ........15 
Table 1.2 Cytokines variation in meningitis  ..........................................................29 
Table 1.3 Frequency of signs and symptoms observed in bacterial meningitis ....33 
Table 1.4 Normal reference ranges of cerebro spinal fluid according to different   
age groups ............................................................................................................40 
Table 1.5 Cerebrospinal fluid findings in central nervous system disorders in 
Children .................................................................................................................43 
Table 1.6 Diagnostic methods for Identification of microorganism in bacterial ......48 
meningitis ..............................................................................................................48 
Table 1.7 Empirical antimicrobial therapy for bacterial meningitis based on  
different age groups ..............................................................................................49 
Table 1.8 Classification of different complications in bacterial meningitis .............52 
Table 1.9 Frequencies of most common complications in bacterial meningitis  
in children ..............................................................................................................53 
Table 3.1 Cerebrospinal fluid supernatant colors and associated conditions........71 
Table 3.2 Summary of characteristics of colonies observed in culture  and  
identification of microorganisms ............................................................................80 
Table 4.1 General characteristics of the study population ....................................88 
Table 4.2 General baseline characteristic of laboratory parameters   
of the study population ..........................................................................................90 
Table 4.3 General baseline characteristics on discharge information of the  
study population ....................................................................................................91 
Table 4.4 Accuracy of CSF cell count in detection of bacterial meningitis  
 based on culture results above 10 cell/ul  ............................................................97 
Table 4.5 Accuracy of CSF cell count in detection of bacterial meningitis  
at > 100cell/ul  .......................................................................................................98 
Table 4.6 Accuracy of pandy test in the detection of bacterial meningitis .............99 
Table 4.7 Capacity of the reagent strip to accurately detect leucocyte alteration  
in the CSFs at the cutoff point of above 10 cells/ul ...............................................100 
Table 4.8 Capacity of the reagent strip to accurately detect leucocyte alteration  
in the CSF at the cutoff point of above 100 cells/ul ...............................................100 
Table 4.9 Pearson chi square test for CSF wbc vs urine reagent strip at  
“trace” as cut off point ............................................................................................101 
Table 4.10 Pearson chi square test for CSF wbc vs urine reagent strip at  
“2 cross” as cut off point ........................................................................................101 
Table 4.11 Results of urine reagent strip leucocytes among children with  
and without bacterial meningitis ............................................................................102 
Table 4.12 Accuracy of the reagent strip to detect cellular alteration in bacterial  
meningitis at different cut off points “trace” and “2 cross”. .....................................102 
Table 4.13 Comparison of leucocyte measures of urine strip and csf count  
for diagnosis of bacterial meningitis ......................................................................104 
Table 4.14 Pairwise comparison of ROC for 2 methods of leucocyte measures 
for the diagnosis of bacterial meningitis ................................................................105 
 
 
7 
 
Table 4.15 Accuracy of reagent strip for detection of protein via pandy test   
at “2 cross” and at “3 cross”…………………………………………………………….106 
Table 4.16 Results of protein strip in children with and without bacterial  
meningitis ..............................................................................................................108  
Table 4.17 Accuracy of the reagent strip to detect protein alteration in BM at 
different cut off points “2 cross” and at “3 cross” ...................................................108 
Table 4.18 Comparison of protein measures between urine strip protein,  
and pandy test  for diagnosis of bacterial meningitis .............................................109 
Table 4.19 Pairwise comparison of ROC for 2 methods of leucocyte measurement 
 for diagnosis of BM...............................................................................................110 
Table 4.20 Frequency of glucose reagent strip results among cases of BM .........111 
Table 4.21 Accuracy of gram stain among culture positive BM .............................112 
Table 4.22 Accuracy of gram stain among (confirmed and probable) BM  ............112 
Table 4.23 Accuracy of culture among all children with BM which included both 
probable and confirmed cases ..............................................................................113 
Table 4.24 Summary of the CSF characteristics of patients with bacterial  
meningitis ..............................................................................................................114 
Table 4.25 Simple logistic regression analysis for baseline characteristics  
that are predictors of BM .......................................................................................117 
Table 4.26 Simple logistic regression analysis of clinical characteristics  
predictors of bacterial meningitis  ..........................................................................118 
Table 4.27 Simple logistic regression analysis of clinical characteristics  
predictors of bacterial meningitis ...........................................................................119 
Table 4.28 Simple logistic regression analysis of laboratory parameters  
predictors of bacterial meningitis ...........................................................................120 
Table 4.29 Multivariate logistic regression analysis for predictors of BM among  
children admitted in Central Hospital of Beira .......................................................121 
Table 4.30 Possible clinical strategy for bed side diagnosis of BM using  
different clinical and laboratory predictors of urine reagent strip ...........................122 
Table 4.31 T test for mean of age, csf wbc, csf neutrophils and csf lymphocyte for 
independent sample in cerebral malaria and meningoencephalitis…………………123 
 
 
 
 
 
 
 
 
 
 
8 
 
ABBREVIATIONS 
 
AIDS – Acquired Immune Deficiency Syndrome 
ARV – Antiretroviral Treatment 
BBB – Blood Brain Barrier 
BM – Bacterial Meningitis  
CNS – Central Nervous System 
CSF - Cerebral Spinal Fluid 
DNA – Deoxyribonuclease Acid  
ED – Emergency Department 
Hb – Hemoglobin 
LP – Lumbar Puncture 
NPV – Negative Predictive Value 
PCR – Polymerase Chain Reaction 
PPV – Positive Predictive value 
TB – Tuberculosis 
RBC – Red blood cells 
WBC – White blood cell 
 
 
 
9 
 
 
ACKNOWLEDGEMENTS 
 
This work was supported by the Deutsch Mozambikanische Gesellschaft (DMG), 
Pediatric Neurology department of Hauner‟s Children Hospital in Munich, Faculty of 
Health Sciences of Catholic University of Mozambique and Central Hospital of Beira in 
Mozambique. 
These three years have been very interesting and difficult at the same time. I have 
learned a lot and many people supported me with their invaluable contribution to the 
study, and I would like to especially thank the following people. 
First of all I like to thank GOD. Secondly I would like to specifically thank my close 
family, my parents and my brothers for always supporting me understanding and 
tolerating my absences whenever busy recruiting patients for the study. Thank you for 
understanding me. 
I would like to especially thank my supervisors Prof. Dr. F. Heinen, Dr. K. Steidel, Prof. 
Dr. J. Huebner and Dr. M. Tacke for their support throughout the research period and 
your critical reading of the manuscript and invaluable input for completion of the thesis. 
My special thanks and my heartfelt gratitude are expressed toward Prof. Dr. F. Heinen, 
who has been an inspiration for me since I was a medical student in my 5th year. He 
inspired me towards research and the inspiration for the concept of bedside diagnosis of 
meningitis. Throughout the years your support has been unconditional, your input, 
invaluable, the discussions inspirational and crucial. Besides the work you really took 
care of me and made me feel at home in Munich and I really enjoyed meeting and 
having dinners with your family. I am very thankful that you are my mentor.  
Dr. Konrad, my heartfelt thanks to you for making everything easy in Beira at the faculty 
and for always making time to hear my problems that I had with the study. Thank you for 
your critical comments on the manuscripts, in projects, reports and the inspiring ideas 
 
 
10 
 
and discussion, we have had. They have really inspired me towards achieving my 
goals. 
A special thanks to Prof. Dr. J. Huebner and his team of microbiologist who have been a 
great support in doing quality control of standard microbiology of Hauner‟s children's 
hospital.  
My extended gratitude goes also towards Consul Lingel who through Deutsch 
Mozambikanische Gesellschaft who funded this research and supported additional 
courses in Munich. 
To the Central Hospital of Beira, I want to thank all the physicians from the Pediatric 
department, who always remembered to call me for lumbar punctures, the head of 
Department Dr. Wingi who always supported this idea from the beginning. I want to 
extend my thanks to Dr. Annett Pfeiffer for her ongoing support, the 5th and 6th year 
medical student for their support in recruitment and my thanks to the guardians and 
children that were enrolled in the study without whose help this study would not be 
possible. 
I also like to thank the laboratory technicians for their support in this research. Last but 
not the least I want to thank Dr. Moritz Tacke and Dr. Amir Seni for their input in creating 
the database. This was all new experience for me and it was very helpful. 
 
 
11 
 
 
1. General Introduction 
 
 
Community acquired bacterial meningitis is a severe infection of the central nervous 
system (CNS) which causes inflammation of the leptomeninges and can rapidly 
progress to multiple organ failure and death (Bloch and Tang., 2011). Despite various 
accomplishments achieved in the field of infectious diseases, especially in bacterial 
meningitis, such as, the introduction of new vaccines and antimicrobial drugs. However, 
there has been very little improvement in the diagnostic methodology. Bacterial 
meningitis is still associated with high mortality and lifelong sequelae (Schuchat et al., 
1997, Scheld et al., 2002, WHO, 2011b). Bacterial meningitis is rated one of the “top 
ten” causes of death among all infectious diseases (Grimwood et al., 2000, Scheld et 
al., 2002). The mortality varies from 10 to 20% and among 50% of survivors, severe 
lifelong disability can ensue (Maria and Bale, 2006, Prober, 2007). 
 
1.1 Historical perspective on meningitis 
 
Infections of the central nervous system are as old as mankind. Anthropological 
specimens dated back as far as 5000 BC have demonstrated signs of Tuberculous 
meningitis (Tyler, 2009). 
 
The first description of patients with meningitis was published by Thomas Willis a neuro 
anatomist, in 1661, who recognized this serious condition and described meningitis as 
an „inflammation of meninges with continual fever‟ and correlated the symptoms with the 
cerebral anatomy (Tyler, 2009). Later, in 1805 the first European descriptions of 
meningococcal disease and epidemics that occurred in Geneva came from Gaspard 
Vieusseux and his colleague Andre Matthey. A year later Elisha North described similar 
outbreak in  Massachusetts (Tyler, 2010). 
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Heinrich Quincke was the first physician to describe and use the technique of lumbar 
puncture. This provided the opportunity for cerebrospinal fluid (CSF) evaluation and the 
diagnosis of bacterial meningitis. Portrayal of CSF chemistry variations currently known 
as the classical CSF reference for meningitis: pleocytosis, hypoglycorrhachia and 
hyperproteinorrachia. This reference is the fruit of analysis of the largest assembly of 
CSF samples  described in history by Fremont Smith and Merritt (Tyler, 2010). Merrit 
and Fremont-Smith emphasized that “Changes that occurred in the cerebrospinal fluid 
were very important  essentially, the same regardless of the organism and consist 
chiefly of an increase in pressure, a pleocytosis, an increase in protein, and a decrease 
in the sugar and chloride contents” as referred by  (Merritt and Fremont-Smith, 1937) 
from (Tyler, 2010). 
 
During the late 19th century the first causative microorganisms for meningitis, 
Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae, were 
identified and Vladimir Kernig and Josef Brudzinski described the cardinal signs that 
accompanied meningitis. The first effective treatment for meningococcus using 
intrathecal equine antiserum was initiated in Germany by Georg Joachmann and in 
America by Simon Flexner (Tyler, 2009, Tyler, 2010). In the year 1913, this intervention 
drastically reduced mortality from 75-80% to 20%. The introduction of sulfonamides in 
1930 and use of penicillin in 1940 further decreased mortality from 20% to 15% - 10%. 
(Swartz, 2004). 
 
The first specific measures for the prevention of bacterial meningitis was the 
development of vaccine against N.meningitidis and the implementation of a vaccination 
program (Tyler, 2010). The introduction of a vaccine against Haemophilus influenzae 
and some serotypes against Streptococcus pneumoniae played a key role in reducing 
morbidity and mortality in countries where these programs were implemented. 
Unfortunately, many developing countries are not yet covered by efficient vaccination 
programs and mortality and morbidity is still very high. Despite such long history and 
advances that have occurred with modern technology, many physicians in developing 
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countries still face major challenges every day in the diagnosis and management of 
bacterial meningitis (Tyler, 2010). 
 
1.2 Definition  
 
Meningitis is defined as an  inflammation of the protective membranes that surround the 
brain and spinal column in particular the arachnoid and pia mater (Bloch and Tang., 
2011). It can be infectious or noninfectious in origin.  The severity of the disease 
depends on the cause. Meningitis can be caused by bacteria, viruses, mycobacteria, 
parasites and fungi (CDC, 2012a). The noninfectious causes of meningitis include 
inflammatory diseases like sarcoidosis, systemic lupus erythematous, cancer like 
leukaemia, drugs , head injury and brain surgery (Prober, 2007, CDC, 2012c) 
Among these, viral meningitis is the most common and bacterial meningitis is the most 
severe and It is the cause for significant morbidity and mortality worldwide (CDC, 
2012a).   
 
Encephalitis refers to the presence of an inflammatory process in the central nervous 
system and is usually accompanied with clinical evidence of neurological dysfunction. 
When the condition is affecting the meninges then it is termed as meningoencephalitis. 
Both  diseases are grouped together as they share same epidemiology, etiology and 
management (Bloch and Tang., 2011). 
 
1.3 Epidemiology 
 
Despite various achievements in the field of bacterial meningitis (BM) with introduction 
of new vaccines, new antimicrobial therapy and improvement in diagnostic methodology 
for cerebrospinal fluid evaluation, bacterial meningitis is still associated with high 
mortality and lifelong disabilities (Schuchat et al., 1997, Scheld et al., 2002). Almost any 
bacterial pathogen that can affect humans, has the capacity to cause BM (CDC, 2012b). 
Throughout history, many studies have persistently demonstrated that S.pneumoniae, 
H.influenzae and N.meningitidis are responsible for more than 70% of cases (Carpenter 
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and Petersdorf, 1962, Hoen et al., 1993). Further confirmations of same pathogens 
came from a report of surveillance system established by the Centre for Disease 
Control and Prevention (CDC). This report had gathered information on bacterial 
meningitis from 27 states in the United States of America (USA) from 1979 to 1981. 
Which demonstrated that indeed the 3 most important pathogens were streptococcus, 
meningococcus and hemophilus which accounted for 80% of the cases with an 
incidence of  3/100.000, from these 76,7/100.000 cases occurred in children below the 
age of one (Schlech et al., 1985). 
 
Further knowledge of other important etiologic agents came through a  laboratory based 
study in USA involving a population of 34 million in 1986 and 2 more pathogens were 
detected namely L.monocytogenes and S.agalactiae. (Schlech et al., 1985). 
 
According to WHO estimation, 500.000 new infections occur each year worldwide 
leading to 50.000 deaths every year (Pollard, 2004). It‟s estimated that the burden of 
disease is higher in low income countries compared to high income countries. The 
highest incidence occurring in sub Saharan Africa (WHO, 2011d). While the endemic 
form is not frequently seen in developed countries (Scheld et al., 2002) though 
outbreaks have occurred in crowded population (Harrison, 2000, Brooks et al., 2006) 
but are more frequent in low income countries (Scheld et al., 2002). The most affected 
area in Africa is the “Meningitis belt”. This zone comprises of 22 countries from Senegal 
to West of Ethiopia (WHO, 2013). This region has had an annual epidemic in past 
decades. From 1993 to 2012 nearly one million suspected cases were reported by 
WHO, causing around 100.000 deaths (WHO, 2013). 
 
1.4 Aetiology 
 
Meningitis is an important differential diagnosis in a febrile child with altered mental 
status or with signs and symptoms that suggest involvement of the brain. Though many 
pathogens are responsible for meningitis, it‟s possible to identify specific pathogens 
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based on the age, immune status of the host and epidemiology of the microorganism 
(Prober, 2007). 
 
The most important pathogens causing bacterial meningitis are: Streptococcus 
pneumoniae, Haemophilus influenzae, Neisseria meningitides , group B streptococcus , 
Listeria monocytogens and Mycobacterium tuberculosis. though there are other 
microorganisms causing similar disease in newborns and immunocompromised 
individuals (Hasbun, 2014). The first 3 are the most common causes. Table 1. Shows 
different causative organism according to different age groups. 
 
Table 1. Aetiology of Bacterial meningitis according to the age groups 
Age groups Causes 
Newborn Group B Streptococcus, Escherichia coli, Listeria 
monocytogenes 
Infants and children  Streptococcus pneumoniae, Neisseria meningitidis, 
Haemophilus influenazae B 
Adolescents and 
young adults 
Streptococcus pneumoniae, Neisseria meningitidis 
Source:(CDC, 2012a) 
 
1.4.1 Neisseria meningitidis 
 
Neisseria meningitidis, a gram negative bacterium is the cause of the endemic form of 
meningitis. The polysaccharide capsule that surrounds the bacteria is important for the 
classification of N. meningitidis into 12 serogroups. Out of these 12 serogroups only 6 
are responsible for most of the infections in humans: A, B, C, W135, X and Y (WHO, 
2011d)  
 
The serogroups are widely distributed around the globe. The serogroups B and C are 
more frequent in America, Europe, and Australia (Jafri et al., 2013) while A is 
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responsible for epidemics in Asia and in Africa accounting for 80-85% of outbreaks. 
Occasionally serogroups can emerge like serogroups C in China or serogroup Y in 
North America (WHO, 2011d) and new strains may also emerge for example, strain Y 
and W135 have been observed in 2 new foci (Jafri et al., 2013, WHO, 2013). Figure 1 
shows global distribution of N. meningitidis serogroups. 
 
(WHO, 2013) Epidemiology bulletin reported that annually 1.2 million cases are 
estimated to occur of N. meningitidis with 135.000 deaths in the region of „Meningitis 
Belt‟ alone. N. meningitidis causes severe brain damage and is fatal in 50% of cases if 
untreated, causing significant mortality within 24 to 48 hours (WHO, 2011b).The 
survivors are in high risk of developing neurological sequelae with cognitive, motor, 
visual and hearing impairment (Edmond et al., 2010a). 
In 2010 a vaccine against  the N.meningitidis strain A was introduced in the counties of 
the „Meningitis belt‟, which has reduced incidence in this region significantly (Jafri et al., 
2013)  
Figure 1. Worldwide distribution of N.meningitidis serogroups responsible for 
meningococcal meningitis. Source (Jafri et al., 2013) 
 
Source (Jafri et al., 2013)
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1.4.2 Haemophilus influenzae type b 
 
Haemophilus influenzae is a gram negative coccobacilus, which is aerobic in nature, but 
may also grow under anaerobic conditions. It is a cause for several severe and life 
threatening diseases in children below 5 years of age. There are 6 capsular types from 
(a-f). In 95% of cases, invasive infections including meningitis are caused by subtype b 
(CDC, 2012b). It was first described in 1892 by Pfeiffer and later named “Haemophilus” 
by Windslow et al in 1920. It is a main cause of bacterial meningitis and other serious 
infections in children below the age of 5. In the pre vaccine era, most of the affected 
children were 18 months or younger (CDC, 2012b). Humans are the only known 
reservoir for Hib. The germ is found in the nasopharynx of 0.5%–3% infants and 
children who are asymptomatic (WHO, 2014b). 
 
Before the wide spread introduction of the Hib vaccine, Hemophilus influenzae type b 
was responsible for almost 45 to 48% of cases of bacterial meningitis in the United 
States of America and a significant cause of death (Schlech et al., 1985, Brouwer et al., 
2010). One in every two thousand children developed Hib meningitis or invasive 
disease below the age of 5. After the introduction of a conjugated Hib vaccine in 1980, 
the incidence of Hib infections decreased by 90%. Currently Hib is responsible for 6.7% 
of  all bacterial meningitis cases (Muller, 2014, Hasbun, 2014). 
 
The conjugated vaccine does not only provide protection to vaccinated children, but 
also decreases the carriage of Hib and protects unvaccinated children by reducing 
exposure of Hib from vaccinated children. In developing countries the vaccination 
program was started in 2007 in 184 countries and has a global coverage with 3 doses of 
45 %. Due to vaccine‟s low coverage for  H. Influenazae‟s vaccine program it remains a 
major problem in many African countries (WHO, 2014b). 
 
Despite the availability of  the conjugate vaccine and appropriate therapy, Hib still is 
responsible for a  case fatality rate of  2 to 5 % in developed countries in comparison to 
20 to 30% in tropical countries  (Naik and Seyoum, 2006, Ramakrishnan et al., 2009, 
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CDC, 2012b). Sigauque et al demonstrated in their study from a Manhica district in 
Mozambique, that the mortality was as high as 55 % among children under 5 years who 
had H. influenzae meningitis (Sigauque et al., 2008). However, due to lack of laboratory 
material, technicians, diagnostic difficulties, no reliable data on Hib meningitis is 
available for the whole country. 
 
1.4.3 Streptococcus pneumoniae  
 
S. pneumoniae, is gram positive encapsulated bacteria with a capsular diversity so 
large that more than 90 serotypes have been identified based on the polysaccharide in 
bacterium‟s capsules. Many subtypes have the capacity to cause invasive 
pneumococcal disease, however only few serotypes cause severe disease worldwide 
(CDC, 2012b). 
 
Serotype distribution and burden of disease varies worldwide. Serotype 1 and 5 are 
more frequent in low income countries (CDC, 2012b). S. pneumoniae meningitis affects 
mostly young children below the age of 5 years and the elderly. In developing countries 
the case fatality  rate for meningitis due to S. pneumoniae in children under the age of 5 
years is as high as 73% (Brouwer et al., 2010).It is the most frequent cause of BM in 
Europe and USA accounting for 58% of cases (Thigpen et al., 2011).  
 
In order to decrease this burden, efforts have been made to reduce the incidence by 
introducing vaccines. Various types of vaccines have been introduced. A 23- valent 
vaccine which contained 74-90% of the serotypes that caused meningitis was initially 
used for high risk groups and showed decrease in 50 % of cases (Bolan et al., 1986, 
Butler et al., 1993). Later a Heptavalent vaccine showed some promising results with a 
decrease in 59% of pneumococcal meningitis in children below the age of 2 years 
(Whitney et al., 2003). This pneumococcal vaccine contained 7 strains that were 
frequent in USA in comparison to other countries in Europe (Prevnar- PCV 7 conjugate) 
(Schuchat et al., 1997). Later the heptavalent vaccine was replaced by a 13 valent 
vaccine ( Prevnar- PCV 13 conjugate) with 6 additional strains to cover other subtypes 
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of pneumococci that caused invasive disease worldwide (Brouwer et al., 2010, NNii, 
2010).  
 
The CDC reported a significant decline in burden of disease due to invasive 
pneumococcal infections in the industrialized countries after introduction of heptavalent 
vaccine, but in non-industrialized countries, is still an important cause of death. The 
Invasive pneumococcal infections in low resource countries, causes between 700.000 
to 1.000.000 deaths every year among children below the age of 5 (Brouwer et al., 
2010, CDC, 2012b). To reduce mortality from pneumococcal disease in low income 
countries, WHO recommended inclusion of the heptavalent vaccine in routine 
vaccination programs worldwide in 2007 (WHO, 2011c).  
 
By 2008 only 26 countries had managed to introduce the heptavalent vaccine. Out of 26   
only 3 were from low income countries and the rest were from high income countries. In 
2012 GAVI (Global Alliance for Vaccine and Immunization) funded Pnuemo ADIP plan 
(Pneumococcal vaccines Accelerated Development Plan) is helping low income 
countries to introduce the heptavalent vaccine. By the end of 2012, through this 
alliance, 88 countries had introduced vaccine against pneumococcal infection, with a 
global coverage estimated at 19%. It is estimated that by 2020 with Global Vaccine 
Action Plan, vaccination coverage will be more than 80% (WHO, 2011c, WHO, 2014b). 
 
The Figure 1.2 Below shows a graph with the trend of case fatality rate among the three 
main pathogens responsible for bacterial meningitis over the past 90 years. 
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Figure 1.2 Demonstrates Trend of three main pathogens responsible for meningitis 
over the 90 years 
 
 Source (Swartz, 2004)
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1.4.4 Listeria monocytogenes 
 
Listeria monocytogenes is a gram positive rod shaped bacterium (Fischbach, 2009). In 
the USA it accounts for 2% of all cases of bacterial meningitis as quoted by ((Brouwer et 
al., 2010) from (Thigpen, 2005). Discovered during 1980 after an outbreak, is found in 
soil, water and sewage. Transmission is mainly via contaminated food (CDC, 2013) 
specially undercooked food or unpasteurized dairy products (Schuchat et al., 1991). 
Children below the age of 3 months and elderly are most frequently affected. One 
important group is pregnant women as they are at higher risk for acquiring this disease 
(CDC, 2013) Symptoms are very similar to other meningitis; mortality ranges from 15-
17% in children and among survivors, 25% develop neurological sequelae (CDC, 2013) 
 
1.4.5 Streptococcus agalactiae 
 
Streptococcus agalactiae also known as group B streptococcus is a leading cause of 
neonatal sepsis and death in USA. However there has been under reporting of Group B 
infections among infants so the epidemiology is unknown in other parts of the world 
(Brouwer et al., 2010). The main risk factors for neonates are premature rupture of 
membranes of the mother, maternal fever and a positive vaginal group b streptococcus 
culture (CDC, 2012d). Infection occurs either vertically from mother to child or later in 
first week of life, while caring for the newborn (Brouwer et al., 2010). Mortality in 
neonates ranges from 7-27% (Brouwer et al., 2010).A third of the surviving children  
develop neurological sequelae with spastic quadriplegia, profound mental retardation, 
hemiparesis, deafness and blindness (van de Beek, 2012). According to the guidelines 
established by the CDC in 2003, every pregnant woman between the 35 to 37 week of 
gestation should have a vaginal and rectal swab for screening S. agalactiae and an 
intrapartum antibiotic prophylaxis should be administered to positive cases (CDC, 
2012d). This recommendation has reduced the infection rate in the USA and Canada, 
but in many developing countries these guidelines have not been established. One 
study done in Malawi demonstrated that 22% of isolates from neonates admitted with 
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sepsis were culture-positive for S.agalactiae. The manifestation of early onset disease 
below 1 months of age was mostly as a neonatal sepsis which accounted for 52% of the 
cases. Late onset infection was mainly as meningitis with 39%, with a case fatality of 
49% (early onset disease) and 29% (late onset disease), which is much higher than 
found in USA. (Gray et al., 2007). 
 
1.5 Risk factors 
 
Many studies throughout the decades have shown various factors associated with 
increased risk of bacterial meningitis.  
 
1.5.1 Age  
 
Several studies have repeatedly demonstrated that there is a direct relation between the 
age and meningitis. Affecting very young and the elderly (Takala et al., 1989, Prober, 
2007),the association seems to be related to lack of immunity in younger children below 
the age of 1 and elderly due to combination of other diseases and immunosuppression 
(Prober, 2007). 
 
1.5.2 Poor Housing and overcrowding 
 
Overcrowding and poor household, facilitate transmission of respiratory droplets from 
the carrier or symptomatic patients to healthy individuals. In study involving college 
freshmen it was observed that college students who were residing in college dormitories 
had a higher risk of acquiring meningococcal disease in comparison to the ones who 
were not (Froeschle, 1999, Harrison, 2000). 
 
1.5.3 Tobacco 
 
Tobacco seems to increase the of risk bacterial meningitis among both active and 
passive smokers (Coen et al., 2006, Slama et al., 2007, Murray et al., 2012). It 
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increases the risk of carriage with more pathogenic bacteria like, H. influenzae, 
pneumococcus, and meningococcus (Slama et al., 2007) increasing risk of transmission 
to children and other  adults. One case control prospective study done in England 
demonstrated that the risk of meningitis was higher among teenagers exposed to 
passive smoking than among a non-exposed group (Coen et al., 2006, Murray et al., 
2012). 
 
1.5.4 Indoor air pollution 
 
In numerous studies done in developed countries passive smoking has been linked to 
the increased risk of developing bacterial meningitis. Lately it has been demonstrated 
that there is a strong association between cooking with fire wood and bacterial 
meningitis. As indoor air pollution with fire wood has a similar effect on children as 
passive smoking, increasing the risk of carriage state among children and predisposing 
to  bacterial meningitis (Staton and Harding, 1998, Hodgson et al., 2001). 
 
1.5.5 Socio- economic factors 
 
Socioeconomic factors have an important role in the increased incidence of bacterial 
meningitis. These factors include poverty, household crowding, limited access to health 
care, and lower educational level are important factors (Reis et al., 2008). 
 
1.5.6 Other factors 
 
Alterations of host defense due to anatomic defects or immune deficits also increases 
the risk of meningitis from less common pathogens such as Pseudomonas aeruginosa, 
Staphylococcus aureus, coagulase-negative staphylococci and Salmonella spp., 
(Prober, 2007, Muller, 2014). Factors that cause immunosuppression such as HIV (Mao 
et al., 1996), congenital asplenia or post-splenectomy (Shutze E et al., 2002) and 
cochlear implants (Reefhuis et al., 2003) increases the risk of bacterial meningitis 
caused by Streptococcus pneumoniae . The  Ig G subclass deficiency, children with 
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head trauma and other skin infection (Prober, 2007) and ventricular shunt (Meirovitch et 
al., 1987, Ronan et al., 1995) have also shown to be associated with increased risk of 
meningitis. 
 
1.6 Pathophysiology of bacterial meningitis 
 
Bacterial meningitis, results from a complex multistep interaction between the host and 
the pathogen. These sequential steps are important for the development of bacterial 
meningitis. Despite many studies on the pathogenesis of bacterial meningitis, many 
features remain unclear. It is crucial to understand this complex process for future 
development of adjunctive treatment to reduce morbidity and mortality associated with 
the disease. Important features responsible for high mortality and morbidity are still not 
clearly understood (Kim, 2003).  
 
Every bacterium that has potential to cause disease in man can also cause meningitis 
but it‟s still unclear why only some are more frequent. Listeria monocytogens, group B 
streptococcus and E  are the main cause of meningitis in neonates, but are not frequent 
in older children and adults. (Kim, 2003) 
 
The first step for development of bacterial meningitis, typically is a colonization of the 
nasopharynx mucosa followed by bacterial invasion of vascular system, survival and 
multiplication of bacteria in the blood stream, passage through blood brain barrier 
(BBB), host inflammatory response and neuronal damage (Kim, 2003). 
 
1.6.1 Transmission and Colonization 
 
Most of the pathogens that cause meningitis are found in nasopharygeal mucosa 
without affecting the host. This state is referred as “Carriage” (Yazdankhah and 
Caugant, 2004). This carriage state can be seen in 10% of asymptomatic population in 
nonepidemic setting (Bolan et al., 1986). Other routes include hematogenous and 
contiguous spread. Despite other routes available for pathogens to access the 
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meninges, in most cases the access is via nasopharynx and transmission of the 
pathogens occurs through close contact and from contaminated nasal or oral droplets 
(Yazdankhah and Caugant, 2004). 
 
Once a bacterium colonizes the nasopharynx it provokes an immune response from the 
host providing natural immunity. The capsule subtypes are responsible for different sero 
subtypes of bacterium. Among 50% of the carriers the bacterium lacks the 
polysaccharide capsule and therefore is non serogroupable (Claus et al., 2002) These 
non serogroupable bacteria can switch on and off capsular production. The lack of 
capsule in the carrier state gives the bacterium opportunity to escape an immune 
response allowing colonization of the nasal mucosa (Swartley et al., 1997). 
 
The prerequisite for colonization is the capacity of the pathogen to adhere to the nasal 
mucosa and escape neutralization of the bacterium from an Immune response. 
Adhesion of the bacteria to mucosa occurs via adhesion molecules called pili or 
fimbriae, hair like structure that are found on the bacterial surface. In case of 
N.meningitidis the type IV pili interacts with a membrane cofactor protein, CD46 (Pujol 
et al., 1999, Johansson et al., 2003). This cofactor protein is found in all cells, except 
erythrocytes (Johansson et al., 2003, Yazdankhah and Caugant, 2004). 
 
Once the colonization has taken place, the bacteria need to survive and grow. For the 
growth, the bacteria use iron and acquires it from lactoferrin and transferrin. The 
meningococci acquires iron by binding human transferrin, and lactoferrin with OMP 
receptor protein, which in turn releases the iron and is uptaken by the bacterium for its 
growth (Larson et al., 2002, Kim, 2003).  
 
The bacteria may escape immune responses by producing Ig A1 extracellular protease. 
These proteases are produced by H.influenzae, S. pneumonia and N.meningitidis which 
cleaves human Ig A1 found in the nasal mucosa. This Immunoglobulin IgA1  has an  
important  role in preventing adherence of the bacterium to the mucosa (Yazdankhah 
and Caugant, 2004, Hasbun, 2014). Any prior damage to the nasal mucosa either by 
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irritants like smoke exposure, prior respiratory tract infections may promote adhesions 
of bacteria to nasal mucosa and facilitate transmission (Hasbun, 2014). 
 
After the invasion of the nasal mucosa, pathogens might cross the nasopharyngeal 
mucosa by different methods. This is done by pinocytosis in the case of N. meningitidis, 
via surface proteins that binds to platelet activating factor (PDF) in the case of 
pneumococcus (Huang and Jong, 2001, Kim, 2003, Maria and Bale, 2006). While 
haemophilus separates the apical tight junction between cells and gains access to blood 
vessels. Once in the blood stream they survive phagocytosis due to presence of the 
capsules and  are resistant to complement mediated bactericidal activity (Kim, 2003). 
 
Pathogens may also access the meninges by hematogenous spread during bacteremia 
via passage of infected leucocytes,(Maria and Bale, 2006) through the choroid plexus , 
via  rupture of superficial cortical abscesses, a contiguous spread from adjacent 
infection or via shunt mechanism in a skull fracture (Kim, 2003). 
 
1.6.2 Survival in the blood streams 
 
Survival of bacteria in the vascular system is essential for multiplication and invasion of 
the meninges. This is possible because these bacteria have developed mechanism to 
escape the immune response by displaying a wide range of surface antigens and 
polysaccharide capsules. This capsule protects them from phagocytosis by neutrophils 
and the classic complement mediated bactericidal activity and aid in multiplication of the 
bacteria (Maria and Bale, 2006, Idro et al., 2005).  
 
1.6.3 Bacterial invasion 
 
The blood brain barrier which is composed of the arachnoid membrane, the choroid 
plexus epithelium and brain micro vascular endothelial cells (BMCE) acts as a barrier 
that strictly regulates passage of molecules and ions into CNS. It is therefore protecting 
the brain from harmful toxins (Tunkel and Scheld, 1993, Maria and Bale, 2006). The 
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structure is semi selective and by the mean of the tight junctions formed by the brain 
micro vascular endothelial cells (BMCE), allows small amount of pinocytosis and active 
transportation for glucose. This barrier also protects the brain from neurotoxins and 
microbes circulating in the blood. The meningeal pathogens can also cross the blood 
brain barrier in form of live bacteria in to the CNS (Kim, 2003). They may cross the 
barrier “transcellulary, paracellularly or via infected phagocytes (Trojan horse 
mechanism)” (Kim, 2008).  
 
There seems to be a correlation between the threshold of bacteremia and development 
of bacterial meningitis, in neonates it has been shown that when an E.coli count >103 
ml1 is found in the blood then it is more likely the neonate to have meningitis in 
comparison with lower than 103 ml1 colonies. Similar conditions were seen with other 
meningeal pathogens  confirming the hypothesis that a  threshold of bacteremia is a pre 
determinant factor for development of meningitis (Kim, 2003). 
 
The first site for bacterial invasion in the CNS seems to be the choroid plexus. The 
choroid plexus is a highly vascular structure and has a very high blood flow of 
approximately of 200 ml/gr/min in comparison with other CNS structures (Tunkel and 
Scheld, 1993). It seems that this high blood flow of the plexus is responsible for bringing 
more bacteria to this site and with the help of the receptors that are found in the 
plexus‟s endothelium it promotes entry into the plexus (Tunkel and Scheld, 1993). 
Huang in his study demonstrated that these proteins are specific for each type of 
bacteria. E coli invades via Ibe A, Ibe B and Omp A, S.pneumoniae via protein Cbp and 
N. meningitidis via Opc, Opa, and Pil C.(Huang and Jong, 2001). Once the bacteria has 
entered the arachnoid space it is capable to further multiply as there are few host 
defenses due to lack of antibody, complement and opsonic activity in the CNS (Maria 
and Bale, 2006). 
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1.6.4 Inflammatory response 
 
Once a live bacterium has crossed the BBB accompanied by leucocytes, these bacteria 
replicate and produce a stronger immune reaction by liberation of pro inflammatory and 
toxic substances which cause further migration of leucocytes particularly of neutrophils, 
across the BBB, causing a condition known as pleocytosis. “This pleocytosis is the 
hallmark for diagnosis of meningitis” (Hoffman and Weber, 2009). 
 
Once the bacteria reaches the subarachnoid space, they further multiply and undergo 
autolysis. This self-destruction releases more cell wall components, lipopolysaccharide, 
teichoic acid, peptidoglycans and bacterial DNA initiating an increased inflammatory 
response. This activates an inflammatory pathway leading to a production of cytokines 
like tumor necrosis factor (TNFα), interleukin 1b further activating release of other 
inflammatory mediators like interferon ϫ (INFϫ), platelet activating factor (PDF), 
chemokines, prostaglandins and nitric oxide (NO). TNFα production increases within 
hours and is strongly related with severity of disease (Maria and Bale, 2006). This starts  
a vicious cycle with further activation of leucocytes which in turn liberates reactive 
oxidants and matrix metaloproteinases (MMP) causing further tissue damage (Maria 
and Bale, 2006, Hoffman and Weber, 2009). 
 
In the subarachnoid space there is an increase in exsudate due to predominance of 
phagocytic polymorphonuclear leucocytes in early phase. In the later phase by 
lymphocytes histiocytes, fibrinogen and blood proteins further contributing to 
inflammatory exsudate (Maria and Bale, 2006). 
   
Nitric oxide has a very important role in the pathogenesis. It is a potent vasodilator and  
causes dilatation of cerebral vessels and increase in blood flow to the brain  aggravating  
cytotoxic damage  to the BBB and further increase cerebral edema (Scheld et al., 2002, 
Kim, 2003). Table 2. Demonstrates the main cytokines that are increased in different 
types of meningitis. 
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1.6.5 Cerebral Edema 
 
The cerebral edema in bacterial meningitis is multifactorial in origin. It can be  
vasogenic, cytotoxic or interstitial in origin (Tunkel and Scheld, 1993). The Vasogenic 
effect is due to increase in BBB permeability, the cytotoxic effect occurs due to swelling 
of the cells which is a result of toxic substances induced by leukocytes via inflammatory 
mediator and due to secretion of antidiuretic hormone (ADH), which further aggravates 
cytotoxic edema with hypotonic extracellular fluid and increase in the permeability of the 
BBB and causes cerebral edema. The interstitial edema occurs due to obstruction of 
subarachnoid structures due to bacterial and tissue debris (Tunkel and Scheld, 1993, 
Scheld et al., 2002, Hoffman and Weber, 2009). 
 
Table 1.2 Cytokines that increase in response to meningitis  
Cytokines     Serum         Viral     Bacterial  
IL 1        +        +       ++ 
IL 6        ++        ++           ++ 
IL 8        -         ++       ++ 
IL 9        -   
TNF        +        + 
Î²               -       + 
PDF -          -       + 
C reactive 
protein 
       +         +       ++ 
IL  interleukin , Î² tumor growth factor 
             Source  (Maria and Bale, 2006) 
 
The increase in cerebral oedema plus the obstruction of the villi at the arachnoid matter 
and in the choroid plexus causes hydrocephalus and interstitial oedema. These 
conditions further increase intracranial pressure which in turn decreases the cerebral 
blood flow and causes loss of cerebrovascular auto-regulation. Once the 
cerebrovascular auto regulation is lost the cerebral blood flow becomes dependent on 
the mean arterial blood pressure which increases to maintain adequate cerebral 
perfusion. In some cases if the blood pressure is lower due to shock it may severely 
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affect cerebral perfusion and increases the risk of neurological injury. In acute 
intracranial hypertension, brain perfusion is also altered and increased the risk of brain 
herniation (Maria and Bale, 2006). The figure 3 summarizes the pathophysiological 
cascade in bacterial meningitis. Source (Sáez-Llorens and McCracken, 2003). 
 
Figure 1.3 Summarizes pathophysiology cascade in bacterial meningitis  
 
Source :(Sáez-Llorens and McCracken, 2003) 
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1.7 Clinical picture 
The clinical manifestations of acute bacterial meningitis varies according to the age of 
the patient. The younger the patient the more subtle and atypical the signs and 
symptoms are. The classical triad of fever, altered mental status and neck stiffness 
which is frequently observed in older children and adults is rarely seen in infants and 
younger children (Sáez-Llorens and McCracken, 2003, Maria and Bale, 2006, Prober, 
2007). 
 
Two important forms of presentation have been described by (Prober, 2007) the acute 
onset form which is rapidly progressive to coma or death within 24 hours which is rare. 
The commonly encountered presentation is the subacute type with several days of 
prodromal symptoms before the development of nonspecific signs and symptoms of 
CNS involvement (Prober, 2007). 
 
In neonates the prodromal signs are low grade fever, poor feeding or refusal to feed, 
somnolence, behavioural change or irritability followed by vomiting, lethargy and 
seizures. The physical examination is also nonspecific and can present signs of 
irritability, hyper reflexia and a bulging fontanel. In severe cases with systemic 
involvement hypotension and disseminated intravascular coagulopathy (DIC) is 
observed (Maria and Bale, 2006). 
 
While in older children prodromal signs are: fever accompanied by upper respiratory or 
gastrointestinal tract symptoms followed by CNS involvement (Prober, 2007). Other 
nonspecific signs include anorexia, headache, myalgia, arthralgia, hemodynamic 
alterations with hypotension and tachycardia. In case of meningococcal infection there 
may be associated dermatological alterations such as petechial purpura or macular 
erythematous rash accompanied to meningeal signs (Maria and Bale, 2006, Prober, 
2007). 
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The signs that demonstrate that CNS is affected are headache associated with 
photophobia results of meningeal inflammation and increased intracranial pressure. 
Other signs include head retraction, neck stiffness, spinal rigidity result of meningeal 
irritation of the spinal root (Prober, 2007, Ward et al., 2010). 
 
Meningeal signs are comprised of nuchal rigidity, back pain, Kerning sign and 
Brudzinski sign. In affected children below the age of 18 months Kerning and Brudzinski 
signs are frequently negative. Earlier studies in adults have shown that nuchal rigidity, 
headache and fever is only seen in 35 - 40% of adults with bacterial meningitis (Puxty et 
al., 1983, Prober, 2007). The neck stiffness, spinal rigidity and head retraction reflect 
irritation of meninges and spinal roots and are mechanism to protect the spinal axis by 
immobilization and shortening of the roots. The stretching of these roots cause pain and 
reflex spasm (Maria and Bale, 2006). It is the stretching of the roots and spasm the 
basis of Kerning and Brudzinski signs (Vincent et al., 1993). 
 
Seizures are frequently observed among children with bacterial meningitis and these 
can be focal or generalized.  Seizures are observed in  44% of H. influenzae, 25% of S. 
pneumoniae and 10% in N. meningitidis meningitis (Dodge and Swartz, 1965). Focal 
seizures are result of  localized involvement of brain parenchyma either by bacteria or 
inflammatory lesion (Samson et al., 1969) There is a strong association between 
seizure (generalized or focal) with diagnosis of bacterial meningitis. About 18% of first 
seizures in children was caused by meningitis. Therefore any child with first episode of 
seizure should undergo a lumbar puncture to exclude the diagnosis of bacterial 
meningitis (Samson et al., 1969, Prober, 2007). 
 
Another important clinical feature common to bacterial meningitis is alteration of mental 
status. This could be due to increased intracranial pressure, cerebritis or hypotension. 
May present as irritability, lethargy, stupor, obtundation or coma (Prober, 2007). 
Intracranial pressure can present with headache, vomiting, bulging fontanel, diastasis of  
cranial sutures, cranial nerve palsy [oculomotor (anisocoria and ptosis) and abducent], 
hypertension with bradycardia, apnea or hyperventilation, stupor , coma or decerebrate 
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posturing (Prober, 2007) However some of the signs associated with bacterial 
meningitis  are not always present at the same time. Due to the non-specificity of clinical 
picture in younger population  it is difficult to make diagnosis of  bacterial meningitis 
based on clinical feature (Curtis et al., 2010).The table below demonstrates frequency 
of  signs and symptom (Valmari et al., 1987). 
 
Table 1.3 Frequency of signs and symptoms that are present in bacterial meningitis  
Signs and symptoms Frequency References 
Fever  94% (Valmari et al., 1987) 
Irritability 85% (Valmari et al., 1987) 
Emesis 82% (Valmari et al., 1987) 
Impaired consciousness 79% (Valmari et al., 1987) 
Neck stiffness in older children 78% (Valmari et al., 1987, Maria and 
Bale, 2006) 
Seizures 10- 44% (Dodge and Swartz, 1965)    
(Valmari et al., 1987) 
Headache in older children  92% (Valmari et al., 1987) 
Focal signs 10- 20% (Prober, 2007) 
Source (Valmari et al., 1987, Maria and Bale, 2006, Prober, 2007) 
 
1.8 Diagnosis and management of bacterial meningitis 
1.8.1. Diagnosis of bacterial meningitis 
When managing community acquired bacterial meningitis, the efforts to make a 
diagnosis and to start an effective, treatment should be started immediately to reduce 
the high mortality and morbidity that accompanies this disease. The task for the pre 
hospital care are the stabilization and transportation of a critically ill child (Muller, 2014). 
Patient must be transported to  hospital with facilities of  Intensive care unit, where 
patient would be managed appropriately. For management of children,  a paediatric ICU 
(Intensive care unit) care is required (van de Beek et al., 2006, Muller, 2014). 
 
The Initial approach, in managing a child with meningitis starts with evaluation of vital 
signs followed by proper history and physical examination. Simultaneously determine, 
based on the findings suspicion for bacterial meningitis and initiate an appropriate 
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approach for diagnosis and antimicrobial treatment (Tunkel et al., 2004). If the child is 
stable and with signs indicating meningitis a lumbar puncture should be performed 
immediately to avoid any delay in diagnosis and the first dose of antibiotic should be 
given while awaiting laboratory confirmation (Tunkel et al., 2004). However, in case of 
the critically ill child with hemodynamic instability, GCS < 11, cardiorespiratory 
compromise, focal neurological signs, persisting focal seizures, signs of intracranial 
mass and intracranial hypertension (headache, vomiting, and papilledema) lumbar 
puncture should be delayed to avoid cerebral herniation and immediate death. In these 
cases first CT of the head should be performed prior lumbar puncture but antimicrobial 
therapy and management of ICP should be commenced simultaneously without further 
delay, while awaiting for the CT results (van de Beek et al., 2006, Prober, 2007, Muller, 
2014). Figure 4 demonstrates the guideline for approaching community acquired BM by 
(van de Beek et al., 2006). 
 
Other contraindications for lumbar puncture include patient with coagulopathy as this 
increases risk of hematoma into the subarachnoid space, skin infection on the site of LP 
(Hasbun, 2014). Contraindication for immediate lumbar puncture (Hasbun et al., 2001, 
Joffe, 2007, Hasbun, 2014) includes: 
- Intracranial hypertension 
- Brain abscess 
- Papilloedema 
- Focal neurological sign (excluding single or isolated nerve palsy) 
- GCS < 11 
- Severe immunodeficiency (e.g., AIDS) 
- New onset of seizure 
- Septic shock 
- Patient with known cerebral lesion.  
 
There have been many studies that recommend a CT scan before performing a LP in 
bacterial meningitis (van de Beek et al., 2006, Fitch and van de Beek, 2007, Kestler et al., 
2013). However the data is not very conclusive till the date. According to a study done, 
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every patient with bacterial meningitis has a raised intracranial pressure, however, 
death by herniation in BM accounts only for 5% of all cases from LP. Many studies have 
measured intracranial pressure in children with bacterial meningitis, (Dodge and Swartz, 
1965). The mean intracranial pressure can rise up to 307 mm H2O which is well above 
the normal value of 70-180 mm H2O (Bonadio, 2014)  reported, but these ICP were still 
lower than reported in a study done by Minns et al. More importantly, despite higher 
pressure in BM in (Minns et al., 1989) study no fatalities were reported associated with LP 
in children with raised ICP. Larsen and Goldstein, 1999 quote in their article that “CT 
does not measure intracranial pressure, and there may be clinically significant ICP in 
the absence of any abnormality on a CT scan” (Larsen and Goldstein, 1999, Bailey et 
al., 2012). This suggests that increased ICP evaluated by CT of the head cannot be 
conclusive and reduce the risk of herniation of intracranial hypertension in context of 
bacterial meningitis. 
 
Another important point is that this recommended guideline for the use of head CT 
before LP to prevent herniation related to increase in ICP cannot entirely be applied to 
lower income countries. Many low income countries only have CT scan for central or 
major hospitals and are not even frequently available or the service is only available 
during certain working hours and hardly ever available during emergencies or there are  
no specialist for interpretation available (Kestler et al., 2013). These guidelines are not 
feasible for low income countries but caution needs to be taken when in presence of 
focal neurological signs (Kestler et al., 2013). Whenever LP is not possible samples for 
blood culture should be acquired prior antibiotic therapy (van de Beek et al., 2006). 
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Figure 1.4 Algorithm for Management of patients suspected with community acquired 
bacterial meningitis. Source (van de Beek et al., 2006) 
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1.9 Laboratory Diagnosis of Meningitis 
 
The crucial step for the diagnosis of bacterial meningitis is the analysis of the CSF 
which is essential. The most common procedure to acquire CSF is via lumbar puncture. 
The procedure is a common practice in the evaluation of a child with fever and / or with 
signs of CNS involvement. In order to interpret the CSF samples it‟s important to 
understand its composition and variation that occur with different ages. 
 
1.9.1 CSF: Formation and Composition 
 
Cerebro-spinal fluid (CSF) is a clear, colourless fluid formed by the choroid plexus of the 
lateral, third and fourth ventricles of the brain. The choroid plexus produces around 70% 
of this fluid by ultrafiltration and secretion. The rest of the CSF is produced by the 
ependymal lining of the ventricles and the cerebral subarachnoid space. On average 
500 ml of CSF are formed daily, but at any given moment only 90-150 ml of CSF is 
present in an adult. Arachnoid villi are responsible for reabsorption of the CSF (Bonadio, 
1992, Fischbach, 2009, Sakka et al., 2011). In children between the age of 4 - 13 years 
at any given time a volume of 65 – 150 ml are found (Bonadio, 1992). In a lumbar 
puncture a volume of 3-5 ml may be taken depending on the age. The volume removed 
during the lumbar puncture  can be restored within an hour of the procedure (Bonadio, 
2014). 
 
Normal intracranial pressure is the result of well a balanced system between CSF 
production and reabsorption which is dependent on venous pressure as all the 
reabsorbed fluid is drained in to venous system. Though continual balance of CSF is 
maintained there is a significant pooling in the lumbar sac site located between L4 to L5. 
This location is used for Lumbar puncture for acquisition of CSF for analysis because of 
the pooling and due to lower risk of damaging the roots (Fischbach, 2009). 
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The CSF has 4 main functions (Fischbach, 2009, Sakka et al., 2011). 
1. Mechanical protection for the spinal cord and the brain by providing buoyance. 
2. Homeostasis of interstitial fluid and regulation of neurological function  
3. Delivery of nutrients to the brain and removal of waste material. 
4. Regulation of the intracranial pressure 
 
The CSF is composed of 99% water, which contains a small amount of glucose, 
electrolytes, minerals, proteins and other nutrients. (Merritt and Fremont-Smith, 1937).The 
chemical composition is strictly controlled to maintain chemical balance. The 
electrolytes like K+, Ca2+, Mg2 are regulated by a specific transport system. Glucose, 
urea, creatinine and proteins enter the CSF by passive diffusion via pinocytosis. The 
protein concentration in the CSF is strictly related to plasma concentration of the 
protein. In case of damaged BBB eg. In bacterial meningitis, albumin, which is found in 
higher concentration in the plasma crosses the BBB causing increase in protein 
concentration in the CSF (Fischbach, 2009). 
 
Though the CSF is considered as acellular a very small amount of cells can be found. 
The parameter of cells found in the CSF varies according to the age. A cell count of 0 - 
5 WBC and RBC in the CSF are considered normal in adults but in children may vary 
from 0-20 cells and In neonates it may be even higher due to BBB prematurity and may 
range from 0-30 cells (Prober, 2007, Fischbach, 2009). 
 
CSF contains a higher concentration of Na2+ and Cl- in comparison with plasma while 
the levels of K+, Ca2+ and Mg2+ are lower. (Bonadio, 1992, Fischbach, 2009). The average 
concentration of electrolytes is: sodium (Na2) 140mEq/l; potassium (K); 2mEq/l, chloride 
115mEq/l; calcium 2,5 to 3mEq/l; phosphorus 1,6mEq/l and magnesium of 2,2mEq/l 
(Merritt and Fremont-Smith, 1937). Table 1.4 Demonstrates all the characteristics of the 
CSF according to the various ages. 
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Only disease can affect the permeability of BBB and permit the entry of elements that 
usually have no access to the barrier and allow entry of erythrocytes and leukocytes 
from blood vessel damage or from meningeal reaction. However, in case of neonates, 
these have a premature BBB and allow passage of leukocytes and proteins in higher 
concentration during the first 4 to 6 weeks of life, but once maturation occurs, the 
number of leukocytes and amount of protein fall to become similar as in infants 
(Bonadio, 1992). In case of meningitis the BBB is also affected. 
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Table 1.4 Normal Reference Ranges of Cerebro Spinal Fluid According Different 
Age groups  
CSF 
Characteristics 
Neonates Children 
1-4 years  
5-18 years  Adults 
Opening pressure                 50-80 mmH2O        100-200 mmH2O 
Leukocytes 0- 30 cells x 
106/L 
 
0-20 cells x 
106/L 
0-10cells x 
106/L 
0 - 5 cells x 
106/L 
       Differential 
Lymphocytes 5-35%                             40-80% 
Monocytes 50-90%                            15-45% 
Polymorphonucler 
leukocytes 
0-8%                             0-6% 
Erythrocytes  0–675 cells x 
106/L 
                             
                           0-10 cells x 106/L 
Proteins  70 mg/dL                             20-45 mg/dl 
Glucose >50% of serum 
glucose 
                           40-70 mg/dl 
Specific gravity 1005      1000-1006 
Bilirubin None                        None  
Source: (Fischbach, 2009, Muller, 2014) 
 
 
1.9.2 CSF alterations in bacterial meningitis 
CSF appearance, cell count and chemistry 
 
The CSF analysis starts with measurement of CSF pressure followed by physical 
examination of the CSF, cell count, gram stain and culture. The cell count is essential as 
the cell morphology can help in differentiating between the different types of meningitis 
and can be performed within 30 min. Normal CSF is acellular or has few leukocytes, 
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cells usually less than 10 cell/ml with one polymorphonucleocyte (PMN) only 
(Rumbaugh and Nath, 2009). 
The CSF is usually colourless and clear, but in bacterial meningitis the CSF colour may 
vary from clear to purulent. Turbidity of the CSF is a result of increased leukocyte, red 
blood cells, protein concentration, glucose or presence of bacteria (Fischbach, 2009). 
 
The normal CSF pressure is usually between 50 - 200 mm H20 depending on age. 
However, in bacterial meningitis, it is usually increased except in the early stages of the 
disease. But in a later stage of the disease the pressure is typically high. In 90% of 
cases the pressure may be higher than 200 mm H20  and in 10 -15% of cases may be 
as high as, or above 500 mm H20 in adults (Merritt and Fremont-Smith, 1937, 
Venkatesan and Griffin, 2009). In children the opening pressure is also increased in 
bacterial meningitis and the median pressure may be as high as 204 mm H20 (Minns et 
al., 1989). 
 
The normal CSf WBC found in the CSF vary between 0-5 cells/mm3 with one 
ploymophonucleocyte observed. In case more than 2 polymorphonucleocytes are 
observed, CSF should be considered abnormal (Rumbaugh and Nath, 2009). 
 
In bacterial meningitis cell count is usually altered, typical finding are presence of 
polymorphonuclear pleocytosis (Pleocytosis is referred as cell count > 10 cells/µl), 
hypoglycorrhachia and raised CSF protein level (Spanos et al., 1989, Venkatesan and 
Griffin, 2009). 
 
The leukocyte count in bacterial meningitis varies. Typically the leukocyte count is 
greater than 1000 cells/µl but in some cases may be as high as 10,000 cells/µl 
(Schuchat et al., 1997, Venkatesan and Griffin, 2009). However, in rare cases, cell 
count may be lower than 100 cells/µl (Venkatesan and Griffin, 2009). When this occurs, 
it‟s known as „normocelular‟ or „developing bacterial meningitis‟ usually observed in 
immunosuppressed patients and is not very common. However, Fremont Smith in his 
study observed that at least 1% of meningitis patient had cell count < 100 cells/µl (Merrit 
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and Fremont-Smith, 1938) as cited by (Venkatesan and Griffin, 2009). But the 
predominance of PMN in the CSF should suggest the diagnosis of BM, though L. 
Monocytogenes can cause lymphomonocytosis (Rumbaugh and Nath, 2009, Brouwer et 
al., 2010). 
 
Viral meningitis usually presents with a cell count, which typically ranges from 10 - 1000 
cell/µl, but usually lower than < 300 cell/µl with predominance of monocytes and 
lymphocytes. In case of some viral infection like herpes, enterovirus and arbovirus there 
could be predominance in PMN during the first 48 hours (Thomson Jr and Bertram, 
2001). In general, there is an overlap between viral and bacterial meningitis therefore 
microorganism identification is essential for confirming diagnosis (Prober, 2007). 
 
CSF glucose is usually reduced and in 75 % of patients is < 50 mg/dl and only in 25 % 
is below 10 mg/dl (Merrit and Fremont-Smith, 1938) as cited by (Jurado and Walker, 
1990). However, in case systemic glucose level is increased the CSF glucose will also 
be high in these cases. So, many authors suggest for correction by calculating CSF: 
serum / glucose ratio = 0.6 (Spanos et al., 1989, Fischbach, 2009). In viral meningitis it 
is often observed that there is a slight decrease in the level of glucose in the CSF, but 
usually is normal, but in cases of TB meningitis it is very low (Fischbach, 2009). 
Hypoglycorrhachia has a strong predictive value if accompanied with pleocytosis and 
clinical signs of BM (Dubos et al., 2008). 
 
The CSF protein is usually elevated in BM. The typical findings are protein above 45 
mg/dl. When the protein is above 80 mg/dl, it has a strong predictive value for BM, as a 
slight increase in protein may also occur in viral and fungal meningitis. (Dubos et al., 
2008, Fischbach, 2009). A higher increase above 500 mg/dl is strongly associated with 
the development of neurological deficits (Schutte and van der Meyden, 1998). 
 
Out of the 3 parameters, leukocytes and protein count are the least influenced by 
antimicrobial therapy, glucose starts increasing after first 24-48 hours after antibiotic 
administration. Protein and leukocyte may still be present until the end of treatment 
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(Steele et al., 1986). The table below summarizes changes seen in the CSF in different 
types of meningitis. 
 
Table 1.5 Cerebrospinal fluid findings in central nervous system disorders in 
children  
Conditions Leukocytes (µl) Protein (mg/dl) Glucose (mg/dl) 
Normal  <5,   
≥75% Lymphocytes 
20-45 >50 (or 75%  of 
Serum Glucose) 
Acute Bacterial 
Meningitis  
100 - 10,000 
 300-2,000 PMN or 
>50%  
100-500 <40 (or <50% 
serum glucose) 
Partially treated 
bacterial meningitis 
5-10,000; PMNs 
usual, but 
mononucleocytes 
prevalent when 
prolonged treatment  
100-500 Normal or 
decreased 
Viral meningitis or 
meningoencephalits 
Rarely >1000 cells 
           < 500 cells 
Early PMN and later 
lymphocytes 
50-200 Generally, normal, 
but may be 
decreased < 40 in 
some viral 
diseases,  
Tuberculous 
Meningitis 
10-500; PMNs early, 
but lymphocytes 
predominate through 
most of the course 
100-3,000; or 
higher in case 
of obstruction 
<50   
Brain abscess 5-200 , when 
ruptures >10.000 
75-500 Normal  
PMN = polymorphonuclear leukocytes 
Source: (Prober, 2007)  
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1.9.3. Gram stain 
 
The CSF gram stain is a simple and rapid diagnostic test for the identification of 
organisms in bacterial meningitis. It is also an accurate test. It is a very simple test than 
can be easily done in a standard laboratory (Gray and Fedorko, 1992). 
 
The test is positive in 75 to 90 % of culture positive bacterial meningitis. The possibility 
of detecting bacteria depends on the concentration of bacteria in the specimen which 
can be increased by the use of centrifugation (Gray and Fedorko, 1992). It has an 
additional value when in presence of culture negative meningitis. The reliability of the 
test increases when concentration of bacteria are above 105 colonies/ml with sensitivity 
up to 97%. The sensitivity may decrease to 60% when bacteria concentration is below 
104 colonies/ml, and to 25% when below 103 colonies/ml (La Scolea and Dryja, 1984). 
 
The sensitivity of gram stain varies according to aetiologic agent. According to a review 
a wide range of sensitivity was observed for H.influenzae with 25 to 65%, S. 
pneumoniae ranging from 69 to 93%, N.meningitidis from 30 to 89%, L.monocytogenes 
from 10 to 35%, S.agalactiae from 80 to 90% and S.aureus with 20-44%. When 
pretreated with antibiotic the sensitivity was further decreased (Brouwer et al., 2010). 
 
1.9.4. Culture 
 
CSF culture is the gold standard for the diagnosis of BM. It has a lower sensitivity in 
patients pretreated with antibiotics but has a high specificity (Brouwer et al., 2010). 
For community acquired bacterial meningitis it is mandatory to use aerobic media and in 
case of neonates, post neurosurgery or shunt related meningitis anaerobic media must 
be used (Brouwer et al., 2010). 
A study by Nigrovic and collaborators found in 159 patients with BM without prior 
antimicrobial therapy a sensitivity of 84% in comparison with those who received 
antibiotic. For those who had received antibiotic less that than 4 hours, the sensitivity 
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had dropped to 72%. By the end of 24 h of antibiotic therapy sensitivity had further 
dropped to 59%. The diagnosis of BM in this study was made with confirmed cases 
(CSF culture positive or csf pleocytosis with wbc>10 cells/UL plus either a positive csf or 
blood culture positive and a positive latex agglutination test) and probable diagnosis of 
bacterial meningitis based on the result of gram stain but no culture confirmation 
(Nigrovic et al., 2008). This emphasizes the need of LP prior to antimicrobial therapy 
when possible to improve diagnosis by culture. Another retrospective study from Brazil 
with 4,100 cases which defined bacterial meningitis either with definite diagnosis that is 
culture positive plus probable meningitis based on CSF parameter alteration. This study 
involving children reported that the culture was positive only in 67% of patients with the 
diagnosis of BM (Bryan et al., 1990). A third study demonstrated that in the case of 
meningococcus sterility occurred as early as 2 h after antibiotic therapy with 3rd 
generation cephalosporin and for S. pneumoniae  after 4 hours of antibiotic therapy 
(Kanegaye et al., 2001). 
 
1.9.5. Latex agglutination 
 
The latex agglutination is a diagnostic method that is used for the aetiologic diagnosis of 
BM and provides results within 10 to 15 min. It‟s is recommended when gram stain and 
culture of CSF, both are negative, to exclude BM (Tunkel et al., 2004). The test uses a 
serum that contains bacterial antibodies which reacts to bacterial antigens of the CSF 
derived from polysaccharide capsule of meningeal pathogens. When antigens are 
present in the CSF a positive reaction is observed in form of agglutination which lasts 
between 2 to 10 min (WHO, 2011d).  
 
As various commercial kits are available the use of the kit is dependents on 
manufacturer‟s instruction. For optimum result the supernatant obtained though the 
centrifugation must be tested immediately. When immediate testing is not possible, it 
should be refrigerated at 2 to 8 oC. The down side of the kit, is that it needs to be kept 
refrigerated before use, this can be a challenge, especially in tropical climates where 
the electricity problem is frequent. As high temperature deteriorates the serum quickly 
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giving unreliable results (WHO, 2011d). The sensitivity of the test varies according to 
different etiological agents. For N.meningitidis it ranges from 29 to 93%, S.pneumoniae 
59 to 100% and for H. influenzae 78 to 100% (Gray and Fedorko, 1992, Wenger et al., 
1990), giving it a limited diagnostic value and is not clinically useful when both gram 
stain and culture are negative (Nigrovic et al., 2008). 
 
1.9.6. PCR 
 
Broad range polymerase chain reaction using 16S RNA gene has been studied 
extensively to evaluate its efficacy in detecting bacterial genome in CSF from patients 
with probable or confirmed bacterial meningitis. Many studies have been conducted 
using the universal primer 16S RNA, which virtually detects all the bacteria that can be 
studied in microbiology followed by species specific identification for penicillin resistant 
pathogens (Saravolatz et al., 2003, Brouwer et al., 2010). 
  
Saravoltz et al, in their studies compared the broad range PCR with microbiology 
(culture and gram stain) results and reported a sensitivity of 100% (95% CI, 81,6% - 
100%; 17 of 17 samples were positive) and a specificity of 98.2% (Saravolatz et al., 
2003).  
Other studies have detected a wide range of sensitivity for the 3 main pathogens that 
cause meningitis. For H. influenzae a sensitivity ranging from 72 to 92% has been 
observed (Gray and Fedorko, 1992, Saravolatz et al., 2003). For S.pneumoniae a 
sensitivity varying from 61 to 100% was observed (Gray and Fedorko, 1992, Hoen et 
al., 1993, Arditi et al., 1998). While for N. meningitis a sensitivity of 88 to 94% has been 
reported (Tunkel et al., 2004, Brouwer et al., 2010). 
 
Another study by Welinder et al. compared the broad range PCR and culture reports, 
demonstrated that the PCR had the analytic sensitivity of detecting bacteria 
concentration as low as 10 CFU /ml for S. pneumoniae. While for S. aureus and E.coli it 
has an analytic sensitivity of 103 CFU /ml. The overall sensitivity of PCR to detect BM 
was of 59% in comparison to 43% of CSF culture. The specificity was equal of 97% for 
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both culture and PCR. However, In patients pretreated with antibiotic PCR showed 
better results with a sensitivity of 79 % in comparison to culture which only detected 
45% of cases among patients with prior antibiotic treatment, which was statistically 
significant with p <0.05 (Welinder-Olsson et al., 2007).  
 
Therefore, in cases of pretreated patients with negative standard microbiology PCR can 
exclude or confirm meningitis and guide management decision. In many hospitals PCR 
of CSF are not performed routinely, and is only used when the gram stain and culture 
are negative or in case of viral meningitis, as the cost per sample vary from 50 to 90 $ 
(Brouwer et al., 2010, Wang and Mayer, 2012). 
 
Various diagnostic methods exist for diagnosis of BM, however, all the tests have 
different sensitivities and specificities, moreover, many of these tests are not even 
available in low resource countries. In low resource countries point of care tests can 
help in early diagnosis and management using tests which are cheap, affordable and 
easy to perform as one person diagnostic test. This approach would definitely benefit 
the patients and orient adequate patient care. The table 1.6 below compares the 
different available tests for diagnosis of BM and their costs.  
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Table 1.6 Diagnostic Method for Identification of Microorganism in Bacterial 
Meningitis 
Methods Sensitivity Specificity Time for 
detection 
Advantage & disadvantages Estimated 
cost  
CSF Culture 
Gold 
standard 
Low  High 3 – 7 days Specific, add information on AB 
sensitivity 
Prior AB, transportation, type of 
media and delay in analysis 
decrease sensitivity.  
8$ for 
negative 
15$ for 
positive 
Gram stain High 
Lower in  
pretreated 
with AB 
High 
 
<1 h Cheap, quick detection 
Cannot subgroup and serotype 
microorganism 
Need of a trained technician 
0.90$/ 
sample 
Latex 
agglutination 
Low High < 1 h Not able to detect all serogroups 
and low sensitivity 
10$ / 
sample 
RT- PCR High High 4-5 h Fast identification, close system 
for analysis and reduced risk of 
contamination. Not widely used 
 
Commercial kits available  
8.5$  for 
negative 
13$ for 
positive  
50-90$ 
Source, (Brouwer et al., 2010, Wang and Mayer, 2012) 
 
 
1.10 Empirical Antimicrobial Therapy 
 
Empirical antimicrobial therapy in BM should be started immediately if a delay in lumbar 
puncture is foreseen (Tunkel et al., 2004). Studies have demonstrated that a delay of 
antimicrobial therapy can be deleterious for patient‟s prognosis. Many guidelines have 
been established for empiric treatment for bacterial meningitis based on age, type of 
microorganism according to age group and antibiotic that will reach CNS have been 
established and can be modified once the results are available and can be tailored 
according to each patient (Brouwer et al., 2010, Sheldon L Kaplan, 2014).  
 
Neonates have a higher risk for meningitis for the factors that have already been 
mentioned earlier in this chapter. Early onset bacterial meningitis is most likely due to 
gram negative bacteria from the genitourinary flora of the mother therefore antibiotic 
must be guided toward these microorganisms. Empiric treatment suggested for this 
group is with ampicillin and aminoglycosides or a 3rd generation cephalosporin to cover 
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group B streptococcus and gram negative bacteria (E. coli, klebsiella, enterobacter). For 
the late onset due to high risk of staphylococci infections, medications containing 
antistaphilococci activity are preferred and drugs like vancomycin or Nafcillin plus a 3rd 
generation cephalosporin (cefotaxime or ceftazidime) is preferred (Sáez-Llorens and 
McCracken, 2003, Prober, 2007). In general empirical treatment can be initiated without 
any delay before CSF results are available, (Brouwer et al., 2010) in their review have 
shown empirical treatment based on subclinical groups which has been demonstrated in 
table 1.7 
 
Antimicrobial therapy destroys bacteria and temporary aggravates host inflammatory 
response and increases tissue damage, dexamethasone a corticosteroid if given prior 
antibiotic administration can reduce the inflammatory response (Tunkel and Scheld, 
1993, Roos and Van de Beek, 2010) and reduce the complication associated with 
H.influenzae to reduce days of fever, CSF proteins levels and for reducing 
sensorineural hearing loss specially in children. However it is only beneficial if given 1 to 
2 hour prior antibiotic (Prober, 2007). However the use of steroid in children with 
pyogenic meningitis in a study done in Malawi did not show any additional benefit 
neither in reducing mortality or neurological sequelae (Molyneux et al., 2002) and this 
concept is also supported in South Africa guideline of management of bacterial 
meningitis(Boyles et al., 2013).
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Table 1.7 Empirical antimicrobial therapy for bacterial meningitis based on different age groups 
Clinical 
subgroups 
Initial AB therapy and dosing regimen Predominant 
microorganisms 
References 
Neonates 
 Early onset 
Ampicillin ( 100-150mg/kg/d Q 8h plus (gentamicin 
5mg/kg/d) Q12h    or  
cefotaxime(100-150mg/kg/d) Q8-12H 
S.agalactiae, E.coli , 
L.monocytogenes, 
Klebsiela  
(Muller, 2014) 
Neonates 
Late onset 
 
For  S.aureus: 
-Ampicillin ( 100-150mg/kg/d Q 8h plus( gentamicin 
5mg/kg/d) Q12h    or Cefotaxime(100-150mg/kg/d) Q8-12H 
-Nafcillin (150-200mg/kg/d) Q8-12H or vancomycin ( 30-
45mg/kg/d) Q 8h plus cefotaxime(150-200mg/kg/d) Q6-8H 
L.monocytogenes, 
S.agalactiae, gram 
negative bacilli  
(Prober, 2007) 
Infants and 
children  
 
 
Low resource 
countries 
Penicillin G (450.000/kg/d) Q4-6h or Ampicillin( 300-
400mg/kg/d) Q4-6h plus gentamycin 7.5mg/kg/d Q8 or 
cefotaxime (100-150mg/kg/d) 
 
Chloramphenicol  100mg/kg/d Q6h plus Ampicillin or 
Penicillin  
S.pneumoniae, 
H.influenzae  and 
N.meningitidis  
 
(Prober, 2007, Muller, 
2014) 
(WHO,2000) 
Immunocompro
missed children  
Ampicillin(300-400mg/kg/d) Q4-6h plus cefotaxime (100-
150mg/kg/d) or  
Vancomycin (60mg/kg/d) Q6h when staphylococcus 
suspected. 
Standard Tuberculosis treatment for meningitis 
Above mentioned 
organism plus 
L.monocytogenes, 
Tuberculosis , S.aureus  
(Prober, 2007, Muller, 
2014) 
 
(WHO,2000) 
Adults   3
rd
 generation cephalosporin plus  
vancomycin (30-60 mg/kg/d)  Q8-12 h 
S.pneumoniae, 
N.meningitidis  
 
Elderly  3
rd
 generation cephalosporin plus 
Ampicillin (12 g/day) Q4 h plus 
vancomycin (30-60 mg/kg/day) Q8 12 h 
S.pneumoniae, 
N.meningitidis, 
L.monocytogenes 
(Prober, 2007, Muller, 
2014) 
 
Nosocomial 
 
Vancomycin ( 35-45mg/kg/d) Q8-12h plus ceftazidime (6g/d 
[ Q8h] or cefepime( 6g/ d[ Q8h) or meropenem(6g/d[Q8h]) 
S.aureus, S epidermidis, 
aerobic, Gram negative 
bacilli  
 
Basilar fracture  3
rd
 generation cephalosporin plus 
vancomycin (30-60 mg/kg/day) Q8 12 h 
S. pneumonia and S. 
aureus and gram  
 
Adapted from (Brouwer et al., 2010) 
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1.11 Complications 
 
During the course of bacterial meningitis, many complications may arise. These 
complications may be systemic or neurological in origin and may be acute or gradual 
onset. Many factors like age, severity of the disease, type of meningeal pathogen, time 
of presentation to the hospital, associated comorbidities of the patient and late initiation 
of antimicrobial therapy are some of the factors that influence onset of complications 
(Sheldon L Kaplan, 2014). Some of these complications may arise post meningitis and 
are known as long term sequelae (Edmond et al., 2010b). 
 
A systemic review by Edmond et al reported, that long term disabling neurological 
sequelae on average among meningitis survivors is of 20%, but it varies from 9% to 
25% across the WHO regions with the likelihood of occurring 3 times higher in Africa 
and Asia in comparison to Europe and America (Edmond et al., 2010b). Another meta-
analysis of 45 report from 1977 to 1991 involving children between the age of 2 months 
to 19 years, reported that in developed countries the risk of neurological complication 
was seen in 17.5% while in developing countries it was higher with 26% (Baraff et al., 
1993). Two thirds of all death due to bacterial meningitis occurs in developing countries, 
and among survivors the rate of subtle neurobehavioral disabilities at discharge is 
estimated to be as high as 50% (Prober, 2007).Table 1.8 summarizes all the 
complications 
 
The most common complications observed in children are sensorineural deafness, 
seizure disorder and motor deficit in comparison to adults who are in higher risk of 
developing hearing loss, motor and cognitive deficit or speech problems. These 
complications are classified as neurological or systemic while neurological can further 
be divided into focal or generalized complications. These complications may start as 
early as the entry of meningeal pathogen to the CNS via BBB and may continue post 
treatment (Siddiqui, 2012, Sheldon L Kaplan, 2014) 
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Table 1.8 Shows classification of different complications in bacterial meningitis  
(Siddiqui, 2012, Sheldon L Kaplan, 2014) 
 
Neurological Systemic 
Acute   : 
- Altered mental status 
- Coma 
- Seizures 
- Subdural effusion or empyema 
- Ventriculitis  
- Hydrocephalus 
- Cranial nerve palsies 
- Sensorineural hearing loss 
- Cerebral edema and raised 
intracranial pressure 
- Hemiparesis or quadriparesis 
- Blindness 
 
- Prolonged Fever  
- Septic shock  
- Disseminated intravascular 
coagulation 
- Vasomotor collapse 
- Reactive arthritis 
- Respiratory distress syndrome and 
respiratory failure 
- Pericarditis or pericardial effusion 
- Bilateral adrenal hemorrhage 
(Waterhouse–Friderichsen 
syndrome) 
- Fluid  and electrolyte imbalance 
- Hypothalamic and  
           endocrine dysfunction 
- Death  
 
 
 
Chronic : 
- Epilepsy  
- Ataxia 
- Cerebrovascular abnormality 
- Neuropyschological deficit 
- Developmental disabilities 
- Intellectual deficit  
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Feldman (1997) identified in his study several clinical factors that are associated to 
adverse outcome in children. These factors include alteration of mental status early in 
the disease; prolonged seizures with more than 72 hours after admission and severe 
leucopenia are predictors for neurological complications. While patients with CNS 
symptoms lasting more than 48 hours, development of focal neurological signs, ataxia, 
or deterioration of consciousness are at a higher risk of developing adverse outcome 
despite adequate antimicrobial therapy. Beside clinical features cerebrospinal fluid 
alterations like hypoglycorrhachia, and increased concentration of bacterial count above 
107 CFU/ml are associated with adverse outcome (Feldman, 1977).  
 
A significant number of children also have multiple neurological deficits (Prober, 2007, 
Sheldon L Kaplan, 2014). Complications that arise during treatment include seizures, 
increase in intracranial pressure, stroke, cranial nerve palsies, cerebellar or cerebral 
herniation and thrombosis of dural venous sinus, ventriculitis, subdural effusion or 
empyema and syndrome of inappropriate secretion of antidiuretic hormone. (SIADH) 
(Prober, 2007).  
Table 1.9 Frequencies of most common complications in bacterial meningitis in 
children 
Complications  Frequency 
Hearing loss 33.6% 
Seizures 12.6% 
Motor deficit  11.6% 
Cognitive impairment 9.1% 
Hydrocephalus  7.1% 
Visual disturbance 6.3% 
Cognitive impairment & hearing loss combined 39.1% 
Cognitive deficit & motor deficit combined 21.1 
Cognitive & motor deficit plus seizures combined  8.1 
Source (Maria and Jr., 2006) 
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Ventriculitis is one of the most common complications observed among neonates in 
bacterial meningitis. Ventriculitis is an inflammation of the lining of the ventricles and the 
CSF found inside the ventricles of the brain. It is associated with CSF obstruction 
especially aqueduct of Sylvius, where the infection acts as an abscess obstructing CSF 
outflow. It is a common complication observed in neonates (Prober, 2007, Sheldon L 
Kaplan, 2014, Maria and Bale, 2006). In one study ventriculitis occurred in 92 % of 
neonates with bacterial meningitis (Berman and Banker, 1966, Salmon, 1972). This 
condition in a severe and rapidly progressive case may lead to brain stem herniation 
and impair the perfusion of the periventricular structures (Salmon, 1972).  
 
Subdural effusion is a collection of fluid in subdural space (Encyclopedia, 2012). In 10 to 
30% of cases of bacterial meningitis subdural effusion may develop and is usually 
asymptomatic in 85% to 90% of cases. Subdural effusion is a common finding in infants. 
It occurs bilaterally affecting the frontal, parietal region and occasionally the occipital 
region. This condition may be accompanied by bulging of the fontanelle, distasis of the 
suture, an increase in head circumference, vomiting, seizures, fever and abnormal 
findings of cranial trans illumination. The diagnosis is made with CT scan or MRI and in 
severe cases it may be managed  with surgical aspiration (Prober, 2007). 
The subdural effusion is the consequence of an efflux of intravascular fluid due to 
thrombophlebitis of veins in the subdural space, increased vascular permeability and 
arachnoiditis. One study reported that subdural effusion occurs in 45% of cases of 
meningitis due to H. influenzae, 30% in the cases of S. pneumoniae  and only 10% in 
case of N. meningitis (Snedeker et al., 1990, Maria and Bale, 2006). 
The syndrome of inappropriate antidiuretic hormone secretion (SIADH) may occur in 
some patients. According to one study SIADH was diagnosed in (22/67) 36.7% of cases 
among children with bacterial meningitis on admission and additional (6/48) 12.5% 
developed the condition on the third day of admission and it was strongly correlated with 
severity of leptomeningeal inflammation. This study also reported that it occurred in 
75% of cases of meningitis due to Streptococcus pneumoniae meningitis (Patwari et al., 
1995). SIADH is characterized by hyponatremia and reduced serum osmolality and can 
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aggravate cerebral edema (Prober, 2007). Other blood alteration includes anemia, 
thrombocytosis and eosinophilia. Anemia occurs due red blood cell hemolysis or bone 
marrow suppression. Another severe complication is a disseminated intravascular 
coagulopathy (DIC), which is usually rapidly progressive. It is accompanied by shock, 
purpura, signs of septicemia, profound hypotension with signs of hemorrhage and 
thrombosis. The severe hypotension observed in DIC combined with endotoxemia 
initiate coagulation process which in combination with thrombosis may produce 
peripheral gangrene which commonly affects lower limbs. This complication most 
commonly accompanies meningococcal meningitis or meningococcal invasive disease 
(Prober, 2007). 
 
1.12 Prognosis 
The prognosis of patient with bacterial meningitis depends on many factors. The most 
important factors that influence the outcome of bacterial meningitis are: age, the 
causative microorganism, CSF parameters like increased level of proteins, the amount 
of bacteremia and its products, an increased wbc in the CSF, very low level of glucose 
and delay in diagnosis and treatment of BM (Hodges and Perkins, 1975, Arditi et al., 
1998). In the United States of America case fatality rate among children above age of 
one month ranged from 0 to 15 % depending on the organism and time of survey 
(Baraff et al., 1993, Schuchat et al., 1997, Thigpen et al., 2011). 
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2. Rationale of the thesis 
 
In 2010 the annual epidemiologic bulletin reported overall that 677 cases of meningitis 
were diagnosed in Mozambique, with a lethality rate of 25.55% (MISAU, 2010). This data 
is an underestimate because it only represents the confirmed cases either with gram 
stain or culture while all bacterial meningitis that are culture negative were excluded. 
Delay in analysis is one important determining factor for the prognosis of a patient with 
bacterial meningitis. 
 
Central Hospital of Beira is the second largest hospital of Mozambique. It is located in 
the central region, in the second largest city of the country in Sofala province. It is a 
tertiary hospital that provides service to 8,496,613 people of the central region (WHO, 
2014a). Which comprises of 4 provinces namely Sofala Manica, Zambezia and Tete. 
Out of which 1,715,557 are from Sofala province alone. The hospital has 1028 beds 
“(extra beds included)” with an annual admission of around 27.000 patients. The 
Hospital has 1028 staff out which 90 are doctors and 318 are nurses. The hospital also 
provides teaching ground to 350 medical and nursing students annually (WHO, 2014a). 
 
The hospital has wide range of services available from pediatrics to neurosurgery. It has 
a central laboratory which does standard blood chemistry and microbiology however the 
hospital has no microbiologist and can only provide basic microbiology test. The 
laboratory is run by laboratory technicians with medium level of education and provides 
services from 7.15 to 2.pm only. The laboratory does not perform CSF, ascetic fluid, 
pleural and cardiac fluid chemistry. Limiting a lot diagnosis of bacterial meningitis 
among other diseases (Author‟s observation). 
 
In the Central Hospital of Beira, CSF analysis of leucocyte including pandy test and 
gram staining does take a minimum of 90 min. Frequently, the CSF analysis are not 
available, which delays the diagnosis and treatment of the child .This delay can be 
catastrophic, because late treatment is associated with high mortality and morbidity. The 
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availability of a sensitive bedside test would allow the initiation of the treatment without 
any delay. 
 
Rural hospitals and primary health care centers in sub-saharan Africa frequently lack of 
suited laboratory, reagents for the tests, and trained technicians to perform the CSF 
analysis. This leaves no other choice but either start empirical treatment or to transfer 
the patient to a hospital with more resources which might cause further delay (Petti et 
al., 2006). 
 
The sub Saharan region has also high prevalence of cerebral malaria which may be 
indistinguishable from bacterial meningitis. So many children present to the hospital with 
meningitis like symptoms but do not have bacterial meningitis. The lack of diagnostic 
facilities further challenges already little resource that is available in the hospitals by 
treating all patients for bacterial meningitis with antibiotics which are expensive and may 
already use up the little stock that is usually available, overburdening the health centers 
and hospitals. Therefore the availability of bedside test for meningitis would lead to a 
rapid screening and help determine if the patient may require or not intravenous 
antibiotic at meningitis doses. 
 
Urine dip strips are widely available and determine the semi quantitative measurements 
of leucocytes, glucose and protein. Therefore, they provide an easily applicable method 
for the measurement of the relevant chemical properties of the CSF. The aim of the 
thesis is to evaluate the use of urine dip strip in the setting of meningitis. 
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                                                     2.1 Objectives  
 
2.1.1 Objective of the thesis 
 
1. To evaluate CSF using a standard urine dip strip (glucose, proteins, leucocytes, 
nitrites and density) and to compare the results with the clinical course and outcome 
and the local standard methods. 
 
2. Development of a bedside treatment algorithm for meningitis, including the use of 
urine dip strip results of first objective 
 
3. Paving the way for the development of a test strip specifically aimed at the CSF 
analysis. 
 
2.1.2 Research questions 
 
1. Is a standard Urine dip strip applicable for CSF analysis at the patient's bedside for 
the diagnosis of meningitis as a one person procedure?  
 
2. What is the sensitivity and specificity of the dip stick in bacterial meningitis?  
 
3. Is a differentiation between BM, viral meningitis, malaria and TB meningitis using dip 
strip possible? 
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3. Methodology 
 
3.1 Study design and study population 
 
A single blinded diagnostical clinical trial (laboratory technicians were not aware of the 
results of the reagent strip) was conducted in paediatric wards of the Hospital Central do 
Beira a tertiary hospital in Sofala Province in Mozambique. 
 
We included children from 2 months to 14 years of age, which presented at the pediatric 
emergency department at the Hospital from November 1st 2012 to February 28th 2014 
from 6.30 am to 9.00 pm from Monday to Sunday. 
 
3.1.1 Study location   
 
Mozambique is located in southeast Africa. It is sub divided in to 11 provinces and 
Sofala is the second largest province of the country. The Central Hospital of Beira is a 
referral hospital of the central region of Mozambique. It is located in Sofala province in 
Beira city, which is the capital of the province. The hospital receives patients from all the 
health centers, district hospitals of the province and from the nearby provinces. It is the 
second largest hospital at the country level and the biggest hospital at the regional level. 
It serves 4 provinces namely Manica, Zambezia, Tete and Sofala with a total population 
of around 8.5 million people. The hospital annually admits 27,068 patients (WHO, 
2014a). The province has an area of 67,218 Km2 and has population of 1,642.920 
according to 2007 census (Sofala, 2007). 
 
3.1.2 Inclusion Criteria  
 
Children between 2 months to 14 years of age who had: 
- Suspicion of meningitis which included altered mental status, meningeal signs, 
(bulging fontanel, neck stiffness, kernig or brudzinski sign), neurological deficit, irritability 
behavioral change or fever without source accompanied by seizures. 
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- Indication of lumbar puncture. 
- Not used antibiotic for more than 48 hours prior lumbar puncture  
- No severe immunosuppression eg. terminal AIDS (Acquired Immune deficiency 
Syndrome) or stage IV AIDS without antiretroviral therapy and cancer patients. 
- Parents willing to have their children participate in the study and undergo lumbar 
puncture and willing to sign informed consent were included.  
 
3.1.3 Exclusion criteria 
 
All the children who did not fulfill inclusion criteria and had used antibiotic more than 48 
hours, or were on treatment for active TB (tuberculosis) or on immunosuppressive drugs 
like anti neoplastic treatment or steroids were excluded from the study. 
 
3.1.4 Patient recruitment  
 
Once a child was observed in the Emergency Department (ED) by the attending 
physician with suspicion of meningitis and indication for lumbar puncture (LP) the study 
physician was called for patient enrollment. 
Patient recruitment took place after the patient was screened by study physicians and 
informed consent was sought. Parents or guardians of children were informed on 
lumbar puncture procedure and its risks, the use of urine strip to analyze CSF and 
explanation was given that 1 ml of the CSF would be stored and would be later 
analyzed for PCR and Cytokine in Munich, Germany.  
 
Once all the formalities had taken place, lumbar puncture was performed. Patients were 
sedated using ketamine prior procedure. For the procedure the skin was disinfected 
with 2% iodine, a sterile kit was used and a normal standard needle with stylet was 
inserted at L3–L4, L4–L5, or L5-S1 interspace. When subarachnoid space was reached, 
the stylet was removed and 2.5 - 3.5 ml of CSF were collected in four different sterile 
tubes (Bonadio, 2014). 
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The first tube contained 0.5 ml to 1 ml of CSF to be used for cell count, pandy test and 
for urine reagent strip testing. The second sterile tube with 1 ml of CSF was used for 
culture, gram stain, Indian ink for cryptococcal evaluation and Ziehl neelsen stain if 
asked. The third and fourth sterile tubes contained 0.5 ml each for PCR and cytokines 
testing.  
 
The first 2 tubes were sent to hematology and microbiology department respectively. 
The other 2 vials were immediately kept in the fridge at 2 to 8 degrees centigrade and 
within 2 hours stored at -80 degrees centigrade while patient recruitment was 
completed. 
 
Once the CSF was obtained 6 drops were used on the reagent strip for leukocyte, 
glucose, proteins, blood, nitrites and density. The reagent strip used for the study was 
the Multistix 10 SG from Siemens. The strips are the same that are used for urine 
examinations. The Multistix 10SG have a small specific areas for enzymatic reaction 
called the “test pads” (Siemens, 2012). These test pads provide semiquantitative 
measurements for leucocytes, protein, glucose, nitrite, blood as well as other tests. 
 
3.2 Reagent strip Multistix 10SG 
 
Each Bottle of the Multistix 10 SG from Siemens, contains 100 strips. The 
recommendations by the manufacturer were followed for the reading of the each test 
pad. The strips are ready for use upon removing from the bottle and maybe evaluated 
visually or using CLINITEK instrument. An instrument which can automatically detect 
colour change and print results. For research purpose the reading was done visually.  
The fig. 3.1 shows a picture of the urine strip  
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Fig. 3.1 Picture of urine strip used in the study from Siemens 
 
Source (Siemens, 2014) 
 
All the recommendations given by manufacturer were followed when examining CSF 
with reagent strip. The reagent strip‟s desiccant was kept all the time in the bottle to 
keep the strip moisture free. 
 
3.2.1 Storage and Handling of strips 
 
To get precise and to avoid false negative or false positive results we followed all the 
instructions provided in the leaflet by Siemens. The bottle was kept between 15 to 30 
degrees centigrade and stored away from the direct sunlight. The desiccant was kept all 
the time in the bottle to keep the strip protected from moisture. 
Monthly quality controls were done with Biorad urine control to check for quality control 
of the test. When any discoloration or any darkening of the strip was noted the bottle in 
question was not used for study patients. 
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3.2.2 Factor affecting the reagents strip results 
 
According to the Siemens leaflet humidity, contaminants in the specimen container, 
direct sunlight could affect strip reading and every effort was made to avoid these 
factors (Siemens, 2012). Any substances that could colour the urine could affect the 
results, but in case of CSF no data were available. 
 
3.2.3 Reagent Test Strip information  
 
Protein  
This test is based on protein-error-of-indicators principle. This principle is based on the 
“ability of protein to alter the color of some acid-base indicator without altering the pH” 
(MediaLab, 2012). The test pad contains 0.3% tetrabromephenol blue, buffer and a non-
reactive ingredient and changes its colour when it is brought into contact with proteins, 
specifically albumin. The protein test is less sensitive to globulin. So in cases of 
mucoproteins which are globulin the test may be negative. When the reagents are in 
contact with albumin it will change its colour from yellow (without albumin) to green or to 
blue depending on the concentration of albumin in the CSF. The protein test pad for 
colour change was read at 60 seconds and compared to standard chart provided by the 
manufacturer and the results were quantified as follow (Siemens, 2012). 
 
 
Negative                           No colour change  
Trace                                Yellow green 
1+      (30 mg/dL)             Green  
2++    (100 mg/dL)           Darker green 
3+++  (300 mg/dL)           Blue green  
4++++ (>2000 mg/dL)      Blue 
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Blood 
 
The test pad contains the diisopropylbenzene dihydroperoxide, a 3,3,‟ 5.5,‟ 
tetramethylbenizidine, a buffer and a non-reactive ingredient. The blood test is based on 
the “peroxidase like activity of haemoglobin”, which catalyses the reaction of the reagent 
substances with the chromogen reacting to erythrocyte but also to haemoglobin and 
myoglobin. The resulting colour ranges from orange to dark blue (Siemens, 2012). 
As the CSF normally does not contain erythrocytes the strip for erythrocyte detection 
can be used to detect blood in cases of intraventricular haemorrhage or subarachnoid 
haemorrhage and it has been used in a study (Marshall and Hejamanowski, 2011). 
This test can be read at 60 seconds for the erythrocytes and for haemoglobin (Hb). The 
strip has the capacity to detect a minimum of 10 RBC/µl (Red blood cells) and was 
quantified as (Siemens, 2012): 
 
For non hemolysed erythrocyte: 
 
Negative                   Yellow no colour change 
Trace (10 RBC/µl)    Yellow with few green spots  
2++ (80 RBC/µl)       Yellow with more green spots  
 
For free haemoglobin (Hb) it is quantified as: 
Trace (10 Hb)           Green 
1+ (25 Hb)                Dark green 
2+ + (80 Hb)             Blue green 
3+++ (200 Hb)          Dark blue 
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Leucocytes 
The test pad contains a derivative pyrrole amino acid ester; a diazonium salt; a buffer 
and a non-reactive ingredients. The test is based on the principle that granulocytic 
leucocytes contains esterase that catalyze the hydrolysis of the pyrrole amino acid ester 
to liberate a 3-hydroxy-5 phenyl pyrrole, which in turn reacts with diazonium, a salt 
buffer which in turn changes the color from white to purple. It can detect both lysed and 
intact leucocyte cells. The leucocyte can be read at 120 seconds and is defined as 
(Siemens, 2012): 
 
Negative                     White (No colour change) 
Trace (5-15 cells/ µl)   Light grey  
1+ (75 cells/ µl)           Dark grey 
2++ (125 cells/ µl)       Light purple 
3+++ (500 cells/ µl)     Dark purple 
 
The elevated glucose above 3g /dl or 160mmol/L may decrease the sensitivity of the 
test results. Other factors that can affect the results are presence of antibiotics like 
cephalotin, cephalexin, tetracycline and high doses of antibiotics may decrease 
reactivity and cause false negative results (Siemens, 2012).  
 
 
Nitrites 
The nitrite test pad contains p-arsanilic acid, 1,2,3, 4- tetra hydrobenzoquinolin-3-ol a 
buffer and a non-reactive ingredients. “The principle of the test is based on the 
conversion of nitrate from diet metabolites to nitrite by action of gram negative bacteria 
in the urine” (Siemens, 2012). Any colour change was defined as negative when no 
colour change occurred and a positive reaction when the test pad changed from white 
to pink. Many gram negative bacteria give a positive result when the number of bacteria 
are higher than 105 colonies per ml (Siemens, 2012). 
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Glucose  
The glucose test pad contains glucose oxidase, perioxidase, potassium iodide, a buffer 
and a non reactive ingredient .The principle of the test is based “on double sequential 
enzyme, reaction utilizing glucose oxidase and peroxidase with a potassium iodide 
chromagen” and the colour changes from green to brown. It is read at 30 seconds and 
is specific for glucose.  There are no substances that can interfere with the reaction of 
the glucose test pad to give false positive results, but a high concentration of ketone 
could give a false negative especially if glucose concentration is low. The glucose result 
was quantified as (Siemens, 2012) : 
 
Negative                    Blue 
Trace (100mg/dL)      Green 
1+ (250mg/dL)           Green brown        
2++(500mg/dL)          Light brown 
3+++ (1000mg/dL)     Darker brown 
4++++ (>2000mg/dL) Dark brown 
 
 
Specific Gravity  
The test pad contains bromthymol blue, poly(methyl, vinyl, ether / maleic anhydride) and 
sodium hydroxide. The principle for the reaction is based on pKa change of of ceratin 
pretreated polyelectrolytes in relation to ionic concentration” (Siemens, 2012). In the 
presence of the indicator the colour changes from blue green to darker green and 
yellow. The test is read at 45 s and increase in osmolality increase can be affected by 
the higher concentration of protein. The test is quantified as :1.000, 1.005, 1.010, 1.015, 
1.020, 1.025, and 1.030 (Siemens, 2012). 
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3.2.4 CSF Evaluation using urine reagent strip 
 
The technique of using CSF on a reagent strip for evaluation of leucocytes, protein and 
glucose has been well described in many studies (Parmar et al., 2004, Joshi et al., 
2013). However the exact amount of CSF for each test pad and the time required for the 
reading of colour change specifically for CSF evaluation has not been well established. 
The reason why the author is following the instruction from the manufacturer for the 
urine analysis and is applying the instructions for the CSF evaluation.  
 
One drop of CSF was removed from the first tube using pasteurs pipette and was 
dropped on the specific test pads and visually read after appropriate timing. In some 
cases the leucocyte reading was prolonged to 150 seconds especially when glucose 
was very high above 2000 mg/dL which was referred as 4++++. 
 
In cases where the first drop of CSF did not cover adequately the test pad another drop 
was dripped on the test pad to cover the area. Visual reading was done comparing each 
pad with corresponding colour block on the bottle. Reading started with the test pad 
which required the shortest time. In this case it started with glucose at 30 seconds 
followed by, specific gravity, which was read at 45 seconds. Followed by blood, protein 
and nitrites all three tests were read at 60 seconds. Finally the leucocyte was evaluated 
at 120 seconds. All the readings were under natural light a photograph was taken and 
the results were recorded in patient‟s case record form.  
 
Once the urine reagent strip test, for CSF evaluation was done the first two tubes were 
sent to the hospital‟s laboratory for biochemistry, cell count, gram stain, culture, pandy 
test and syphilis test if required. The other two tubes were stored at - 80 degrees for 
control of standard microbiology, PCR and cytokine test in the laboratory of Hauner‟s 
Children‟s Hospital in Munich, Germany. The laboratory technicians were not aware of 
the reagent strip results and received a laboratory chart sheet which was 
pseudonymized using a study number. 
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3.3 Patient evaluation and data recording 
 
Once the patient was recruited a full physical examination was done, vital signs were 
taken and registered in patient‟s case report form. The blood glycemia was measured 
for every patient at the bedside and a rapid malaria test was done. In the case of 
patients who were already on fluid therapy and had the fluid or glucose bolus prior to 
lumbar puncture, this information was also recorded. 
 
A full history was taken from patients who could speak or from parents whose children 
were not able to speak or had impaired consciousness. Signs and symptoms that were 
important variables for the study were clearly defined in order to avoid false 
interpretation by the study physician. 
 
The important variables were: 
1. Fever prior admission: this was subjective information provided by caregivers as 
“body being hot”. Most of the caregivers do not have access to the thermometer 
so the exact temperature was not used for defining fever prior to admission. 
 
2. Symptom duration: any symptoms (headache, fever, behavioural change, poor 
feeding, loss of appetite, feeling sick, vomiting or other) which started first before 
admission were defined as 0 to 24h, 24 to 48h or more than 72 hours. 
 
3. Irritability: defined as an abnormal reaction to normal stimuli, in context of smaller 
children it was defined as crying or overreaction to touch or any sensitive stimuli 
(William C. Lloyd III, 2013). 
 
4. Behavioural change:  Any change to the response of the child to a sensorial, 
motor or painful stimuli which was not appropriate for the age. Possible 
inappropriate reactions included being overly calm or aggressive or just not 
wanting to play, feeling sleepy or having a slurred speech (Dictionary, 2009). 
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5. Coma: Was defined using 2 scales. Glasgow coma scale (GCS) and Blantyre 
coma scale (BCS). The definition of severe coma included GCS< 8 and BCS< 2. 
The Blantyre coma scale was used in children below the age of 2 years and for 
above the age of 2 years Glasgow scale was used. For children with disabilities a 
modified Glasgow coma scale was used (Chowdhury et al., 2001). In a coma 
patient, daily evaluation of GCS or BCS score was recorded, beside that every 8 
hour evaluation was done either by the study doctor or attending physician and 
was recorded to find out the duration of coma. 
 
6. Kernig sign: Performed with the patient in supine position, with knees and hip 
flexed the physician attempts extension of the knee. The sign was interpreted as 
positive when it was not possible to extend the knee beyond 135 degrees without 
causing pain (Ward et al., 2010). In cases where the sign was positive it was 
measured daily until the sign disappeared.  
 
7. Brudzinki sign: There are several signs described by the Polish paediatrician 
Josef Brudzinski for meningitis. In our study we evaluated Brudzinski‟s neck sign. 
This test was performed with the patient in supine position. One hand of the 
physician is kept behind the head and other on the chest. Then, a flexing of the 
neck was attempted. The test was considered positive when a patient‟s lower 
limbs were flexed (Ward et al., 2010). As with the kerning this sign, was 
evaluated daily until the disappearance of the sign 
 
8. Nuchal rigidity was defined as impairment or difficulty in flexing the neck (Maria 
and Bale, 2006). 
 
9. Antibiotic use: Name, number of doses, dates of antibiotics were recorded, in 
cases, where an antibiotics was changed it was also referred. 
 
 
 
 
 
70 
 
3.4. Examination of the Cerebral Spinal Fluid 
 
Laboratory examination of the CSF is usually the first step to confirm the presence of 
bacterial meningitis. Cytological examination preceded centrifugation. The typical 
findings associated with bacterial meningitis are following (WHO, 2011a): 
- Turbidity 
- Increased opening pressure (>180 mm H20) 
           Pleocytosis: PMN leukocytes and WBC count > 10 cells/ µl for older children,  
           for infants it was considered 10-30 WBC/ µl with 50% PMN. 
- Decreased glucose concentration (<45 mg/dL) 
- Increased protein concentration (>45 mg/dL) 
 
Once the CSF arrived in the Hospital‟s laboratory. The first tube was taken to 
hematology department and the second sterile tube was taken to the microbiology 
laboratory. The volume of the sample was noted for both tubes. In the Hematology 
department physical examination of the CSF, followed by cell count and Pandy test was 
done. While in microbiology laboratory gram stain, culture, Indian ink and antibiotic 
sensitivity test were done. 
 
3.4.1 Physical Examination of Cerebro Spinal Fluid 
The physical and cytological examinations were done in the Hematology Department of 
the Central Hospital of Beira. CSF physical was noted on the patient‟s laboratory sheet. 
Normally CSF is crystal clear, but in case of any pathology, it may be turbid or cloudy. 
The appearance was reported as turbid, clear, xantochromic, purulent or opalescent. 
The appearance is altered in different conditions and pathologies. For study purposes 
the turbidity was further divided in slightly turbid and turbid. The table 3.1 shows 
different colours of the CSF and conditions associated with.  
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Table 3.1 Cerebro-spinal Fluid Supernatant Colours and Associated conditions 
 
CSF or supernatant color  Conditions or or Causes  
  
Clear 
 
Xanthochromia 
 
Normal 
Yellow  
 
Orange  
Pink  
 
Cloudy or turbid        
 
 
Opalescent slightly yellow   
 
Opalescent to slightly purulent             
              
Green  
 
 
Brown 
Breakdown of blood products 
 
Blood breakdown products 
High carotenoid ingestion 
 
CSF Leukocytes > 200 wbc/mm3 
RBC > 400 / mm3 
 
Tuberculous Meningitis 
 
Bacterial Meningitis 
 
Hyperbilirubinemia 
Bacterial  Meningitis 
 
Meningeal Melanomatosis 
  
Source: (Seehusen et al., 2003, Fischbach, 2009) 
3.4.2 CSF cell count and Pandy test  
3.4.2.1 Cell count 
The cytological examination based on the cell count was performed in a Neubauer 
chamber. White blood cells were differentiated into polimorphonuclear cell or 
lymphocytes and erythrocytes were counted. The chamber has 9 main squares which 
are further divided into smaller squares. When the CSF was clear the uncentrifuged 
CSF was diluted with one drop of crystal violet solution 1:1 dilution was preferred and 
then, it was directly inoculated in the groove. The WBC were counted under microscope 
(Ochei and Kolhatker, 2008, Cheesbrough, 2009). In case of the turbid CSF it was 
diluted 1:10 with crystal violet solution and then the cells were counted microscopically 
(Ochei and Kolhatker, 2008).  
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The calculation was done using the following formula for Neubauer chamber 
(Cheesbrough, 2009):  
Cells in 1µl = no of cells in 4 main square x 25  
 
When cell count was below 5 cell/µl then the cell differentiation was not performed and 
cell count above 5 cells/ µl were considered abnormal and differential was reported in 
percentages (Cheesbrough, 2009). 
 
Glucose and protein chemistry was not done as there were no reagents available and 
the chemistry machine has not been functioning for past 8 years. 
 
3.4.2.2 Pandy’s globulin test 
 
This semiquantitative test detects an increase in the level of globulins, which indirectly 
can be interpreted as an increase in total protein level of CSF by estimation. It is only of 
use when CSF total protein cannot be measured. However in some connective tissue 
disorder, multiple sclerosis and neuro syphilis the Pandy test may be positive due to 
presence of globulins despite the normal CSF levels of proteins (Cheesbrough, 2009). 
This is exactly what urine strip doesn‟t measure. By measuring the albumin level in the 
CSF it gives a better estimate of total protein in the CSF in comparison to Pandy test. 
 
Procedure  
 
First, 1 ml of the saturated phenol (reagent No 45) was pipetted into a glass test tube, 
then the laboratory technician added one drop of the supernatant of CSF to the phenol 
containing tube (not to be agitated) and observed for a reaction against a dark 
background. The procedure of adding the CSF supernatant was done at eye level, so 
immediate cloudiness that occurred could be observed (Cheesbrough, 2009, MISAU 
and Beira, 2010) 
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Reporting of the results were as follows: 
 
A positive Pandy test was defined as any appearance of cloudiness within the CSF the 
sample. When no change occurred, it was reported as a negative Pandy reaction. 
In case of low protein content, the Pandy reaction can be very minute, leading to a false 
negative. Therefore, it is necessary to maintain optimal circumstances for evaluation. In 
order to avoid missing cloudiness it was important to do the test at eye level for 
detection of even a slight reaction (Cheesbrough, 2009) 
 
3.4.3 Cerebro Spinal Fluid Gram stain  
 
The second sterile tube containing CSF was analysed in the microbiology department of 
the Central Hospital of Beira. Once the CSF sample arrived in the department the 
volume of the sample was noted. If less than 1 ml of CSF was available, then it was 
directly plated onto blood agar plate (BAP) and onto a chocolate agar plate (CAP) and 
the rest used for the Gram stain and Indian ink. When more than > 1 ml of CSF was 
available, then it was centrifuged according standard operating procedure defined by 
the Ministry of Health The CSF was centrifuged for three to five minutes at 1500 rpm to 
sediment bacteria for culture and gram stain (MISAU and Beira, 2010).  
 
In order to guarantee precise results and avoid false negative, the author followed all 
the recommendation by Ministry of Health of Mozambique standard operating procedure 
on CSF handling and storage for microbiology as CSF stability varied a lot with 
environmental changes (MISAU and Beira, 2010). 
 
The samples for microbiology were analyzed within 30 minutes at room temperature. If 
direct processing of sample was not possible, the  samples were kept in an oven at 35 
degrees for maximum of 12 to 24 h, especially when the lumbar puncture was done 
outside the laboratory working hours e.g at night or during the weekend (MISAU and 
Beira, 2010). 
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After centrifuging the sample, the supernatant was used for Indian ink for criptococcus 
detection. In case of tuberculous meningitis suspicion, sediments that remained after 
the culture was sent to TB diagnostic department for Ziehl Neelson test. When only one 
tube of CSF was collected, first analysis was done in the microbiology laboratory and 
what remained later was sent to hematology department for further analysis. 
 
In cases when more than 2 ml of CSF was available, then TB culture and GeneXpert 
were ordered when tuberculous meningitis were suspected. GeneXpert is an automated 
technology, which uses a cartridge based amplification assay for detection of 
Mycobacterium tuberculosis and can also detect the rifampcin resistance, though the 
technology has been tested in sputum (WHO, 2014c) the local technicians are also 
using the GeneXpert for CSF analysis at the Hospital. 
 
The sediment was used for gram stain and culture in the first few months till June 2013 
after this period centrifugation was not done at the hospital as the centrifuge machine 
was broken, this could have further reduced the detection of bacteria through gram stain 
and culture.  
 
3.4.3.1 Gram Stain  
The gram stain gives a presumptive diagnosis and sometimes a definitive diagnosis 
when identification of species is possible (Fischbach, 2009). The procedure was done 
according to standard operating procedure (SOP) established by the ministry of health 
(MISAU and Beira, 2010) 
 
Gram stain procedure:  
- We centrifuged the clear CSF at about 3 to 5 min at the 1500 RPM rate. A few 
drops of the sediment were transferred to the slide and were spread uniformly in 
a thin film for staining procedure. In the case of a purulent CSF, it was not 
centrifuged and smear was made. 
- Once the sediment was fixed to the slide and air dried the staining was started. 
- First the sediment was covered by crystal violet stain for 60 s  
 
 
75 
 
- After 60 seconds the crystal violet stain was washed with clean running water 
and drained. 
- The next step was to use a second stain iodine, which was also kept for another 
60 seconds, 
- After 60 seconds  it was again washed and drained  
- The last stain to cover the smear was safranine which also needed 60 seconds, 
then washed off again and air dried prior visualization by microscope. 
- The first examination was done with 40x objective, to evaluate smear distribution, 
neutrophils and then observed with objective 100 x oil-immersions.  
- Gram positive appeared dark purple (e.g. staphylococci, streptococci, micrococci, 
pneumococci, enterococci, diphtheria bacilli, anthrax bacilli) and gram negative 
pink (WHO, 2011a) 
 
Reading the gram stain results: 
 
These were read under the microscope as a gram positive organism when appeared as 
dark violet or purple and as gram negative when the microorganisms appeared as red 
or pink. N.meningitidis occurs extracellularly or intracellularly and were described as a 
gram negative kidney shaped diplococcic, Strepotococcus pneumoniae also occurs 
extra or intracellularly and were described as gram positive lanceolated diplococcic or 
gram positive diplococci in short chain, while gram negative organisms were described 
as gram negative bacilli and gram negative cocci (Cheesbrough, 2009, MISAU and 
Beira, 2010). 
 
When neutrophils were observed this was an indicative of bacterial meningitis and was 
reported as polimorphonuclear leukocytes observed and were classified as few, 
moderate and many or lots (MISAU and Beira, 2010). Occasionally live bacteria were 
observed, but when CSF culture detection was not possible either because they were 
very few, in this case we reported as live bacteria observed and probable meningitis 
was considered if other results of CSF parameters were also altered (Cheesbrough, 
2009). 
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A presumptive diagnosis of bacterial meningitis with gram stain was made when 
(Cheesbrough, 2009, MISAU and Beira, 2010): 
a. If a negative intracellular or extracellular diplococci were observed it was suggestive 
of N.meningitidis. 
b. If a gram positive diplococci or a short chain diplococcic were observed it was 
suggestive of streptococci which could be S. pneumoniae  
c. When gram negative rod was observed it was suggestive of possible H. influenzae or 
E.coli. As E.coli too present as gram negative rod. Further attempt of differentiation was 
not done as reagents are not available locally. 
 
3.4.4   CSF Culture  
 
3.4.4.1 Storage and stability of the cerebral spinal fluid sample 
According to MISAU‟s standard operating protocol the maximum time allowed for CSF 
to stay at the room temperature was 30 min without the transport media and 2 hours if 
the CSF was transported with the transport medium. When conditions did not allow for 
immediate inoculations of the sediment onto culture broth, it was recommended that the 
CSF must be kept at 350C in an incubator, until the inoculation was done, the next 
morning. All the samples that were collected after 3 pm were kept in the incubator so 
the sample could be evaluated the next morning, including during weekends (MISAU 
and Beira, 2010, WHO, 2011a). 
 
3.4.4.2 Inadequate samples  
The CSF samples were considered inadequate when: 
 
1. There was a delay of 24 hours or more for evaluation as the sensitivity of detecting 
bacteria such as HIB and N. Meningitis both decrease as these do not tolerate low 
temperatures. Though sensitivity decreases the CSF was still cultured as per protocol of 
the Hospital (MISAU and Beira, 2010). 
 
2. The quantity for evaluation was less than < 0.5 ml. 
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3.4.4.3 CSF Culture procedure 
The culture procedure was done according to the standard operating procedure 
approved by the Ministry of Health. Before inoculating the sediment the culture media 
stored in the fridge at 2 to 8 degrees centigrade were brought to room temperature and 
were checked for any signs of contamination. If the plates seemed clear then the 
sediment process was carried out. The sediment from centrifuged specimen was 
dropped on a chocolate agar plate and a blood agar plate, streaked and incubated for 
18 to 24 h at 35 to 37° C with ~5% CO2 in a candle-jar (MISAU and Beira, 2010).  
 
The first evaluation of growth on the culture plate was done in 24 hours. The second 
reading was done at 48 h and a third at 72 hours. In case of not having observed 
bacterial growth the culture media plates were still kept till the seventh day. If after a 
week no growth was observed, then the culture plates were discarded (MISAU and 
Beira, 2010).  
When bacteria grew identification and antibiotic sensitivity was done and noted in the 
patient's laboratory file.  
 
3.4.4.4 Culture media for meningeal pathogen 
There are different culture media for growth of meningeal pathogen. The blood agar 
plate contains a trypticase soy agar plate which contained 5% sheep blood. This media 
is ideal for the growth of S. pneumoniae. However occasionally the hospital did not have 
sheep blood, then human blood was used to make the blood agar plates. Though this is 
not recommended by WHO, because antibodies in the human blood could negatively 
impact the growth of S. pneumoniae (MISAU and Beira, 2010, WHO, 2011a). 
Alternatively, we used chocolate agar plate when human blood was used for blood agar 
plate preparation for study patients (WHO, 2011a).  
  
The chocolate agar plate is a medium which is supplemented with NAD (nicotinamide-
adenine-dinucleotide) and V factor which is ideal for the growth of H.influenzae (WHO, 
2011a). 
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While for N.meningitidis growth, both chocolate agar and blood agar plate were used 
and humid atmosphere was provided by adding water plate at the bottom of the 
incubator to enhance the growth of N.meningitidis. The culture media before being 
inoculated were brought to room temperature and were checked for any sign of 
contamination prior to inoculation (WHO, 2011a). 
We followed the following procedure for inoculation of CSF to primary culture plate 
(MISAU and Beira, 2010): 
 
- We inoculated 1 to 5 drops of CSF directly onto the blood agar plate and 
chocolate agar plate,  
- When CSF was clear we centrifuged, and one drop of the sediment, was 
inoculated to the primary culture media. 
- Plates then were streaked using a wire loop which was sterilized at each step. 
- Blood and chocolate agar plate after inoculation process were incubated at 35- 
37 0 C in a candle jar. 
- Another broth with brain heart infusion (BHI) as a backup media was also 
prepared for each sample and was inoculated with some of the sediment pellet.  
 
The first evaluation was done at 24 hours, second at 48 h. In case nothing grew plates 
were still kept till the 7th day. If on the 7th day, no growth of microorganism was observed 
than the culture plates were discarded (WHO, 2011a).  
 
When bacteria were observed, identification and antibiotic sensitivity were done and 
recorded in the patient's laboratory file.  
A presumptive diagnosis was made based on gram stain and growth of bacteria on 
culture media. Table 3.2 demonstrates characterization of colonies and identification of 
microorganism in different culture media used in the Central Hospital of Beira (MISAU 
and Beira, 2010). 
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Table 3.2 Summary characteristics of colonies observed and identification of 
microorganisms 
 
Bacteria Blood agar Chocolate agar Identification 
scheme 
Neisseria 
meningitidis 
< 1-2mm, transparent dew like 
colony, non hemolytic  
< 1-2mm, transparent 
dew like colony  
Neisseria  
Streptococcus 
pneumoniae 
< 1-2mm, greyish or green 
umbilicated or plane, 
(sometimes mucoid)α-hemolitic 
< 1-2mm, 1-2mm, 
greyish or green 
umbilicated or plane, 
(sometimes mucoid ) 
Streptococcus 
Haemophilus 
influenzae 
Normally doesn't grow  1-2mm, greyis humid. Haemophilus 
Coliforms  1-3mm, grey, humid or mucoide, 
elevated some time show signs 
of hemolysis   
1-3mm, grey, humid or 
mucoid, elevated, 
irregular border 
Enterobacter 
Streptococci β-
hemolíticus 
< 1-2mm, transparent, elevated 
,β-hemolítica 
< 1-2mm, white, 
elevated  
Streptococcus 
 
 
Identification and characterization of N.meningitidis  
 
When N.meningitidis was suspected we performed Kovak‟s oxidase test.  
The reagent of this test tetramethyl-p-phenylenediamine dihydrochloride turns into 
purple when in contact with organisms that contains the cytochrome c. This color 
change is the basis for the identification of N.meningitidis. This test is used for 
determining presence of the cytochrome oxidase which helps identification of N. 
meningitidis; however other members of the same group also produce a positive 
reaction (WHO, 2011a). 
 
The preparation of the Kovak reagent was done in the following manner. We used the 
filter paper method for Kovak‟s oxidase test (MISAU and Beira, 2010, WHO, 2011a). 
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Procedure for Kovak Test: 
- The filter paper strip was placed in a petri dish with a few drops of oxidase 
reagent; 
- Then the filter paper was left to dry; 
- After the paper was dry, the isolate grown on the blood agar plate was picked by 
a sterilized loop and rubbed into the oxide treated filter paper;  
- Then the filter paper was observed for colour change which occurred within 30 
seconds. 
 
Reporting Kovak‟s test results  
The colour change of the oxidase paper from white to purple was considered as a 
positive test (WHO, 2011a). 
 
Identification of S. pneumoniae  
 
Catalase test  
Catalase is an enzyme that is found generally in most microorganisms. When catalase  
produced by microorganism is exposed to oxygen it causes degradation of hydrogen 
peroxide (H202) into water (H20) and oxygen (02).The production of oxygen is observed 
as bubbles on the slide (MISAU and Beira, 2010, WHO, 2011a).  
 
The main purpose of this test is to differentiate between gram positive cocci, catalase 
producing microorganism like staphylococci, micrococci from microorganisms like 
streptococcus, enterococcus which are catalase negative (WHO, 2011a). 
 
Some organism that have catalase activity are Echerichia coli, Enterobacter aerogenes, 
Klebsiella pneumoniae, Proteus vulgaris, Staphylococcus and Shigella dysnteriae 
(MISAU and Beira, 2010, WHO, 2011a). 
However the test can give false negative or false positive results. One major limitation is 
the age of the culture. If the culture is older than 18 to 24 hours the capacity of the 
bacteria to produce catalase is reduced giving a false negative reaction. While another 
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important factor that causes false positive results occurs during the inoculation of a 
colony from the culture media if blood is also streaked with the colony. This blood from 
the media plate will produce a false positive reaction (WHO, 2011b). 
 
Procedure for catalase test (MISAU and Beira, 2010, WHO, 2011a): 
- The isolate were cultured on the blood agar plate at 35 to 37o C for 18 to 24 
hours in a candle jar; 
- The next day a colony from the blood agar plate using a sterilized loop was 
placed on a microscope slide; 
- One ml of 2% of  H2O2 was  added to the slide; 
- In cases of catalase positive reaction, immediate bubbling was observed 
 
Reporting of the test  
 
Oxidase reaction was considered as positive when bubbling was observed and was 
considered as negative when no bubbling was observed (WHO, 2011a). Other tests for 
species identification of S. pneumoniae were not available and were not performed at 
the hospital 
 
Identification of Stahylococcus  
 
Coagulase test  
Coagulase testing is a procedure for observation of cultured microorganism that has the 
capacity to produce coagulase enzyme which coagulates plasma. The conversion of 
fibrinogen into fibrin causes agglutination and coagulates plasma. The main objective of 
the test is to differentiate between the coagulase positive staphylococcus aureus from 
coagulase negative staphylococcus. This differentiation of coagulase positive and 
negative staphylococci, aids in the distinction between pathogenic or non pathogenic 
form of staphylococcus. The more pathogenic or virulent strain of staphylococci 
produced more coagulase (MISAU and Beira, 2010). 
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The test tube method for coagulase was used in our study to differ microorganism that 
produces coagulase from those which don‟t produce this enzyme. Once colonies of 
microorganism were observed in culture, especially if staphylococcus was observed 
further analysis was done to see if the staphylococcus species was coagulase positive 
or not (MISAU and Beira, 2010).  
 
Coagulase procedure 
 
- Three test tubes were used, one for positive control, one for the negative control 
and one for the sample test; 
- Two ml of human plasma was placed in each glass test tube; 
- To the negative control test tube a sterile broth was added 
- To the positive control tube 0.2 ml of broth with a known colony of 
staphylococcus was inoculated and observed; 
- To the 3rd “test” tube a 0.2 ml of culture broth was added;  
- The colony from the culture medium plate was inoculated using sterile inoculation 
loop into the test tube containing plasma to avoid any contamination; 
- The colony with broth  was homogenized into plasma, but never agitated 
- All the three test tubes were incubated for 2 hours at 37 0 C for 2 hours; 
- If no changes were observed than it was again left in the oven for an extra 2 
hours and read again. If still no changes was observed it was left at room 
temperature for a day and then discarded the next day. 
 
Reporting of coagulase results: 
The reading was done as positive when plasma coagulation took place and negative 
when no coagulation occurred. In cases of no reaction it was still kept at room 
temperature overnight before the final reading, if by then no changes occurred it was 
considered as negative and the test was discarded. Positive cases were reported as 
“Coagulase positive staphylococcus aureus” (MISAU and Beira, 2010, WHO, 2011a). 
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3.4.4.5 Aerobic and nonaerobic differentiation of meningeal pathogen 
 
Thioglycolate  
A liquid broth media contains sodium thioglycolate which reacts to oxygen, keeping 
oxygen level. It‟s used to differentiate between aerobic and anaerobic pathogens. Once 
inoculated with the CSF, 24 hours later the reading was done. 
 
When the growth was observed on the top of the medium it was considered as strong 
aerobic and when growth was observed at the bottom it was considered as strongly 
anaerobic.  
 
3.5 Case definition for bacterial meningitis according WHO (WHO, 2003): 
 
Clinical description 
 
Bacterial meningitis is characterized by acute onset of fever (usually > 38.5 °C rectal or 
380 C axillary), headache and one of the following signs: neck stiffness, altered 
consciousness or other meningeal signs and seizures. 
 
Laboratory criteria for diagnosis 
 
Bacterial meningitis can be confirmed by three methods. (1) Culture method: isolation of 
a bacterial pathogen from a normally sterile clinical specimen such as CSF or blood. (2) 
Alterations of CSF glucose, protein and presence of high number of leucocytes. (3) 
Gram stain results. 
 
3.5.1 Case classification of bacterial meningitis according to WHO (WHO, 2003): 
 
Suspected: Any child with sudden onset of fever (> 38.5 °C rectal or 38.0 °C axillary) 
and one of the following signs: neck stiffness, altered consciousness or other meningeal 
signs. 
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Probable: A suspected case with CSF examination showing at least one of the 
following: 
- Turbid appearance; 
- Leucocytosis (> 100 cells/mm3); 
- Leucocytosis (10-100 cells/ mm3) and either an elevated protein (> 100 mg/dl) or 
decreased glucose (< 40 mg/dl). 
 
Confirmed: A case that is laboratory-confirmed by growing (i.e. Culturing) or identifying 
(i.e. By Gram stain) a bacterial pathogen (Hib, pneumococcus or meningococcus) in the 
CSF or from the blood in a child with a clinical syndrome consistent with bacterial 
meningitis 
 
3.5.2 Case definition according to modifies WHO criteria for study purpose 
An appropriate history and physical examination accompanied by CSF pleocytosis, 
negative bacterial culture and gram stain for CSF and negative blood culture  
 
For the study purpose we had to modify the WHO criteria for probable bacterial 
meningitis based on the available tests locally and these were as follow: 
a. Suspicion case plus CSF turbidity plus either CSF leukocytosis or a positive 
Pandy test with negative gram stain or CSF culture. 
b. Suspicion case plus either CSF turbidity or gram stain results with identification 
of a microbial agent or with the presence of live bacteria or with lots of 
neutrophils observed as defined by the laboratory but no confirmation was 
done on the aetiologic microorganism (Cheesbrough, 2009),  
c. Suspicion case plus positive Pandy test plus cell count results between 10-100 
cells/ mm3. CSF glucose below < 40 mg/dl and CSF protein > 100 mg/dl were 
not added to the cell count information as referred by WHO guideline because 
CSF glycemia were not available in the Central Hospital of Beira, but the 
positive Pandy reaction was considered instead of CSF total protein. 
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d. Suspicion case plus CSF cell count above 100/ mm3 alone were used for 
diagnosis of probable bacterial meningitis. 
 
However, children who had cell count of > 100 cell with all other CSF laboratory tests 
negative and did not improve with antibiotic treatment within 72 hours and needed 
additional antiviral treatment were diagnosed as meningoencephalitis and for statistical 
analysis purpose they were included in meningoencephalitis group. 
 
The gram stain that contained lots of polimorphonuclear leucocytes and live bacteria‟s 
visible were considered gram stain negative as no staining of bacteria were seen, but 
laboratory guideline (Cheesbrough 2009) clearly defines that in cases when neutrophils 
are observed in CSF specially more than 5, this is indicative of pyogenic meningitis 
though the gram stain is negative. Based on this information in our study children with 
symptoms of meningitis who had neutrophils present in the gram stain were considered 
as having probable bacterial meningitis. 
 
For analysis purpose both confirmed cases and probable bacterial meningitis were 
considered as having diagnosis of  bacterial meningitis. 
 
3.6 Ethical clearance 
The protocol for the study was revised and approved by the National Bio-Ethical 
Committee of Mozambique, and later approved by the Centre for International Health 
from Ludwig Maximillians University. Administration approval was acquired from the 
Central Hospital of Beira for conducting study. Administrative approval form Catholic 
University of Mozambique was acquired for storage of CSF at -80 degrees.  
 
3.7 Statistical analysis 
 
All manually written data from the patient‟s case record form was later entered in 
electronic case report forms in Microsoft Access 2010 and double checked. Later the 
data was analyzed via SPSS (Predictive Analytic Software and Solution) Version 16 
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(Texas –USA) for most of the analysis, Graphs and ROC curves were created using 
Medcal ® Version 13.1.2.0. 
 
For continuous data: mean, standard deviation, interquartile range was calculated. 
Confidence intervals were estimated under the assumption of a normal distribution. For 
each laboratory variable; sensitivity, specificity, positive predictive value, negative 
predictive values were calculated. ROC curve was designed to find the best cutoff value 
for each parameter of the reagent strip. The Pearson chi square test was used to 
compare qualitative variables. The student t-test for independent sample was used for 
quantitative data to see the difference between the age and mean CSF WBC among 
children with cerebral malaria, bacterial meningitis and meningoencephalitis. 
 
Univariate analysis of diagnostic variables was used and their unadjusted odds ratio 
were calculated as well as 95% Confidence Interval (95% CI). Variables that were found 
to have a p value ≤ 0.02 were used for multivariate logistic regressions which were 
calculated using the regression model for development of bedside diagnostic model 
which could predict bacterial meningitis based on clinical symptoms and urine reagent 
strip results. The multivariate logistic regression was calculated in SPSS using 
conditional logistic regression and Hosmer Lameshow index and Nagel kerke r was 
considered to evaluate goodness of fit of the model. Hosmer Lameshow above 0.05 
was considered.  
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4. Results 
 
4.1 Baseline characterization of the study population  
 
4.1.1 Demographics 
 
During the period of 15 months from November 2012 to end of January 2014, 250 
patients were screened for bacterial meningitis in the Central Hospital of Beira from 6.30 
a.m. to 9 p.m from Monday to Sunday. 
 
From 250 patients screened, 200 underwent lumbar puncture, 10 were lost either 
because of an accident in lumbar puncture or it wasn‟t possible to get enough CSF for 
analysis, e.g. less than 0.5 ml  
 
Therefore CSF samples from 190 pediatric patients were included in the study. From 
those, 10 were later excluded from the study (3 due to antibiotic use more than 48 
hours, 3 due to age below 2 months, 2 due to use of steroids and 2 due to terminal 
AIDS). In the end 180 patients were included in the study.  
 
The study involved 180 participants, out of which 68 (37.8%) were female and the 112 
(68.2%) were male. The mean age was 4.09 years, with minimum age of 2 months and 
maximum of 13.3 years. 
 
The table 4.1 summarizes other baseline characteristics of the study population. It can 
observed from the table that the most common presenting symptoms at admission were 
fever in 167/180 (92.7%) cases followed by seizure in 155/180 (86.1%), irritability in 
103/180 (57.2%) and behavioural change was observed in 98/180 (54.4%) children.  
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Table 4.1 General baseline characteristics of study population 
Characteristics of study participants Values  
Demographics of patients  
Age  ( mean, min and max) 4.09 yrs.( 2 mo -13.3 years) 
Gender  
   Male -no (%) 
   Female -no (%) 
 
112/180 (62.2) 
68/180 (37.8) 
Duration of fever prior admission  
   < 24h- no (%) 
   24-48h- no (%) 
   >72h- no (%) 
 
41/167 (24.5) 
38/167 (22.8) 
88/167 (52.7) 
Medication prior admission 
   Antibiotic prior admission (total) - no (%)  
   One antibiotic prior admission - no (%) 
   Two antibiotics prior admission - no (%) 
   Antimalarial drugs prior admission- no (%) 
   Traditional treatment- no (%) 
93/180 (51.7) 
76/93 (81.7) 
44/76 (57.9) 
32/76 (42.1) 
34/93 (36.5) 
10/93 (10.7) 
Malnutrition on admission - no (%) 
(Mild, moderate and severe combined) 
23/180 (12.8) 
HIV Status known at admission 10/180 (5.5) 
Symptoms and signs at presentation  
Severe coma on admission (GCS< 10 or BCS< 2) - no (%) 60/180 (33.3) 
Seizure on admission  
   1 episode of seizure- no (%) 
   2-4 episodes of seizure- no (%) 
   > 5 episodes of seizure - no (%) 
155/180 (86.1) 
62/155 (40.0) 
61/155 (39.3) 
32/155 (20.6) 
Signs of hypovolemic  shock at presentation 17/180 (9.4) 
Other signs and symptoms 
Headache - no (%) (among the children who could speak) 
Vomiting no (%)                                                                                                     
Altered mental status - no (%) 
Irritability- no (%) 
Unable to feed- no (%) 
Hepatosplenomegaly- no (%) 
Bulging fontanel 
Kernig sign - no (%) 
Brudzinski sign- no (%) 
Neck stiffness - no (%) 
Opisthotonus  
 
65/115 (56.5) 
79/180 (43.9) 
98/180 (54.4) 
103/180 (57.2) 
81/180 (45) 
43/180 (23.9) 
36/70 (51.4) 
27/180 (15) 
35/180 (19.4) 
80/180 (44.4) 
37/180 (20.5) 
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Among patients admitted 93/180 (51.7%) were already on treatment prior admission 
with less than 48 hours of treatment. Among those patients that were on treatment 
76/93 (81.7%) were using either oral or parenteral antibiotic drug at admission. While 
34/93 (36.5%) were on antimalarial drugs and 10/93 (10.7%) were on traditional 
medicinal prior admission. Among antibiotic users 44/74 (57.9%) were using one 
antibiotic (oral or parenteral) and the rest 36 (42.1%) were using 2 antibiotic drugs at 
admission.  
 
Children who had a diagnosis of malaria and were on malaria treatment with coartem a 
combination of artemether and lumefantrine 34/93 (36.5%) developed seizures with 
change in mental status and were admitted with either diagnosis of severe malaria or 
cerebral malaria.  
 
Among children on antibiotic treatment 55/76 (72.3%), almost a third had no diagnosis 
prior admission and were on empiric treatment for bacterial infection. Only 21 (27.7%) 
children with antibiotic had a diagnosis of upper respiratory tract infection and 
piodermatitis during the time of admission. 
 
Most of the children came to the hospital in an advanced stages. Among 60/180 (33.3%) 
of children had severe coma on admission. While among children with seizures which 
accounted for 155/180 (86.1%) of cases a 62/155 (40%) came with one episode to the 
hospital while two third of these children only presented to the hospital when they had 
more than 2 episodes of seizures. Among those children with more than 2 episodes of 
seizures a 61/155 (39.3%) of children presented to the hospital when they had between 
2-5 episodes of seizures. While a 20.6% (32/155) were brought to the hospital after 
having more than 5 episodes of seizures at home. This data demonstrates that children 
often arrive to the hospital in a later stage.  
 
The table 4.2 summarized the baseline characteristic of the laboratory parameters 
among the study population. A mean peripheral WBC count among children admitted 
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was 16.44% with a SD of 10.48, and mean neutrophil count was of 62.10% with SD 
19.08. Mean Lymphocyte were 26.21% with a SD of 16.1. 
 
Table 4.2 General baseline characteristics of laboratory parameters of the study 
population  
 
Laboratory parameters 
 
Values 
Full blood count   
WBC (mean  SD)  
IQR 
Neutrophil % (mean  SD) 
IQR 
Lymphocyte % (mean  SD) 
IQR 
Platelets 103 (mean SD) IQR 
ESR (mean SD) 
 
16.44 10.48  
[10.00-19.25] 
62.10 19.08 
[49-77] 
26.21  16.1 
[13-39] 
353.7 211.7 [175-489] 
46.6 19.5 
CSF parameters 
Pleocytosis (WBC cell > 10 cells) - no (%) 
Positive CSF culture- no (%) 
Positive gram stain- no (%)  
Positive Pandy test- no (%) 
 
43/168 (24.1) 
17/180 (9.4) 
17/180 (9.4) 
20/160 (12.5) 
Other tests  
HIV  was not done- no (%) 
HIV test done n =108 
HIV positive- no (%) 
HIV negative- no (%) 
72/180 (40) 
 
26/108 (24.1) 
82/108 (75.9) 
Malaria test  
 Positive rapid test - no (%) 
 Positive thick and thin blood film- no (%) 
 
40/180 (22.2) 
29/180 (16.1) 
Blood culture no (%) 1/10 (10) 
FBC was measured in 169 patients, Neutrophil % was present in 152, lymphocytes % in 159, platelets in 
169 and ESR was measured in 10 patients 
 
At admission only 5.5 % (10/180) patient‟s guardian knew their children‟s HIV status. 
However during admission HIV test was only done among 108/180 (60%) of cases. 
Among those who had tested for HIV 26/108 (24.1%) had a positive test and the rest 
82/108 (75.9%) had a negative test.  The table 4.3 demonstrates discharge information 
on the patients. 
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Table 4.3 General baseline characteristics on discharge information of the study 
population 
Most frequent diagnosis at discharge  
Meningoencephalitis- no (%) 
Severe malaria no (%) 
Cerebral malaria no (%) 
Bacterial meningitis- no (%) 
Pneumonia - no (%) 
Tuberculous meningitis 
Suspected meningitis 
Others 
48/180 (26.6) 
16/180 (8.9.) 
21/180 (11.6) 
32/180 (17.7) 
20/180 (11.1) 
5/180 (2.7) 
7/180 (3.9) 
31/180 (17.7) 
Patients survived- no (%) 
Patient died- no (%) 
Patient abandoned- no (%)  
155/180 (86.1) 
22/180 (12.2) 
3/108 (1.7) 
Complications 
Respiratory failure- no (%) 
Cerebral abscess- no (%) 
Cerebral infarction - no (%) 
Hydrocephalus- no (%) 
Subdural effusion- no (%) 
Others- no (%) 
67/180 (37.2) 
16/180 (8.9) 
2/180 (1.1) 
3/180 (2.8) 
8/180 (4.4) 
2/180 (1.1) 
36/180 (20) 
Neurological sequelae 
Paralysis (hemiplegic and quadriplegic) - no (%) 
Minor and moderate behavior change- no (%) 
Gait problems- no (%) 
Hearing loss,  
Vision alteration - no (%) 
Others 
32/180 (17.7) 
9/180 (5) 
6/180 (3.3) 
5/180 (2.8) 
3/180 (1.7) 
2/180 (1.1) 
7/180 ( 3.8) 
Paralysis - no (%) 
Quadriplegia no (%) 
 - Meningoencephalitis - no (%) 
 - Bacterial meningitis  
 - Cerebral malaria 
 - Tuberculous meningitis  
Hemiplegia no (%) 
9/32 (28.8) 
7/9 (77.8) 
3/7 (42.8.) 
2/7 (28.5) 
1/7 (14.2) 
1/7 (14.2) 
2/9 (22.2) 
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4.1.2 Patient’s discharge information 
  
The most frequent diagnosis observed in our study at discharge were 
meningoencephalitis 48 (26.6%), followed by malaria 37 (20.5%), bacterial meningitis in 
32 patients with (17.7%), tuberculous meningitis 5 (2.7%) and 31 (17.7%) had mixed 
diagnosis as shown in table 4.3  
 
Out of 37 (20.5%) children with malaria, 21 (11.6%) had the diagnosis of Cerebral 
malaria and 16 (8.9%) had the diagnosis of severe malaria. Among children with 
cerebral malaria laboratory confirmation by rapid test was 18/21 (85.7%) and the other 3 
(14.2%) were confirmed with malaria slide.  
While the 16 cases of severe malaria (8.9%) had the diagnosis either confirmed by 
rapid test at admission. Either from hospital or a prior rapid malaria test done in health 
centres within 10 days of admission or a positive malaria slide.  Among those with 
cerebral malaria 11 cases also had comorbidity like: meningonencephalitis, probable 
bacterial meningitis, HIV and sepsis. 
 
Diagnosis of bacterial meningitis was confirmed by positive culture only in 17 (53.1%) 
and the rest (46.9%) had a diagnosis of probable bacterial meningitis for analysis 
purpose final diagnosis of bacterial meningitis included both confirmed cases plus 
probable cases.  
  
Tuberculous meningitis in 5 (2.7%) were not confirmed by laboratory parameters, but 
the diagnosis was based on clinical features, positive contact with a TB patient plus 
thrombocytosis and increased ESR or with predominance of either lymphocytes or 
monocytes in full blood count. One patient had a diagnosis based on CT scan results 
(hydrocephalus) while others were diagnosed by excluding other diagnosis like bacterial 
meningitis, meningoencephalitis, cerebral malaria and possible HIV encephalopathy. 
 
The category of other diagnosis, which comprised of 31 patients, had different 
diagnosis. 17 (54.8%) with febrile seizures, 6 (19.3%) with sepsis out of which 4 
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(66.6%) had septic shock at admission. Other diagnoses were: 2 (6.2%) with ischemic 
stroke due to vasculitis, 2 (6.2%) with pulmonary tuberculosis, 1 (3.2%) cerebral 
abscess, malformation of vena galena 1 (3.2%) and 1 (3.2%) with cerebral metastasis 
due to retinoblastoma. 
 
Among the 180 patients admitted to the study, 22 (12.2%) had died. The cause of death 
among these patients were six meningoencephalitis with either respiratory or multi 
organ failure (27.3%), five (22.7%) due to cerebral malaria, four (18.1%) due to septic 
shock, four (18.1%) due to bacterial meningitis, two (9%) due to Tuberculous meningitis 
and one (4.5%) due to a cerebral abscess. 
 
Neurological sequelae were present in 32/180 (17.7%) patients at discharge. Severe 
paralysis accounted for 5%, minor and moderate behavioural change in 3.3%, gait 
problem (unable to walk and ataxic gait), 1.7 % presented hearing loss which included 
hypoacusia and deafness and  1.1 % had some kind of vision deficits: included blurred 
vision and difficulty in  recognizing mother with children who could not speak and 
blindness in patient who were able to speak. Details with exact numbers of neurological 
sequelae are presented in Table 4.3. 
 
Among the 32 children with neurological sequelae 9 (28.1%) developed paralysis. Out 
of which 2 (22.2%) had hemiplegic paralysis; one due to stroke and other due to 
meningoencephalitis. While the other 7 (77.8%) developed spastic quadriplegia. For 
whom meningoencephalitis accounted for 3 (42.9%) cases of quadriplegia, bacterial 
meningitis was responsible for 2 (28.6%) cases and one (14.8%) case due to cerebral 
malaria and one (14.8%) due to tuberculous meningitis was observed. The table 4.3 
summarizes all the neurological sequelae observed. 
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4. 2 General characteristics and demographics of children with bacterial 
meningitis  
 
Among 180 cases evaluated 32 (17.7%) were diagnosed as bacterial meningitis. The 
table 4.21 summarizes CSF characteristics and laboratory parameters of these children. 
The mean age among children with bacterial meningitis was 42.5 months  SD 40.6 
months range [2 mo - 132 mo], the gender was equally distributed. 
 
Among 32 children with bacterial meningitis a positive HIV test was observed in 6 (26%) 
children. Among which 3 (50%) were on antiretroviral therapy for 2 to 3 years with no 
signs of terminal AIDS. While other 3 (50%) were on PMTCT (Preventing Mother –to-
Child-Transmission) program with antiretroviral prophylaxis with a negative PCR on 
admission. 
 
Malnutrition was observed in 6 (18.8%) of children with 2 (33.3%) having severe 
malnutrition: one with marasmatic kwashiorkor and one with marasmus. Most of the 
children (28/32) were psychomotorically normally developed. Four (12.5%) had delayed 
development on admission; none had any neurological disability at admission. 
 
The most frequent presenting signs and symptoms among children with bacterial 
meningitis were: Seizures 27 (84.4%), severe coma: 14 (43.8%), agitation 12 (37.5%), 
incoherent speech 8 (25%), signs of shock at admission 4 (12.5%) and fixed gaze 3 
(9.3%) was observed. 
 
Seizure was one of the most frequently observed symptoms among the admitted 
children. From these children 7 (21.9%) had one episode of seizure at admission, 12 
(37.5%) had between 2 to 4 seizures while 8 (25%) had more than 5 episodes of 
seizures. Three children were admitted in status epilepticus. 
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Headache was observed in 13 (40.6%), behavior change in 28 (87.5%), irritability 25 
(78.11%) and 19 (59.4%) were unable to feed or eat at admission. Opisthotonus was 
present in 12 (37.5%), photophobia was observed in 11 (34.4%) and nuchal rigidity in 
27 (84.4%) patients. A bulging fontanel was present in 7 (21.9%) of children with BM. 
Symptoms duration varied among children with BM: 9 (28.1%) had symptoms less than 
24 hours, 2 (6.2%) between 24 to 48 hours and 21 (65.6%) had symptoms for more 
than 72 hours prior admission. 
  
On physical examination the main vital signs were as follow: mean systolic arterial 
pressure was 92 mmHg 14.8 with a range [66 - 137], the mean respiratory rate was 32 
11.6 [22 – 68], the mean heart rate was 123 24.9 [88 – 160] and the mean 
temperature in centigrade (0C) at admission was 38.3 0.8 [37.5 – 40]. 
 
Antibiotic treatment prior admission in the study was given in 15 (46.8%) patients, but 
none had received antibiotic for more than 48 hours. The most frequently used antibiotic 
was Penicillin G 6/15 (33.3%), 2/15 (13.3%) received metronidazole, 2/15 (13.3%) 
received  ceftriaxone. Five (33.3%) received other antibiotics. 
 
Comorbidities among children with BM  
The comorbidities observed in our study among children with bacterial meningitis were: 
Pneumonia with 6 / 32 (18.8%) 
Malaria 6 / 32 (18.8%) 
Sepsis 2/32 (6.2%) 
Otitis and cellulitis 2/32 (6.2%) 
Femur fracture 1/32 (3.1%) 
 
4.3 Results of Cerebrospinal Fluid Analysis 
 
4.3.1 CSF leucocyte count 
Among 180 samples of CSF collected, 125 (69.4%) were considered normal based on a 
CSF cell count below 10 cell / mm3. Forty three (23.9%) were considered as having 
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pleocytosis (wbc >10 cell / mm3). In twelve (6.7%) cases, samples had missing data on 
CSF cell count.  Among all CSF with normal cell count 7 (5.6%) had positive gram stain 
and 9 (7.2%) had positive culture 
 
Among the 43 (23.9%) samples with abnormal cell counts, the average cell count was 
311.56 ± 421.23 with an (Inter quartile range) IQR of [22-363]. Out of these 43 samples 
only 7 (41.2%) samples had a positive gram stain results and 6 (35.2%) samples had a 
positive CSF culture results.  
 
The diagnose of bacterial meningitis for analysis purpose was based on confirmed 
cases (which included culture positive, or gram stain positive) plus probable bacterial 
meningitis based on modified WHO criteria for bacterial meningitis. In our study we had 
32/180 (17.7%) cases of bacterial meningitis. Out of which 17/32 (53.1%) were gram 
stain and culture positive. While cell count of above 100 cells were observed 17/32 
(53.1%) and positive pandy test among bacterial meningitis was observed in 13/32 
(40.6%) of cases  
 
Accuracy of CSF cell count in detection of bacterial meningitis based on a gold standard 
(positive CSF culture) in comparison with a diagnosis of bacterial meningitis (Confirmed 
plus probable) was tested. 
 
Table 4.4 Demonstrates the accuracy of cell count in detection of bacterial 
meningitis based on culture results above 10 cell/ul 
 
 
 
 
 
Sensitivity = 40%, specificity = 75.8%, NPV = 92.8%, PPV = 13.9%   
 
CSF cell count  Culture positive 
BM 
Culture negative BM 
>10 cells/ul 6 37 
<10 cells/ul 9 116 
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The sensitivity of the CSF cell count above 10 cell count for diagnosis of culture positive 
bacterial meningitis was of 40%, specificity of 75.8%, PPV of 13.9% and a NPV of 
92.8%. Among the CSF samples with a normal cell count below 10 cells/ul 9/15 (60%) 
had a negative culture while more than 10 cell counts only 6/15 (40%) had a positive 
CSF culture. The table 4.4 demonstrated that most of the culture positive bacterial 
meningitis 60% of the patients had normo cellular bacterial meningitis. 
 
Based on WHO modified criteria for diagnosis of bacterial meningitis an additional 16 
(46.9%) patients were considered to have bacterial meningitis, totaling 32 cases of 
bacterial meningitis (confirmed plus probable). We tested the accuracy of the CSF wbc 
cell count for diagnosis of BM at 100 cells/mm3   cutoff point.  
 
Table 4.5 demonstrates CSF cell count accuracy in detection of bacterial 
meningitis at > 100 cell/ul 
 
 
 
 
    
         
         Sensitivity = 56.7%, specificity = 81.8%, NPV = 89.6%, PPV = 39.53% 
 
 
According to the table 4.5 CSF cell count with a cutoff point above 100 cell/ul for 
diagnosis of bacterial meningitis the sensitivity of cell count was only 56.7% a specificity 
of 81.8% a NPV of 89.6% and PPV of 39.53%. Overall accuracy of the test was 76.7%.  
 
4.3.2 CSF Pandy test  
 
A semi quantitative Pandy test which measures globulin level and indirectly gives an 
estimate of total protein in CSF was performed in 160 (88.9%) patients. In twenty cases 
the data was missing or analysis was not done (11.1%). Out of 160 samples that had 
Pandy test, 21 (13.1%) had positive results. 
 
CSF pleocytosis Bacterial 
meningitis  
No bacterial 
meningitis 
>100 cells 17 26 
<100 cells 13 112 
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Table 4.6 Accuracy of pandy test in the detection of bacterial meningitis 
(confirmed plus probable)  
    
                  
 
 
Sensitivity = 43.3%, specificity = 93.8%, NPV = 87.7 %, PPV = 61.9% 
 
The sensitivity and specificity of pandy test in detection of protein in cases of bacterial 
meningitis was of 43.3% a specificity of 93.8%, a NPV of 87.7% and a PPV of 61.9% 
with an overall accuracy of the test 84.3%.  
 
4.4 CSF Evaluation with reagent strip  
 
4.4.1 Leucocytes  
 
The urine reagent strip was tested in 180 samples among these 95 (52.8%) were 
considered normal or with no alteration and 85 (47.2%) showed alteration for 
leucocytes. We compared the accuracy of the reagent strip in detecting leucocytes in 
the CSF and compared to CSF wbc cell count done in the laboratory at different cutoff 
values. First to test the capacity of urine strip detection of cell count and secondly to test 
the performance of urine strip and compare with the standard cell count method for 
diagnosis of bacterial meningitis. 
 
The sensitivity and specificity of the “trace” (defined by value of 0 to 15 cells/ul) reading 
on the urine dip strip to detect elevated CSF count (defined by value of > 10 cells/ul) 
was calculated. 
 
 
 
Pandy test  Bacterial 
meningitis  
No  bacterial 
meningitis  
Positive 13 8 
Negative 17 122 
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Table 4.7 Capacity of the urine reagent strip to accurately detect leucocyte 
alteration in the CSF at the cutoff point of above 10 cells /ul 
 
Reagent Strip CSF >10 cells CSF ≤ 10 cells 
Trace positive 37 40 
Trace negative  6 85 
             Sensitivity =86 %, specificity= 68%, NPV=93.4%, PPV= 48% 
 
Table 4.8 Capacity of the reagent strip to accurately detect leucocyte alteration in 
the CSF at the cutoff point of above 100 cells/ul 
 
Reagent Strip CSF>100 cells CSF ≤ 100 cells 
2 cross 19 22 
Negative 4 122 
             Sensitivity = 82.6%, specificity = 84.7%, NPV = 96.3%, PPV = 46.3% 
 
When we tested the accuracy of the reagent strip at “trace” and at “2 cross” to detect 
wbc cell changes in CSF we observed that the sensitivity at “trace” was higher with 86% 
but a specificity of 68%, and NPV of 93.4%, were lower in comparison to “2 cross”.The 
“2 cross” cutoff point had a lower sensitivity with 82.6% but a higher specificity with 
84.7% and NPV of 96.3%. 
 
We tested correlation among leucocyte count of Multistix urine reagent strip and CSF 
cell count at 10 cells/ul and 100 cells/ul as cutoff point results using a Pearson chi 
square and continuity correction for their significance. Table 8 shows the correlation 
between the 2 tests and their significance levels.  
The table 4.9 and 4.10 demonstrates the Pearson chi square correlation between the 
two types of tests. 
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Table 4.9 Pearson chi square test for CSF wbc vs urine reagent strip at “trace” as 
cut off point   
 
                                                        CSF wbc cell count vs  Urine reagent strip  
      Value                                 Asymp Sig( p-value) 
Pearson Chi-square    37.644 <0.001 
Continuity correction  
2x2                                                         
  35.489 <0.001 
Likelihood ratio                            40.258 <0.001 
 
 
Table 4.10 Pearson chi square test for CSF wbc vs urine reagent strip at “2 cross” 
as cut off point  
 
                                                        CSF wbc cell count vs  Urine reagent strip  
      Value                                 Asymp Sig( p-value) 
Pearson Chi-square    48.58 <0.001 
Continuity correction  
2x2                                                         
  44.971 <0.001 
Likelihood ratio                            41.781 <0.001 
 
We found a significant correlation between the urine reagent strip leucocyte evaluation 
at “trace” with CSF wbc cell count (p <0.001) and at “2 cross” cut off point with a  
(p <0.001) at 99.9% confidence level 
 
Once the significant correlation was established among the two tests. We further tested 
urine reagent strip capacity to detect cell alterations in bacterial meningitis (confirmed + 
probable). 
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Table 4.11 Results of urine reagent strip leucocyte among children with and 
without bacterial meningitis 
 
 
 
 
 
 
 
 
 
 
 
Table 4.12 Accuracy of the reagent strip to detect cellular alteration in bacterial 
meningitis at different cut off points “trace” and “2 cross”  
 
Reagent Strip  Bacterial 
meningitis n=32 
No bacterial 
meningitis n= 168 
Trace positivea 27 58 
Trace negativea 5 90 
2 crossb 24 22 
negativeb 8 126 
 
             aSensitivity = 84.3%, specificity = 60.8%, NPV = 94.7%, PPV = 31.7% 
 
                    bSensitivity = 75%, specificity = 85.14%, NPV = 94.0%, PPV = 52.1% 
 
Bacterial meningitis was present in 27/32 (84.3%) of the cases when urine reagent strip 
showed a “trace” reading. With a sensitivity of 84.3% a specificity of 60.8%, a NPV of 
94.7% and a PPV of 31.7%. In comparison with 75% of sensitivity observed at “2 cross” 
as cut off point, a specificity of 85.14% a NPV of 94.0% and a PPV of 52.1%. However 
though the sensitivity of “trace” was higher than “2 cross” specificity of “trace” was lower 
with 60.8% in comparison with 85.14% observed in “2 cross” cut off point.  
As per bacterial meningitis diagnostic criteria using cell count of > 100 cells/ul is 
considered. We used the “2 cross” which represents more than 125 cells /ul for best cut 
off value for the diagnosis of bacterial meningitis. 
To further determine the best cutoff point for leucocyte for detection of BM we 
constructed ROC (receiver operating curve). 
Reagent strip 
reading 
Bacterial meningitis 
n= 32 
No Bacterial 
meningitis n= 148 
Negative  5 90 
Trace 0 20 
1 cross 3 16 
2 cross 4 9 
3 cross 20 13 
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4.3.2 Construction of ROC (receiver operating curve) to determine cut off point for 
leucocyte  
 
To conclude a better cut off point for the diagnosis of bacterial meningitis using reagent 
strips to evaluate leukocytes alteration a ROC curve was drawn to conclude the best 
possible cutoff point for the reagent strip test. 
 
On the basis of the results of sensitivity and specificity of leukocyte from reagent strip 
Multistix, ROC was constructed. On the Y axis sensitivity values are shown while in X 
axis specificity is demonstrated. Along the curve different cut off points were evaluated. 
 
Fig. 4.1 Demonstrates ROC curve for urine strip leucocyte for diagnosis of 
bacterial meningitis  
ROC for Urine strip leucocyte
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AUC 0.830, SE 0.074, 95% CI [0.6886-0.974] p<0.0001 
 
The AUC (area under the curve) for urine leucocyte strip was 0.830 AUC 0.830 with a 
SE 0.074 at 95% CI [0.6886-0.974] p<0.0001. 
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As bacterial meningitis typically leads to CSF cell count above 100 cells /ul. Therefore a 
reading of 2 cross of the urine dip strip (which represents leucocyte above 125 cells /ul) 
was used as the best cutoff point for diagnosis of bacterial meningitis. 
 
The CSF cell count sensitivity for diagnosis of bacterial meningitis at 100 cells as cutoff 
point in comparison with urine strip at 2 cross for the diagnosis of bacterial meningitis 
were compared. The table 4.13 summarizes diagnostic performance of both CSF wbc 
and leucocyte from urine reagent strip from table 4.5 and 4.12. 
 
     Table 4.13 Comparison of leucocyte measures of urine strip and CSF for 
diagnosis of bacterial meningitis 
Leucocyte  Sensitivity % Specificity %   NPV %  PPV % 
CSF cell 
count  
      56.7     81.8  89.6  39.53 
Urine strip at 
2 cross 
     75     85.14  94.0  52.1 
 
The urine strip performed better with a sensitivity of 75% in comparison to 56,7% of 
CSF cell count, a specificity was also higher with 85.14% in comparison to 81,8% of 
CSF cell count and so were the NPV of 94.0% and PPV 52.1% in comparison to NPV of 
89.6% and PPV of 39.53% of standard leucocyte count.  
 
We also compared the performance of cell count and strip leucocyte for the diagnosis of 
bacterial meningitis with ROC curve. The fig.4.2 demonstrates comparison of two ROC 
for measurement of leucocytes in diagnosis of bacterial meningitis  
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Fig 4.2 Pairwise comparison of two ROC for measurement of leucocytes in 
diagnosis of bacterial meningitis  
 
ROC comparing 2 methods of leucocyte measures for the  diagnosis of bacterial meningitis
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Comparison of the 2 ROC for the diagnosis of bacterial meningitis  
 
Sample size: 168  
BM: 30 
No BM: 138  
 
Table 4.14 Pairwise comparison of ROC for 2 methods of  leucocyte measures  in 
diagnosis of bacterial meningitis 
 
 AUC SEa 95% CIb 
Csf Cell count  0.780 0.0487 0.709 to 0.840 
Strip leucocyte  0.848 0.0424 0.784 to 0.898 
a De long et al, 1998 
b Binomial exact  
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Difference between the area 0.0680, SE, 0.0555, 95% CI [0.0408 – 0.177], p = 0.2204 
Though the performance of the urine strip for leucocyte count in detection was higher 
than the CSF cell count the difference was not statistically significant with a p = 0.2204. 
However though statistically insignificant this difference is clinically significant as the 
urine dip strip reading takes only 2 minutes and it can be done at patient‟s bedside as 
one person procedure. While the CSF cell count may take up to 2 to 3 hours in our 
hospital, it requires a trained technician and laboratory facilities (Moosa et al., 1995, 
Cheesbrough, 2009). 
 
This statistical insignificance could be due to smaller sample size of children with 
bacterial meningitis among compared groups due to missing data 6.6 (12/180) on CSF 
cell count. Based on the clinical relevance the urine strip results were used for simple 
logistic regression analysis and for multivariate logistic regression analysis. 
 
4.4.2 Protein  
 
Among the 180 samples of CSF collected, 145 (80.5%) showed a positive reaction 
(including trace and 1 cross which measure protein level below 30 mg/dl). As bacterial 
meningitis typically leads to a CSF protein concentration of 100 mg/dL or higher. 
Therefore, the “2 cross” reading which represents a protein concentration of 100 mg/dL 
was used. Based on this cut off point at 2 crosses 69 (38.3%) were considered positive 
for protein and 111 (61.7%) were considered normal. 
 
As there is no information in the literature regarding an equivalent cutoff value for Pandy 
test„s detection capacity, of total protein in the CSF; we attempted to develop a cutoff 
point for protein detection for Pandy test at various levels to determine which value in 
the urine strip was the best cutoff point for Pandy test. 
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Table 4.15 Accuracy of reagent strip for detection of protein in pandy test at “2 
cross” and at “3 cross”  
 
 
 
         
 
                
  
         a Sensitivity = 89.4%, specificity = 70.2%, NPV = 98%, PPV = 28.8% 
         b Sensitivity = 68.7%, specificity = 89.8%, NPV = 98.2%, PPV = 28.8% 
 
When compared reagent strip accuracy in detecting protein alteration at 2 cross 
(equivalent to 100 mg /dL) the reagent strip demonstrated a better sensitivity with 89.4 
% in comparison with 68.7% at “3 cross” (equivalent to 300 mg /dL), while specificity 
was higher with 89.9% at “3 cross” in comparison to 70.2% observed in “2 cross”. The 
negative predictive value didn‟t show alteration with 98.2% and 98% at 3 and 2 crosses 
respectively. 
 
The best cutoff value with higher sensitivity in detecting proteins in pandy test is at “2 
cross” for urine strip. The overall performance of the urine strip to evaluate results of 
pandy test was demonstrated via ROC. This is demonstrated via Fig. 4.3.  
 
 
 
 
 
 
 
 
 
Reagent strip Pandy positive Pandy negative  
2 crossa 17 42 
Negative  2 99 
3 crossb 12 15 
Negative  10 133 
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Fig. 4.3 the ROC to demonstrate overall performance of the urine strip to detect 
protein in pandy test  
ROC for urine strip protein measurement in Pandy test 
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      AUC 0.841, SE 0.0520, 95% CI [0.775 – 0.894], p <0.0001 
      Sensitivity: 73.68%, specificity 87.23 
 
 
The urine strip capacity to detect protein in comparison to pandy test which is the 
standard method at the Central Hospital of Beira, had an overall sensitivity of 73.68% a 
specificity of 87.23% and an  AUC of 0.841 with SE 0.0520 at 95% CI [0.775 – 0.894],  
p <0.0001. 
 
Urine strip protein alteration in bacterial meningitis 
 
Once it was established that the urine strip has the capacity to detect protein in the CSF 
and is comparable to local standard method. Sensitivity and specificity of urine strip 
protein in diagnosis of bacterial meningitis was calculated. A comparison of the two 
tests (urine strip and pandy) was made for diagnosis of bacterial meningitis. The table 
 
 
108 
 
4.13 demonstrated results of protein strip in children with and without bacterial 
meningitis. 
 
The table 4.16 demonstrates results of protein strip in children with and without 
bacterial meningitis.  
 
Reagent strip 
reading 
Bacterial 
meningitis n= 32 
No Bacterial 
meningitis n= 148 
Negative  3 32 
1 cross 4 72 
2 cross 3 29 
3 cross 16 10 
4 cross 6 5 
 
 
Table 4.17 Accuracy of the reagent strip to detect protein alteration in bacterial 
meningitis at different cut off points “2 cross” and at “3 cross”  
 
Reagent Strip  Bacterial 
meningitis n= 32 
No bacterial 
meningitis n= 148 
2 cross positivea 27 58 
Negativea 5 90 
3 crossb 24 22 
negativeb 8 126 
 
 aSensitivity = 78.12%, specificity= 70.27%, NPV= 93.7%, PPV= 36.2% 
 b Sensitivity = 75.0%, specificity= 85.1%, NPV= 94.03%, PPV= 52.1% 
 
When reagent strip accuracy in detecting protein alteration at 2 cross (equivalent to 100 
mg /dL) among children with bacterial meningitis was calculated, the urine reagent strip 
demonstrated a better sensitivity with 78.12 % in comparison to 75% at “3 cross” 
(equivalent to 300 mg /dL), while specificity was lower with  70.27 % at “2 cross” in 
comparison with 85.1% observed in “3 cross”. The negative predictive and positive 
predictive value were also lower at “2 cross” with 93.7% and 36.2% in comparison to “3 
cross”  with 94.03% and 52.1%. However the results of sensitivity were more important 
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in this case for early detection of bacterial meningitis and “2 cross” was used as best cut 
off value was used. 
 
Comparison of urine strip and pandy test for diagnosis of bacterial meningitis  
 
When CSF protein alteration in diagnosis of bacterial meningitis was compared  the 
urine strip demonstrated better sensitivity in comparison to pandy test. The table 4.15 
summarizes diagnostic performance results from table 4.5 and 4.14. 
 
     Table 4.18 Comparison of protein measures for reagent strip and pandy test for 
diagnosis of bacterial meningitis 
 
Protein Sensitivity % Specificity %   NPV %  PPV % 
CSF Pandy 
test  
      43.3     93.8  87.7  63.1 
Urine strip at 
2 cross 
     78.12     70.27  93.7  36.2 
 
The urine strip performed better with a sensitivity of 78.12% in comparison to 43.3% 
pandy test, the specificity was lower with 70.27 % in comparison to 93.8% in pandy test. 
The NPV of 93.7 % in urine strip was higher than of the pandy test 87.7% but PPV 
36.2% of urine strip was lower than the  63,1% observed in pandy test.  
 
We also compared the performance of the urine strip protein with pandy test for the 
diagnosis of bacterial meningitis with ROC curve. The fig. 4.4 demonstrates comparison 
of the two ROC for measurement of protein in diagnosis of bacterial meningitis  
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ROC comparing  2 method for protein measurement for diagnaois of bacterial meningitis  
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The Fig. 4.4 demonstrates comparison of the two ROC for measurement of 
protein in diagnosis of bacterial meningitis  
 
Comparison of the 2 ROC for the diagnosis of bacterial meningitis for protein alterations 
Sample size: 160 
BM: 30 
No BM: 130  
 
Table 4.19 Pairwise comparison of ROC for protein alteration in diagnosis of 
bacterial meningitis 
 AUC SEa 95% CIb 
Csf pandy test 0.797 0.0544 0.727 to 0.857 
Strip protein 0.673 0.0466 0.595 to 0.745 
a De long et al, 1998 
b Binomial exact  
 
Difference between the AUC 0.124, SE, 0.0549, 95% CI [0.0167 – 0.232], p = 0.0236 
 
 
As demonstrated via the pairwise comparison of ROC in fig 4.4 for urine strip protein 
has better performance in detecting protein alteration in bacterial meningitis in 
comparison to pandy test with a difference in the area of  0.124 with a SE, 0.0549 at 
95% CI [0.0167 – 0.232], p = 0.0236, which is statistically significant. 
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4.4.3 Glucose 
 
As there were no facilities present to measure the CSF glucose level, it was not 
possible to compare the urine dip strip glucose field with quantitative measurement. 
Therefore, only the connection between the dip strip reading and the diagnosis of 
bacterial meningitis was evaluated.   
 
Table 4.20 Frequency of glucose reagent strip results among cases of bacterial 
meningitis 
 
 
 
 
 
 
 
 
Sensitivity = 50% specificity = 87.8%, PPV = 47.06%, NPV = 89.04% 
 
Pearson chi square was tested among these categorical variables to test for 
independence. We observed a significant relationship between negative CSF glucose 
and bacterial meningitis, X2  (1, N = 180) = 24.58, p <0.0001 
 
Negative glucose was observed in bacterial meningitis patients and the strip 
demonstrated a sensitivity of 50% specificity of 87.8%, PPV of 47.06% and a NPV of 
89.04% 
 
4.4.4 Nitrate and density  
 
Both variables were tested however no correlation was possible with bacterial 
meningitis so they were excluded from the study. 
 
 
 
 
Reagent strip for 
glucose  
With Bacterial 
meningitis  
Without bacterial 
meningitis  
Negative 16 18 
Positive 16 130 
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4.5 The Cerebrospinal fluid gram stain results 
 
 
CSF gram stain was done in 180 patients. Among these 16 (8.9%) were considered 
positive and 144 (91.1%) were considered negative, however in 4 cases 
polimorphonuclear leucocytes were observed and in one active bacteria were observed. 
Among the 16 positive gram stain 1 (6.25%) was considered contaminated as CSF 
leucocyte and culture were both negative in this patient. 
 
Table 4.21 Accuracy of gram stain among culture positive bacterial meningitis  
 
 
 
 
 
 
Sensitivity = 82.35%, specificity= 98.77%, NPV= 98.17%, PPV= 87.5% 
 
Table 4.22 Accuracy of gram stain among (confirmed and probable) bacterial 
meningitis  
 
 
 
 
 
Sensitivity = 46.88%, specificity= 99.32%, NPV= 89.63%, PPV= 93.75% 
 
The gram stain in our study demonstrated a sensitivity among the culture positive 
bacterial meningitis of 82.35% in comparison with 46, 88% bacterial meningitis  
(Confirmed plus probable). While the specificity was 98.77 % and 99.32 % respectively. 
 
The most frequent microbial agents observed among the positive gram stain were 6 
(37.5%) gram positive diplococci, 5 (31.3%) gram negative bacilli, 3 (18.75%) gram 
positive cocci in clusters and 2 (12.5%) gram negative diplococci. 
 
Gram stain Culture positive 
bacterial meningitis  
Culture negative 
bacterial meningitis  
Positive 14 2 
Negative 3 161 
  
Gram stain With Bacterial 
meningitis  
Without bacterial 
meningitis  
Positive 16 1 
Negative 17 147 
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4.6 Cerebrospinal fluid culture results  
 
The 180 sample of CSF that were cultured only 17 (9.4%) were positive, 3 (1.6%) 
contaminated CSF was included in culture negative group. The sensitivity of culture 
among children with diagnosis based on clinical and other laboratorial parameters was 
17 (53.1%) specificity of 100% a NPV of 90.8% and PPV of 100%.  
 
Table 4.23 Accuracy of culture among all children with BM (confirmed and 
probable)  
 
 
 
 
 
 
 
           Sensitivity = 53.13%, specificity = 100%, NPV= 90.8%, PPV= 100% 
 
 
4.7 Other laboratory tests for evaluation of bacterial meningitis  
 
Blood culture were only done in 10 patients and only one person had a positive results 
who had septicemia. Because of a small sample size, blood culture findings were not 
considered in the statistical analysis. 
 
For detection of mycobacterium tuberculosis Ziehl Nielsen was performed in 15 cases 
and indian ink was for detection of Crypytococcus meningitis was performed in all 
patients. However for both test (Ziehl Nielsen and indian ink) results were negative 
therefore were not included in statistical analysis. 
 
The table 4.24  summarizes all the cases of bacterial meningitis and CSF characteristic. 
 
 
 
 
Culture  With Bacterial 
meningitis  
Without bacterial 
meningitis  
Positive 17 0 
Negative 15 148 
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Table 4.24 Summarizes the CSF characteristics of patients with bacterial 
meningitis 
** Not applicable as patient died 
 
 
 
 
 
PT ID CSF  
color 
CSF 
cell 
count 
Strip 
wbc 
Pandy Gram stain Culture  Neurologi
cal 
sequelae 
M001 Turbid 8 3+ + Lots of PMN        - No 
M006 Clear Missing 3+ + GN bacilli Positive No 
M013 Turbid  0 3+ -           -       - No 
M015 Clear  0 Neg - GN bacilli Positive Yes 
M022 Clear 125 2+ - GP diplococci Positive No 
M043 Clear 322 Neg - GN bacilli Positive No 
M044 Clear 58 Neg - GN bacilli Positive No 
M046 Turbid 
white 
304 3+ -           -      -   No 
M048 Clear 3 1 + - GP diplococci Positive         *** 
M056 Purulent 0 3+ +          -      - Yes 
M062 Clear 1020 3+ + GP diplococci Positive Yes  
M063 Purulent 4 3+ -         -      - No  
M071 Turbid 
white 
42 3+ -         -      - No 
M079 Clear 0 Neg - GP diplococci Positive No 
M080 Turbid 103 3+ + GP diplococci Positive No 
M086 Turbid 
yellow 
38 3+ + Bacteria 
observed 
No growth No 
M094 Turbid 323 2+ - GP diplococci No growth        *** 
M103 Turbid 111 3+ -         -       - Yes 
M104 Turbid  missing 3+ + GP diplococci Positive Yes 
M105 Turbid 1020 3+ +         -       - No 
M123 Turbid 1841 3+ -         -        - No 
M136 Purulent 575 3+ + Lots of PMN  No growth Yes 
M141 Clear 3 Neg +         - Positive No 
M154 Turbid  816 3+ - Lots of PMN      - Yes 
M157 Turbid  3 3+ - GP diplococci Positive No 
M159 Turbid 595 3+ Missing           -      - No 
M164 Clear 0 1+ -          - Positive Yes 
M172 Clear 0 2+ -          - Positive No 
M186 Turbid 125 3+ + GP diplococci Positive *** 
P01 Turbid 128 3+      +          -      -        *** 
P03 Clear 1 3+ + GP diplococci   Positive No 
P05 Purulent 1 3+ + GN bacilli Positive Yes 
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4.8 Laboratory parameters and imaging among children with BM 
 
The reagent strip was positive for leucocyte “trace” in 27/32 patients (84.4%). While the 
laboratory examination showed pleocytosis in thirteen patients (40.6%) only. 
The elevated CSF protein level was detected using the dip strip in 22 patients (68.75%) 
while pandy test was positive in 13 out of 30 (43.3%) with BM. The reagent strip for 
protein detection in comparison with pandy test, demonstrated better capacity of protein 
detection among children with BM. 
 
Culture results 
Among 32 children that had diagnosis of BM 17 (53.1%) had positive culture. The 
identified bacterial were: 
Streptococcus pneumoniae 5 /17 (29.4%) 
Staphylococcus aureus (2 catalase positive) 3 /17 (17.6%) 
Pseudomonas spp 3 /17 (17.6%) 
Neisseria meningitidis 2/17 (11.76%) 
Morganella morgagani 2/17 (11.76%) 
Proteus spp 1/17 (5.9%) 
Echerichia coli 1/17 (5.9%) 
 
Culture results and antibiotic use 
 
In order to understand the low detection rate of culture in diagnosis of bacterial 
meningitis and to observe if prior antibiotic had any effect we further analyzed the data 
for antibiotic use among culture positive and culture negative bacterial meningitis with a 
single antibiotic or a combination of 2 antibiotics. 
 
Combination therapy was given to 6/10 (60%): 
Ampicillin + ceftriaxone 1/10 (10%) 
Ampicillin plus gentamycin 1/10 (10%) 
Penicillin plus chloramphenicol in 4/10 (40%), 
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Single antibiotic was given to 4/10 (40%): 
Oral metronidazole 1/10 (10%) 
Ceftriaxone 1/10(10%) 
Penicillin G 2/10 (20%) 
 
We observed that out of 15 patients who had antibiotic prior admission 10 (66.6%) had 
culture negative BM. Among those who received antibiotics prior to admission therapy 
6/10 (60%) had received two antibiotic drugs. 
 
Among culture positive cases only 5/17 (29.4%) patients had antibiotic therapy. Most 
had oral therapy. One had received two doses of erythromycin, two patients were on 
cotrimoxazol prophylaxis and two children received parenteral antibiotic (1 x ampicillin; 
1 x ceftriaxone) with a dose each. 
 
Head ultrasound  
Ultrasound was done among 7 children with bulging fontanel, of which 4(57.4%) were 
normal and 3 (42.8%) were abnormal. One child was shown to have involvement of the 
ventricles and two children had dilated ventricles and hyperechogenity of the meninges. 
 
CT scan 
Only one patient with BM had a CT scan done which demonstrated signs of cerebral 
edema and later after 21 days signs of hydrocephalus. The other 10 CT results 
belonged to children with TB meningitis, and children who developed neurological 
sequelae.  
 
4.9 Treatment of bacterial meningitis in Central Hospital of Beira  
Most children with bacterial meningitis at admission had combination of antibiotics: 
Penicillin G alone was used in children above the age of 5 years and for < 5 years 
combination therapy was used: 
Penicillin G plus gentamycin in 3/32(9.3%)  
Penicillin G plus chloramphenicol in 3/32(9.3%) 
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Ampicillin plus chloramphenicol in 7/32 (21.8%) 
Ceftriaxone and ampicillin in 8/32 (25.0%) 
 
The rest of patients had a mono therapy with Penicillin 4/32 (12.5%) and 7/32 (21.8%) 
with ceftriaxone.  
 
4.10 Logistic regression analysis  
In order to create a predictive model for bedside diagnosis we did simple logistic 
regression analysis of all the signs and symptoms which were predictors of bacterial 
meningitis in our study. The table 4.22 summarizes all the variables used with 
unadjusted odds ratio. Only variable with p value < 0.02 were used in multilvariate 
logistic regression. 
Table 4.25 Simple logistic regression analysis for baseline characteristics that are 
predictors of bacterial meningitis  
Predictors BM 
 n= 32 (%) 
No BM 
n=148 (%) 
Unadjusted Odds 
ratio [ 95%CI] 
 
p- value 
Gender                            
Male                           
Female 
16(50) 
16(50) 
96(64.8) 
52(35.1) 
0.54 (0.25-1.70) 
1 
0.19 
 
Age  
0-2yrs  
>2 yrs 
16(50) 
16(50) 
49(33.1) 
91(61.4) 
1.85(0.85 - 4.03) 
1 
0.1175 
Predisposing conditions  
Pneumonia 
Yes 
No 
 
6(18.7) 
26(81.2) 
 
23(15.5) 
125(84.4) 
 
1.25 (0.46 -3.38) 
 
 
0.65 
Otitis media/ 
sinusitis/periorbital 
cellulitis n=8 
Yes 
No  
 
 
 
2(6.2) 
30(93.8) 
 
 
 
6(4) 
142(96) 
 
 
 
1.57(0.30 - 8.19) 
1 
 
 
 
0.58 
Undernourished  
Yes 
No 
 
6 (18.7) 
26(81.3) 
 
17(11.5) 
131(88.5) 
 
1.77 ( 0.64 to 4.93) 
1 
 
0.26 
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Table 4.26 Simple logistic regression analysis of clinical characteristics 
predictors of bacterial meningitis  
 
Predictors BM n= 32 
Number (%) 
No BM n=148 
Number (%) 
Unadjusted Odds 
ratio 
 (95%CI) 
p- value 
Fever 
Yes 
No 
32(100) 
0  
133(90) 
15 (10) 
******* **** 
Duration of symptoms 
0-48h 
>48h 
11(34.3) 
21(65.6) 
76(51) 
72(48.3) 
0.49 (0.22 - 1.10) 
1 
0.08 
Temperature 
< 38 
>38 
6(18.8) 
26(81.2) 
46(31) 
102(68.9) 
0.5.86 (0.19 – 1.32) 
1 
0.16 
Behavior change 
Yes 
No 
28(87.5) 
7(21.8) 
70(47.3) 
78(52.7) 
7.80 (2.60 - 23.34) 
1 
0.0002 
Vomiting 
Yes 
No 
21(65.6) 
11(34.4) 
58(39.1) 
90(60.8) 
2.96 ( 1.33 - 6.59)  
1 
0.0079 
Irritability 
Yes 
No 
25(78.1) 
7(21.9) 
122(82.4) 
26(17.6) 
0.76(0.29 -1.94)  
 
0.56 
Hepatosplenomegaly 
Yes 
No 
6(18.8) 
26(81.2) 
37(25) 
111(75) 
0.69 (0.26 -1.81)  
1 
0.45 
Bulging fontanel n=70 
Yes  
No 
6(19.3) 
25(80.6) 
30(79) 
8(21) 
0.62(0.17 - 2.18) 
1 
0.45 
Seizure 
Yes  
No 
27(84.3) 
5(15.6) 
128(86.4) 
 20(13.5) 
0.84(0.29 to 2.44) 
1 
0.75 
Severe coma 
Yes 
No 
10(31.2) 
22(68.8) 
44(29.7) 
104(70.3) 
1.07(0.47-  2.45) 
1 
0.86 
Signs of shock 
Yes 
No 
4(12.5) 
28(87.5) 
13(8.8) 
135(91.2) 
1.48(0.45 - 4.88) 
1 
0.51 
Photophobia 
Yes 
No 
11(34.4) 
21(65.6) 
30(20.3) 
118(79.7) 
2.06 (0.89 to 4.73) 
1 
0.08 
Headache n=115 
Yes 
No 
14(43.8) 
18(56.2) 
51(61.4)  
32(38.6) 
0.48 (0.21 - 1.11) 
1 
0.08 
Unable to feed 
Yes 
No 
19(59.4) 
13(40.6) 
62(41.8) 
86(58.1) 
2.02(0.93 - 4.41) 
 
0.07 
*Unable to calculate odds ratio as denominator is 0 
 
 
119 
 
Table 4.27 Simple logistic regression analysis of clinical characteristics 
predictors of bacterial meningitis cont. 
 
Predictors BM n= 32 
Number 
(%) 
No BM 
n=148 
Number (%) 
Odds ratio 
[ 95%CI] 
p- value 
Kernig sign 
Yes 
No 
12(37.5) 
20(62.5) 
15(10.1) 
133(89.9) 
5.32(2.17 -12.99) 
1 
0.0002 
Brudzinski sign 
Yes 
No 
14(43.8) 
18(56.2) 
21(14.2) 
127(85.8) 
4.07(2.03- 10.86) 0.0003 
Nuchal rigidity 
Yes 
No 
22(68.8) 
10( 31.2) 
56(37.8) 
92(62.2) 
3.61(1.59 - 8.18) 0.0021 
Opistotonus 
Yes 
No 
12(37.5) 
20(62.5) 
25(16.8) 
123(83.2) 
2.95(1.28 - 6.80) 0.011 
HIV status n=108     
Yes 
No 
6(26) 
17(74) 
20(23.5) 
65(76.5) 
1.14(0.39 - 3.30) 0.45 
     
 
The most important predictors for bacterial meningitis in our study were behavior 
change with an OR 7.80(2.60 - 23.34) P = 0.0002, vomiting was also a strong predictor 
with an OR 2.96 (1.33 - 6.59) P = 0.0079, Kernig sign OR 5.32 (2.17 -12.99) P= 0.0003 
for clinical features and for laboratory parameters specially urine reagent strip were: 
leucocyte from reagent strip at 10 cell OR 8.37(3.05 - 22.99) P < 0.0000, leucocyte from 
reagent strip at 100 cell OR (17.18(6.85 - 43.09) P < 0.0001, protein of reagent strip at 
100 mg/dl 8.40(3.40 - 20.95) P < 0.0001 and glucose from reagent strip  had OR 7.22 
(3.08-16.90) P <0.0001  
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Table 4.28 Simple logistic regression analysis of laboratory parameters 
predictors of bacterial meningitis  
  
Predictors BM n= 32 
Number 
(%) 
No BM 
n=148 
Number (%) 
Odds ratio 
 [ 95%CI] 
p- value 
Full blood count 
WBC n=169 
>10.000 
<10.000 
20(69) 
9(31) 
99(70.7) 
41(29.3) 
0.92(0.38 - 2.18) 
1 
0.85 
Thrombocytosis n=169 
Yes 
No 
13(44.9) 
16(55.2) 
38(27.1) 
102(72.9) 
2.18(0.95 - 4.95) 
1 
0.06 
CSF analysis 
CSF pleocytosis  n=168 
Yes 
No 
17(56.6) 
13(43.4) 
26(18.8) 
112(81.2) 
5.63(2.43 -13.03)   
1 
<0.0001 
CSF leucocytes at 100 cellls n=168 
Yes 
No 
14(48.3) 
15(51.7) 
9(6.5) 
130(93.5) 
13.48 (4.99 - 36.40) 
1 
< 0.0001 
CSF pandy test n=160 
Yes  
No 
12(40) 
18(60) 
7(5.4) 
123(94.6) 
11.71 (4.07-33.65 ) 
1 
< 0.0001 
CSF Gram stain 
Yes  
No 
15(50) 
16(50) 
1 
148(100) 
129.70(16.11 - 1044.07) 
1 
< 0.0001 
CSF Culture 
Yes 
No 
17(53.1) 
15(46.8) 
0 
148(100) 
*** ** 
Reagent strip analysis 
Strip leucocytes at “Trace”   
Yes 
No 
27(84.4) 
5(15.6) 
58(39.2) 
90(60.8) 
8.37(3.05 - 22.99) 
1 
< 0.0001 
 Strip leucocytes at 2 cross  
Yes 
No 
24(75) 
8(25) 
22(14.8) 
126(85.2) 
17.18( 6.85 - 43.09) 
1 
< 0.0001 
Reagent strip protein at 2 cross  
Positive 
Negative 
25(81.2) 
7(18.8) 
44(29.7) 
104(70.3) 
8.40( 3.40 - 20.95) < 0.0001 
Reagent strip glucose 
Negative 
Positive 
16(50) 
16(50) 
18(12.2) 
130(87.8) 
7.22(3.08-16.90) <0.0001 
*** Unable to calculate odds ratio as nominator is 0 
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Table 4.29 Multivariate logistic regression analysis for predictors of bacterial 
meningitis in children admitted in Central hospital of Beira  
 
 
 
          Predictors    Odds ratio 95%CI                p- value 
Behavior change       7.80(2.60 - 23.34)                0.0002 
Vomiting       2.96(1.33 - 6.59)                0.0079 
Kernig sign       5.32(2.17 - 12.99)                            0.0002 
Brudzinski sign       4.07(2.03 - 10.86)                0.0003 
Nuchal rigidity       3.61(1.59 - 8.18)                0.0021 
CSF pleocytosis        5.63(2.43 -13.03)                0.0001 
Strip leucocyte at “Trace”       8.37(3.05 - 22.99)              <0.0001 
Strip leucocyte at “2 cross”       17.18(6.85 - 43.09)              <0.0001 
Strip protein  at “2 cross”       8.40(3.40 - 20.95)              <0.0001 
Strip glucose negative       7.22(3.08 - 16.90)              <0.0001 
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Table 4.30 Possible clinical strategy for bed side diagnosis of bacterial meningitis using different clinical and laboratory 
predictors of urine reagent strip 
 
   Clinical model 
 
Sensitivity   % 
95% CI 
 
Specificity % 
95% CI 
 
PPV  % 
95% CI 
 
NPV % 
95% CI 
 
Overall 
prediction 
value 
 
AUC 
95% CI 
Model 1 
Fever  
Behavioural change  
Nuchal rigidity 
Strip leucocyte “Trace”  
 
 
58.62 
(38.9 -  76.48) 
 
 
90.07 
(84.15 -  94.3) 
 
 
53.1  
(34.7 -  70.9) 
 
 
91.89 
(86.27 -  95.7) 
 
 
85% 
 
 
        0.857 
(0.797 -  0.905) 
Model 2 
Fever 
Kernig sign 
Brudzinski signs 
strip leucocyte  2 ++  
Strip protein  2 ++  
strip glucose negative 
 
 
72 
 
(50.6 -  87.9) 
 
 
90.9 
 
(80.3 -  94.9) 
 
 
      56.2 
 
(37.6 -  73.6) 
 
 
95.2 
 
(90.5 -  98.08) 
 
 
 
88.3 
 
 
     
 
      0.854 
(0.793 -  0.902)  
Model 3 
Fever 
Altered mental status  
nuchal rigidity  
strip leucocyte  2 ++ 
strip protein 2 ++ 
strip glucose negative 
 
 
72 
 
(50.6 -  87.9) 
 
 
 
 
90.9 
 
(80.3 -  94.9 
 
 
       56.2 
 
(37.6 -  73.6 
 
 
95.2 
 
(90.5 -  98.08) 
 
 
88.3 
 
 
      0.854 
(0.793 -  0.902)  
Model 4 
Fever  
Strip leucocyte at trace 
Strip protein  2 ++ 
Strip glucose negative 
 
 
67.86 
(47.6 -  84.12) 
 
 
 
91.4 
(85.8 -  95.37) 
 
 
 
59.3 
(40.4 -  76.3) 
 
 
 
93.9 
(88.7 -  97.18) 
 
 
 
87.8 
 
  
 
      0.835 
(0.77 -  0.86) 
Model 5 
Fever  
Strip leucocyte at 2 ++ 
Strip protein  2 + 
Strip glucose negative 
 
73.91 
(51.9 -  89.77) 
 
90.45 
(84.7 -  94.55) 
 
 
53.1 
(34.7 -  70.9) 
 
 
95.9 
(91.39 -  98.5) 
 
 
88.3 
 
       0.874  
(0.816 -  0.918 
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Based on the most important predictors for BM we did a multivariate logistic regression 
analysis with variable including clinical and urine reagent strip results. 
Model 5 based on fever, strip leucocyte at 2 cross, protein at 2 cross and strip glucose 
as negative tailored for early diagnosis is the best model which had a sensitivity of 
73.91 % which is far from ideal. However we were most interested in specificity and 
which was 90.45% and the overall prediction values which gives percentage of cases 
correctly identified. In the 5th model the overall prediction value was of 88.3% and it is 
the simplest model and is the best model for the early diagnosis.  
 
4.11 Cerebral malaria and menigoencephalitis  
 
In order to differentiate between cerebral malaria, meningoencephalitis and bacterial 
meningitis we compared the mean of CFS wbc and age using t test for independent 
sample.  
Table 4.31 T test for mean of age, csf wbc, csf neutrophil and csf lymphocyte for  
independent sample in  cerebral malaria and meningoencephalitis 
  
  Cerebral malaria n = 21            Meningoencephalitis n = 48 
 Mean  SD 95% CI  P 
value  
Mean  SD 95% CI P value 
Age  
months 
47.8 39.8 29 - 65.9 <0.001 61 50 46.5-75.7  0.04 
CSF 
WBC/ul 
22 75.8 12.5-56.5 <0.001      66 224 3.3 -136 <0.001 
CSF 
Neu % 
13.7 31.6 0.6 - 28.1 <0.001 12 27 3.3 - 20.6 <0.001 
CSF 
Lym %  
5.2 16.6 2.3 - 12.8 <0.001 9.4 24 1.9 - 16.9 <0.001 
 
When mean of age, CSF WBC, CSF neutrophils and lymphocytes were evaluated using 
t test for independent sample. A difference in CSF cell count and age is observed 
among the two groups (cerebral malaria and meningoenecephalitis). However, this 
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difference in the mean of CSF cell count observed between the 2 sample of 40.13, 95% 
CI [54.5317 to 134.8026] when tested for statistical significance,  the cell count in 
malaria though was lower than menigoencephalitis it was statistically insignificant  t(67) 
= 0.846, p=0.40 , so they were not included in the study and a differentiation between 
these 2 group was not possible. 
Due to lack of gold standard for diagnosis of meningoencephalitis the reagent strip 
performance in meningoencepahlitis was not calculated only difference among CSF 
WBC was evaluated among children with bacterial meningitis and meningoencephalitis. 
 
The figure 4.5 below demonstrated the difference between the 2 groups (Cerebral 
malaria and meningoencephalitis)  
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The figure 4.6 below demonstrated the difference between the 2 groups in CSF wbc 
(Bacterial meningitis and meningoencephalitis)  
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5. Discussion  
 
Bacterial meningitis is a life threatening disease. Prompt diagnosis and treatment are 
important predictors of patient outcome. Many studies have been done in attempt to 
diagnose bacterial meningitis using simple methodology based on clinical signs and 
symptoms to very complex and expensive tests such as latex agglutination tests, real 
time PCR and cytokine levels for evaluation of CSF to aid diagnosis of bacterial 
meningitis.  
 
In resource limited areas most of these tests are not available and diagnosis can be 
very difficult. Often the doctor finds themselves in dilemma when dealing with 
unconscious child with no laboratory resources and with high burden of malaria in most 
African countries. Clinically it is almost impossible to distinguish bacterial meningitis 
from cerebral malaria or meningoencephalitis, thus clouding the decision to start 
antibiotic or not. In these cases physicians feel pressured to start empirical antibiotic 
therapy thus using already little resource that is available in these areas. 
 
Many studies have attempted differential diagnosis between bacterial and viral 
meningitis based on CSF parameters like leucocyte count, protein and glucose 
concentration cutoff points and have come up with various models (Bonsu and Harper, 
2004, Karanika et al., 2009, Águeda et al., 2013). However many of these models have 
been created using laboratory analysis and patients from developed countries where 
prevalence of bacterial meningitis is lower (Thigpen et al., 2011). 
 
Bonsu and Harper in their study predicted a model based on CSF pleocytosis which 
used age, CSF WBC count , CSF protein concentration and CSF neutrophil percentage 
and with those results came up with a very accurate model that predicted bacterial 
meningitis in 80 % of cases (Bonsu and Harper, 2004). But Bonsu and Harper in their 
model, excluded CSF with low WBC. The normocellular bacterial meningitis is observed 
among very ill children. It is commonly observed among children with some 
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immunosuppression and systemic complications (Brouwer et al., 2010). Freemont Smith 
also presented in his study that 1 % of patients with bacterial meningitis had CSF cell 
lower than 100 cell count (Merrit and Fremont-Smith, 1938). 
The ideal test for diagnosis of bacterial meningitis should have a 100% sensitivity and 
100 % specificity to determine diagnosis of BM and not to miss any case. However no 
single test till today has shown to be 100% sensitive and 100% specific, warranting that 
clinical and laboratory parameters need to be evaluated together for the diagnosis. 
Many studies have used urine reagent strip for diagnosis of meningitis (Moosa et al., 
1995, Parmar et al., 2004) with different sensitivities and specificities, however, our 
study seems to be the first that has attempted bedside diagnosis algorithm for diagnosis 
of BM using urine strip.  
 
The main objective of our study was to test sensitivity and specificity of the reagent strip 
among children that were admitted in Central Hospital of Beira and based on the results 
try to establish a bed side diagnostic algorithm using reagent strip to differentiate among 
children with meningitis or not and those who require antibiotic treatment from those 
who do not require. 
 
Findings of the study 
In our study the prevalence of 17.7 % bacterial meningitis was observed among children 
admitted in the study. The diagnosis of bacterial meningitis in the study included both 
confirmed and probable cases. When we compared the prevalence among culture 
positive cases our study demonstrated a lower prevalence with 9.4%, which was very 
low in comparison to 15% that was observed in a study done in Manhica district in 
Mozambique (Sigauque et al., 2008). When the prevalence was compared to the results 
from Maputo Hospital our study had a slight lower prevalence for culture positive cases 
with 9.4% in comparison to 13.8% of culture positivity observed in Maputo (Zimba et al., 
2009). The study from Maputo included patients of different age groups, neonates to 
adults, including HIV and AIDS patients, which were excluded in our study this could 
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partially explain the lower prevalence. There was no gender difference observed in our 
study as referred by (Sigauque et al., 2008) in his study. 
 
The lower culture positivity in our setting could be explained by lower detection rate of 
microbes in our minimally equipped laboratory. The laboratory‟s working hours are one 
major drawback. It has been known that the delay in analysis decreases the survival of 
bacteria like N. meningitis and lowers the detection rate (WHO,2011). The other 
important factor that could explain lower sensitivity is the use of antibiotic prior lumbar 
puncture (Brouwer, 2010). Among children admitted with diagnosis of BM. A 46.8% 
were already on treatment prior admission which could explain the lower detection rate. 
In his review Brouwer referred sensitivity of culture in developed countries is higher and 
ranges from 75%-85% when compared to developing countries like Brazil with 67%. 
Antibiotic use as an added effect could lower detection to below 50% (Sáez-Llorens and 
McCracken, 2003). Especially in meningococcal meningitis the CSF sterilization can 
occur as early as 2 hours after administration of a single dose of third generation 
cephalosporin‟s (Kanegaye et al., 2001). 
 
When we further analyzed our data we observed that among culture negative BM 10/15 
(66.6%) had parenteral therapy, of these 10 (66.6%) who had antibiotic 6 had combined 
therapy which explains why turbid and purulent CSF were culture negative and the 
lower sensitivity of the gold standard . 
 
The most common pathogens observed in our study were Streptococcus pneumoniae 
with 29.4%, Neisseria meningitidis 11.76%. This is significantly different than observed 
in other studies done in Mozambique. Both studies from Mozambique were done in 
Maputo and demonstrated very different results. The study from Manhica district 
demonstrated that overall the three main pathogens S.pneumoniae, H.influenazae and 
N.meningitidis all together accounted for 73% of all cases (Sigauque et al., 2008). While 
our study from Hospital patient‟s demonstrated very low frequencies of S.pneumoniae 
with 4.8%, and N.meningitidis in 5.4%. 
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We did not find any Haemophilus Influenzae in our study. This fact could be due to the 
vaccination program that has been established in the country since 2010. The study 
done in manhica district which compared Haemophilus Influenzae  disease in children 
before and after vaccine introduction demonstrated significant reduction from 91% - 
85% in invasive cases of hemophilus (Sigauque et al., 2013) However, we also had 
8/20 (40%) of very turbid CSF where no growth of bacteria was observed. Further 
analysis with PCR may give more information. 
 
Staphylococcus aureus in CSF culture may be contaminant. It was observed in 2 cases 
in our study. One patient had severe malnutrition and suppurated otitis media at 
admission with altered mental status and the other developed meningeal symptoms 
post femur fracture. The first patient later developed S.aureus from pus from the ear. 
Both cases in the study were more likely due to infection outside CNS and one post 
trauma, both conditions have been also documented by (Pedersen et al., 2006) and due 
to clinical features that were compatible with meningitis it was less likely to be 
contaminant. 
 
Other very interesting pathogen in our study was Morganella morganii seen in 2 patients 
M 043 and M 044. Both patients were admitted at more or less the same time. One 
patient with 36 months of age showed slight CSF wbc count elevation with 322 with 
98% lymphocytosis and a negative pandy test. He was admitted initially with diagnosis 
of cerebral malaria due to opisthotonus, lumbar puncture was done to exclude BM. 
 
The second patient was 11 years old with a positive HIV test. He was also initially 
admitted with diagnosis of cerebral malaria with high parasitemia and developed 
hemoglobinuria and respiratory distress due to non cardiogenic pulmonary edema. This 
is a severe complication of malaria which is frequent among adults but has also been 
observed in immunosuppressed children with HIV (Hendriksen et al., 2012).  
Both morganella cases were observed in children with cerebral malaria who were 
already admitted in the ICU and lumbar puncture in both cases was done at 40 h and at 
48 h, both patients were on artesunate therapy and antibiotic was later added due to 
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their worsening condition. We suspect that both cases may have been acquired 
nosocomiallly or were contaminants. However definitive conclusion cannot be made. 
 
Morganella morganii is caused by gram negative rod is known as an opportunistic 
infection. There is very little in literature on morganella infections most of information is 
found in isolated cases (O'Hara et al., 2000). There has been reports of a neonatal 
sepsis (Dutta and Narang, 2004) case with fatal sepsis. A case of meningitis in an adult 
patient with stage IV Hodgkin disease which developed the meningitis via 
hematogenous from urinary tract (Samonis et al., 2001) and a case of nosocomially 
acquired meningitis with morganella in a cardiosurgurgical centre (Williams et al., 1983). 
In a report by William et al most of  the patients that had morganella infection the source 
of detection was blood, wound, urine, feces and only 2 cases were found in 
nasopharyngeal secretion and sputum (Williams et al., 1983). 
 
Most frequent presenting signs and symptoms among children with bacterial meningitis 
were: Severe coma: 14/32 (43.8%), seizures 27/32 (84.4%) which was slightly higher 
than reported in other studies (Berkley et al., 2001, Sigauque et al., 2008). This could 
be explained by the fact that (51.7%) of the patients came very late to the hospital with 
more severe signs and symptoms. In fact 20 children who were later admitted in the 
hospital had already one episode of seizure that was reported by one of the parents at 
home and sought medical treatment in nearby health center who were discharged with 
diagnosis of febrile seizure prior admission with either antibiotic or antimalarial 
treatment and came rather later to the hospital when patient‟s condition became worse. 
 
Broad spectrum antibiotic use was found in 43% of admitted children. This is 
significantly higher than 11% reported by Roca (Roca et al., 2009). But this information 
is not surprising, antibiotics are easily available in local pharmacies and prescription is 
usually not required. An additional effect to this point is that almost 48% of the children 
in our study already had been seen by a health worker with complaint of fever who were 
treated with either antimalarial in case of positive malaria test or antibiotic in case of 
negative malaria test.  
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Other clinical features observed were signs of shock at admission (12.5%) agitation 
(37,5%), nuchal rigidity (68.8%), Brudzinski sign (43.8%), Kernig (37.5%) and 
opisthotonus (37.5%). Similar findings were observed for nuchal rigidity (Berkley et al., 
2001) for coma (Berkley et al., 2001), agitation was slightly higher in report of Manhica 
study (Sigauque et al., 2008), brudzinski sign and kernig as meningeal sign was slightly 
lower as reported in study by (Karanika et al., 2009). 
 
Headache was observed in 13 (40.6%), behavior change in 28 (87.5%), irritability 25 
(78.11%) and 19 (59.4%) were unable to feed or eat and symptoms duration varied 
among children with BM: 9 (28.1%) had symptoms less than 24 hours, 2 (6.2%) 
between 24-48 hours and 21 (65.6%) had symptoms for more than 72 hours prior 
admission. Other sign tested among children with BM was photophobia which was 
observed in 11 (34.4%). 
 
Overall sequelae among children with BM was 28.1%. Which is significantly high and 
similar findings were observed in many low income countries (Edmond et al., 2010b). 
The most common type of sequelae found was seizure (12.5%), minor motor deficit 
(9.1%), and cognitive impairment (9.1%). These findings were similar as reported in 
systematic review and meta-analysis by Edmond et al. Major motor deficit like 
quadriplegia and hemiplegia was observed all together in (12,5%). Hearing loss was not 
frequently observed. These findings differ slightly from (Edmond et al., 2010b), but our 
sample with BM was rather small and besides we had very heterogeneous population of 
microorganism. 
 
Use of reagent strip for BM 
 
When we compared the accuracy of reagent strip leucocyte‟s capacity to detect CSF 
wbc alterations we noted that at “trace” (>15 cells/ul) and at 2 cross (>125cells/ul) the 
accuracy was similar with 0.72, however the sensitivity, specificity, NPV and PPV were 
different with higher sensitivity for 10 cell cut off point. We found sensitivity of 86 %, 
specificity of 68%, NPV 93.4%, PPV of 48% Sensitivity in our study was higher than 
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observed in study done in Brasil , but they had better specificity and NPV (Sudbrack et 
al., 2004). However, Mossa et al achieved a sensitivity of 97 % for diagnosis of bacterial 
meningitis based on use of urine strip and a specificity of 100 %. This could be 
explained that the standard laboratory facilities were of high standard and were 
immediately analyzed reducing false negative (Moosa et al., 1995).  
 
When we used “2 cross” as cutoff point results were as follow: sensitivity of 82.6%, 
specificity of 84.7%, NPV of 96.3%, PPV of 46.3% which were rather similar with those 
presented by Simone et al. using “trace” as cutoff point for the CSF alteration had rather 
good accuracy. However in bacterial meningitis the CSF cell count usually is above 100 
cell (Prober, 2007) because using a lower cut would increase false positives a cut off of 
“2 cross” was used . 
 
We further tested the accuracy of reagent strip leucocyte in detecting BM and compared 
with CSF wbc and we observed that the reagent strip performed better than standard 
CSF wbc. Sensitivity of the reagent strip in detecting BM was higher with 73.3% in 
comparison with CSF wbc of 56.7% and so were the specificity at 85.14%, NPV at 
94.3% and PPV of 50.89% in comparison to CSF wbc at 81.8%, 89.6% and 39.53% 
respectively. This information reflects the poor quality of laboratory results which are 
common in developing countries, (Petti et al., 2006) due to various factors delay in 
analysis can reduce CSF wbc by 32%, not centrifuging accordingly (Steele et al., 1986) 
and inexperienced laboratory technicians (Petti et al., 2006). 
 
We compared the protein from reagent strip and compared with pandy test a semi 
quantitative test that measures globulins (Cheesbrough, 2009). When we calculated the 
best cutoff point for protein detection and for detection of BM we found that 100 mg /dl 
in reagent strip was the best cutoff point. However we did not find any literature that 
made similar comparison with pandy test.  
Many studies have demonstrated comparison of reagent strip and CSF total protein 
(Moosa et al., 1995, Sudbrack et al., 2004). As this test was not available we compared 
with local available results. 
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We found a sensitivity of 89.4%, a specificity of 70.2%, a NPV of 98%, a PPV of 28.8%. 
When we compared the pandy test reaction against urine reagent strip protein with 
overall accuracy of 0.69 which was rather good in comparison with 300mg/dl. Using 
300mg/dl cutoff point many cases with protein above 100mg/dl would be missed.   
 
When compared the reagent strip protein alteration among children with BM against the 
pandy test detection for alterations in BM. The strip performed better with a sensitivity of 
78.12%, specificity of 70.27%, NPV of 93.7%, and PPV of 36.2% in comparison with 
43.3%, 94.62%, 87.2 %, and 63.1% respectively. 
This results can be explained because a positive pandy test is slight or minimum when 
the concentration of CSF protein is below 200 mg/dl giving a slight turbidity which 
disappears within seconds and may give false negative results (Cheesbrough, 2009). 
 
Bedside clinical model for prediction of bacterial meningitis 
 
After analysis with different variable observed in our study that were significant in 
univariate anlaysis we choose: behavior change with an OR 7.80 (2.60 - 23.34) P = 
0.0002, vomiting which had an OR 2.96 (1.33 - 6.59) P = 0.0079, Kernig sign though not 
often seen among younger children was a strong predictor with an OR 5.32 (2.17 -
12.99) P= 0.0003 for clinical features. For laboratory parameters based purely on urine 
reagent strip results which were: leucocyte from reagent strip at “Trace” OR 8.37(3.05 - 
22.99) P < 0.0000, leucocyte from reagent strip at “2 cross” OR (17.18(6.85 - 43.09) P < 
0.0001, protein of reagent strip at “2 cross” 8.40 (3.40 - 20.95) P < 0.0001 and glucose 
negative from reagent strip had OR 7.22(3.08-16.90) P <0.0001. 
 
When we predicted clinical model via multiple logistic regression for patients bedside 
diagnosis using reagent strip we observed that the simplest model using 4 variables : 
fever with positive leucocyte reaction on the reagent strip at “2 cross” a positive protein 
reaction on the reagent strip at “2 cross” and a negative glucose reaction had a 
predicted sensitivity of 73,91%, a specificity of 90.45% a NPV 95.9% a PPV of 53.1% 
with an overall prediction of 88.3% in accurately predicting bacterial meningitis. 
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Though many clinical algorithms have been published like Spano‟s model, Hoen‟s 
model and one most recent publication from Angola (Lussiana et al., 2011) who in her 
work has used simplified predictor for low resource limited contexts, but none could be 
applied to our patients in Beira, simply because all of the models mentioned above have 
used laboratory parameter like CSF cell count, CSF total protein count and glucose 
concentration. The last two are not analyzed in our setting which is a Central Hospital. 
One can imagine how difficult or it is almost impossible to apply in health centers in 
districts where laboratories are minimally equipped. Moreover all these models heavily 
rely on accuracy of laboratory technician work and prompt analysis of CSF.  
 
Most health center and hospital‟s laboratory only work till afternoon and lumbar 
punctures done after these hours either are analyzed in emergency laboratory (rural 
district and central hospital have these laboratories) which only performs pandy test and 
CSF wbc and results may only be available after 3-4 hours depending on workload 
(authors‟ observation and informal interview with colleagues from districts). 
 
To overcome this major drawback we had to use alternatives that could be applied to 
our context so we tested urine reagent strip applicability in BM. Our predictive model 
though has lower sensitivity with 73.91% for diagnosis of BM it has a very high 
specificity and NPV which in our context is very useful. 
 
Sensitivity which defines proportion of people who have positive test that have the 
disease and specificity which defines proportion of people without disease will test 
negative (Akobeng, 2007) Which is more useful in our context? We already know that 
between 100-500 wbc cell count in CSF can also be observed among children with 
meningoencephalitis, (Prober, 2007) overlapping among this range is common and 
based on cell count alone for this particular range it is almost impossible to differentiate 
between these 2 diseases. However, when the test is negative (specificity) which in our 
case is 95.3%, can rule out the disease in 95.3% of controls thus avoiding unnecessary 
treatment. In decision making, on when to introduce antibiotics and stimulate decision of 
other diagnosis. In context of children with cerebral malaria it is almost impossible to 
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distinguish from bacterial meningitis a simple test at bed side can help in doing 
differential diagnosis. 
 
Negative predictive value is also another important result in our model because its NPV 
of 95.9%. NPV defines the proportion of people with negative test that do not have the 
disease (Akobeng, 2007), in our model could predict that 91.6% would be disease free 
when all the predictors in model are negative or in other words it would miss 9.4% of 
cases of BM alone. However NPV is dependent on population prevalence (Akobeng, 
2007), as this study was performed in Beira for a period of 15 months one can estimate 
that this prevalence is more or less accurate and could be applied to our context in 
Beira. 
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6. Conclusion 
 
Our results confirm that reagent strip has good sensitivity and specificity in 
differentiating whether a child has meningitis or not. It can aid physician in decision 
making. Though many studies have used reagent strip and have shown different test 
performance and some authors have also recommended (Parmar et al., 2004) as a 
screening test, in areas where other diagnostic possibilities are difficult. It can be used 
as the urine strip has a good sensitivity (Romanelli et al., 2001). To conclude reagent 
strip has shown better performance in diagnosis of BM comparing the results with 
standard laboratory analysis available in our setting. It is necessary to use this test 
where no laboratory is available to guide decision making. However the test also has its 
limitation and can miss cases of normocellular BM or reading can be altered if 
necessary condition of storage are not followed. In cases of bloody or accident in 
lumbar puncture the color change in test pad can be altered giving false positive results 
in some cases. In these cases caution needs to be taken when interpreting results, 
most important is the clinical judgment that will dictated final decision making. 
 
 
7. Limitation 
 
Limitation of the study 
 
The main limitation of the study was the minimally equipped laboratory in the Central 
Hospital of Beira which lack of good “Gold standard” the CSF WBC and CSF culture. 
Another limitation was some missing data in CSF wbc and pandy test results from the 
hospital which affected the results of the study. 
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Limitation of the urine reagent strip 
  
One major limitation is that the urine reagent strip‟s semi quantitative test pads are not 
standardized for CSF parameters and this makes it slightly challenging. For example  
the minimum glucose detection capacity of reagent strip is at 100mg/dl and is negative 
when at 30 mg/dl . These values are very different from standard CSF glucose values 
and thus difficult diagnosis. The same condition is applied on protein. A reagent strip 
which would have a better cut off values standardized for CSF parameters could 
potentially benefit and could show different results. 
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Appendice 1 
 
Ethical consent form 
 
Study Number      
 
 Consent form 
 
Name of the Principal Investigator : Dr. Kajal Dhirajlal Chhaganlal 
 
Name of the Orgnization : Ministry of Health , Central Hospital of Beira 
 
Names of Parteners : Catholic University of Mozambique , Faculty of Health Sciences- Beira 
 
       Ludwig Maximillians University – Munich 
 
 
Information: 
 
We are working for the Ministry of Health of Mozambique in Central Hospital of Beira. We are 
studying a new method for the diagnosis of meningitis at patient‟s bedside. 
 
You / your child ( dependent) has a suspicion of a disease called Meningitis, and your 
condition is such as to confirm the diagnosis , it needs a test which is called lumbar puncture , 
which extracts cerebrospinal fluid from the lumbar region for analysis for meningitis . 
 
The study aims to use urine reagent strip to look for changes of cerebrospinal fluid chemistry 
and compare with the conventional method which uses biochemistry machines and culture of 
cerebrospinal fluid for analysis, methods that usually takes 30 min to 48-72 hours, 
respectively, compared with reagent strip that usually takes less than 2 minutes to obtain 
results . However the aim of the study is to evaluate the performance (sensitivity and 
specificity) of the urine reagent strip for a rapid diagnosis of meningitis at the patient‟s   
bedside. To find the answer to this important question, we're doing this study in 202 children 
in this hospital, to better respond to our question. The result of the study will improve our 
knowledge about the use of reagent strip as a quick means of diagnosis and help develop an 
appropriate strip for spinal fluid that could be used in Mozambique and other countries and 
may benefit society in general. 
 
You / your child will perform all tests and receive all the supportive treatment for meningitis 
according to the guideline of diagnosis and treatment of meningitis in our hospital. In the 
case of not accepting to participate in the study if there is an indication for lumbar puncture 
by attending doctor it will be done for diagnostic purpose independent of participating in the 
study. 
 
Participation in the study signifies permission for the use of cerebrospinal fluid for further 
analysis. 3ml of cerebrospinal fluid will be drawn from patient. Out of which 5 drops for the 
examination of urine reagent strip and 0.5- 1ml will be stored for PCR and Cytokines analysis, 
which will be held in Ludwig Maximillians University in Munich, for better study of the type of 
microorganisms, especially in cases of encephalitis for which we have no means of diagnosis 
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in our Hospital. The rest of liquor will be sent to the central laboratory of the Hospital for 
routine analysis of meningitis. Besides the cerebrospinal fluid, the attending physician may 
order other exams such as full blood count, HIV Test, X-ray , CT and other tests .These are 
not part of the study, but the results will be recorded in the patient's file and kept in 
confidential. 
 
The expected duration of the study for the participant is from now until the time of discharge. 
Starting now with an interview and examination of the child which takes less than 30 minutes 
and child‟s evaluation at regular intervals until discharged. There will be no financial cost to 
participate in this study and no payments for yourself or your child. We will keep all records in 
a locked place and use the information solely for the purpose of the study. 
 
If you or your child does not wish to participate in the study, their refusal will not affect your 
/(your child/ dependent) diagnosis and treatment decision. You will benefit of all facilities 
available in this center. 
 
You (or your child) may stop participating in this research at any time you want, without losing 
your rights as a patient. 
 
If you have any question, You may do it now or in later stage or if you want to ask more 
questions in a later stage you can contact Dr. Kajal D Chhaganlal: 825643910 or Dr. 
Ermelinda Gomes: 825010098 
 
This proposal was reviewed and approved by the National Ethics Committee of 
Mozambique. The committee has the task of ensuring that research participants are 
protected from harm. 
 
Certificate of Consent 
For this particular test the patient _________________________________ or guardian 
(Mr/Mrs) ______________________________________________, hereby, for all legal 
purposes,declares giving full permission to the attending physician, to proceed with  
necessary investigations for the diagnosis of meningitis, and execute the designated exam 
"lumbar puncture" and use of cerebrospinal fluid for the diagnosis of meningitis.  
 The above procedure was explained to me and hereby I authorize. 
Lumbar puncture is performed to examine the cerebrospinal fluid (CSF), especially in 
suspected meningitis (to confirm or rule out this hypothesis). 
 
COMPLICATIONS and GUIDELINES: 
1. The pain that accompanies the lumbar puncture procedure is similar to that of blood 
collection for examination. 
2. After undergoing lumbar puncture the child should remain at rest on his stomach in supine 
position for a few hours. Despite this care approximately 10% of these people, may 
experience headache. If the child has this headache, he /she should have absolute rest for 
48 hours straight, lying, preferably in the facedown position, taking plenty of water and other 
hydrating beverages according to medical indication. 
3. After collection of cerebrospinal fluid in the lumbar region it may occur, in addition to 
headache at the puncture site slight pain but rarely infection. 
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I declare that I have received all the necessary and clear information from the study doctor 
on study methodology, risks and benefits.  I had the opportunity to ask questions and they 
were answered satisfactorily. I have access to the full text and of all the terms of ethical 
consent form shown by the study doctor. 
 
I declare that i have thoroughly been informed of the present risks that are posed due to 
procedure and of any complication that may arise with the disease. I also confirm that i have 
understood well all the information provided to me. 
 
After all the clarifications and having read and understood all the information on this document, 
of the procedure and the use of cerebrospinal fluid for use on reagent strip and other 
Laboratory analysis, I give my, CONSENT for performing the above mentioned procedure 
which was indicated by attending physician and extend the same consent to his other team 
members. 
 
 
Beira, _____________ of _________________ of _________________ 
 
 
Signature of patient‟s guardian                                                               Degree of Kinship 
 
 
If you do not know how to read or write: 
Type the name of literate witness (selected by patient or responsible child) 
 
Name of the witness                                                         Signature of the witness 
 
 
     
Date        /           /______                                                Date        /____/______           
 
    
 
Full name of the doctor  ....................................................................... Date ___/___/_____ 
Signature of the doctor  ........................................................................ Date ___/___/_____ 
Full name of principal investigator ........................................................ Date ___/___/_____ 
Signature of the principal investigator .................................................. Date ___/___/_____ 
 
 
 
 
 
